Document:

SWK
HOLDINGS CORPORATION

 

and

 

SWK FUNDING
LLC,

 

as Borrowers,

 

 

LOAN AND
SECURITY AGREEMENT

 

Dated June 29,
2018

 

$20,000,000.00

 

 

CERTAIN FINANCIAL
INSTITUTIONS,

 

as Lenders

 

and

 

STATE BANK
AND TRUST COMPANY,

 

as Agent

 

 

    	 

     

    

TABLE
OF CONTENTS

Page

 

	SECTION  1.   DEFINITIONS; RULES OF CONSTRUCTION	1
	1.1   Definitions	1
	1.2   Accounting Terms	27
	1.3   Uniform Commercial Code	27
	1.4   Certain Matters of Construction	27
	SECTION  2.   CREDIT FACILITIES	28
	2.1   Revolver Commitment	28
	2.2   [Reserved]	30
	SECTION  3.   INTEREST, FEES AND CHARGES	30
	3.1   Interest	30
	3.2   Fees	31
	3.3   Computation of Interest, Fees, Yield Protection	31
	3.4   Reimbursement Obligations	32
	3.5   Illegality	32
	3.6   Inability to Determine Rates	32
	3.7   Increased Costs; Capital Adequacy	32
	3.8   Mitigation	33
	3.9   [Reserved]	33
	3.10   Maximum Interest	33
	SECTION  4.   LOAN ADMINISTRATION	34
	4.1   Manner of Borrowing and Funding Revolver Loans	34
	4.2   Defaulting Lender	35
	4.3   [Reserved]	36
	4.4   Borrower Agent	36
	4.5   One Obligation	36
	4.6   Effect of Termination	36
	SECTION  5.   PAYMENTS	36
	5.1   General Payment Provisions	36
	5.2   Repayment of Revolver Loans	37
	5.3   Payment of Other Obligations	37
	5.4   Payments on Borrower Advances; Dominion Accounts; Joint Royalty Accounts	37
	5.5   Marshaling; Payments Set Aside	39
	5.6   Post-Default Allocation of Payments	39
	5.7   Application of Payments	40
	5.8   Loan Account; Account Stated	40
	5.9   Taxes	41
	5.10   Lender Tax Information	41
	5.11   Nature and Extent of Each Borrower’s Liability	42
	SECTION  6.   CONDITIONS PRECEDENT	44
	6.1   Conditions Precedent to Initial Loans	44
	6.2   Conditions Precedent to All Credit Extensions	45
	SECTION  7.   COLLATERAL	45
	7.1   Grant of Security Interest	45
	7.2   Lien on Other Collateral	46
	7.3   [Reserved]	46
	7.4   Other Collateral	46
	7.5   No Assumption of Liability	47
	7.6   Further Assurances	47
	7.7   Continuation of Security Interest	47

 

    	 	-i-	 

     

    

Page

 

	SECTION  8.   REPRESENTATIONS AND WARRANTIES	47
	8.1   General Representations and Warranties	47
	8.2   Complete Disclosure	53
	8.3   Updated Representations and Warranties	53
	SECTION  9.   COVENANTS AND CONTINUING AGREEMENTS	53
	9.1   Affirmative Covenants	53
	9.2   Negative Covenants	60
	9.3   Financial Covenants	63
	SECTION  10.   EVENTS OF DEFAULT; REMEDIES ON DEFAULT	64
	10.1   Events of Default	64
	10.2   Remedies upon Default	66
	10.3   License	67
	10.4   Setoff	67
	10.5   Remedies Cumulative; No Waiver	68
	SECTION  11.   AGENT	68
	SECTION  12.   BENEFIT OF AGREEMENT; ASSIGNMENTS	68
	12.1   Successors and Assigns	68
	12.2   Participations	68
	12.3   Assignments	69
	12.4   Replacement of Certain Lenders	70
	SECTION  13.   MISCELLANEOUS	70
	13.1   Consents, Amendments and Waivers	70
	13.2   Indemnity	71
	13.3   Notices and Communications	71
	13.4   Performance of Obligors’ Obligations	72
	13.5   Credit Inquiries	73
	13.6   Severability	73
	13.7   Cumulative Effect; Conflict of Terms	73
	13.8   Counterparts	73
	13.9   Entire Agreement	73
	13.10   Relationship with Lenders	73
	13.11   No Advisory or Fiduciary Responsibility	73
	13.12   Confidentiality	74
	13.13   GOVERNING LAW	74
	13.14   Consent to Forum	74
	13.15   Waivers by OBLIGORS	75
	13.16   Power of Attorney	75
	13.17   PATRIOT Act Notice	76

 

    	 	-ii-	 

     

    

LIST
OF EXHIBITS AND SCHEDULES

 

 

	Exhibit A	Assignment and Acceptance
	Exhibit B	Compliance Certificate
	Exhibit C	Conditions Precedent
	Exhibit D	Agency Provisions
	Exhibit E	Credit and Collection Policy
	Exhibit F	Investment Policy
	 	 
	Schedule 1-A	Eligibility of Types of Advances
	Schedule 1-B	Commitments of Lenders
	Schedule 2	Deposit and Other Accounts
	Schedule 3	Business Locations
	Schedule 4	Names and Capital Structure
	Schedule 5	Patents, Trademarks, Copyrights and Licenses
	Schedule 5.4-A  	Collections Into Joint Royalty Accounts
	Schedule 5.4-B	Collections Pursuant to the Cambia Transaction Documents
	Schedule 6	Restrictive Agreements
	Schedule 7	Litigation
	Schedule 8	Plans
	Schedule 9	Labor Contracts
	Schedule 10	Existing Affiliate Transactions

 

    	 	-iii-	 

     

    

LOAN
AND SECURITY AGREEMENT

THIS LOAN AND
SECURITY AGREEMENT (this “Agreement”) is dated June 29, 2018, among SWK HOLDINGS CORPORATION, a Delaware
corporation (“Holdings”), SWK FUNDING LLC, a Delaware limited liability company (“SWK”,
and together with Holdings and each other Person party hereto as a borrower from time to time, collectively, “Borrowers”
and each a “Borrower”), the financial institutions party to this Agreement from time to time as lenders (collectively,
“Lenders”), and STATE BANK AND TRUST COMPANY, a Georgia banking corporation, as agent for the Lenders (“Agent”).

R E C I T A L S:

Each Borrower has
requested that Lenders make available a revolving credit facility to Borrowers, which shall be used by Borrowers to finance their
mutual and collective enterprise of originating and thereafter administering and servicing loan transactions. In order to utilize
the financial powers of each Borrower in the most efficient and economical manner, and in order to facilitate the financing of
each Borrower’s needs, Lenders will, at the request of any Borrower, make loans to all Borrowers under the revolving credit facility
on a combined basis and in accordance with the provisions hereinafter set forth. Borrowers’ business is a mutual and collective
enterprise, and Borrowers believe that the consolidation of all revolving credit loans under this Agreement will enhance the aggregate
borrowing powers of each Borrower and ease the administration of their revolving credit loan relationship with Lenders, all to
the mutual advantage of Borrowers. Lenders’ willingness to extend credit to Borrowers and to administer each Borrower’s collateral
security therefor, on a combined basis as more fully set forth in this Agreement, is done solely as an accommodation to Borrowers
and at Borrowers’ request in furtherance of Borrowers’ mutual and collective enterprise.

Each Borrower has
agreed to be jointly and severally liable for loans and all outstanding other obligations under this Agreement and to guarantee
the obligations of each of the other Borrowers under this Agreement and each of the other Loan Documents.

NOW, THEREFORE,
for valuable consideration hereby acknowledged, the parties agree as follows:

SECTION
1.            
DEFINITIONS; RULES OF CONSTRUCTION

1.1              
Definitions. As used herein, the following terms have the meanings set forth below:

“Accommodation
Payment” is as defined in Section 5.11.3.

“Affiliate”
means a Person: (a) which directly or indirectly through one or more intermediaries controls, or is controlled by, or is under
common control with, another Person; (b) which beneficially owns or holds 10% or more (or, in the case of a Borrower holding Equity
Interests in a Customer to whom Borrower has made Borrower Advances, 20% or more) of any class of the Equity Interests of a Person;
or (c) 10% or more of the Equity Interests with power to vote of which is beneficially owned or held by another Person or a Subsidiary
of another Person. For purposes hereof, “control” means the possession, directly or indirectly, of the power to direct
or cause the direction of the management and policies of a Person, whether through the ownership of any Equity Interest, by contract
or otherwise.

“Agent
Indemnitees” means Agent and all of Agent’s officers, directors, employees, Affiliates, agents and attorneys.

“Allocable
Amount” is as defined in Section 5.11.3.

    	 	-1-	 

     

    

“Anti-Corruption
Laws” means all laws, rules and regulations of any jurisdiction applicable to Borrowers or any of their Subsidiaries from
time to time concerning or relating to bribery or corruption.

“Anti-Terrorism
Law” means any law relating to terrorism or money laundering, including the PATRIOT Act.

“Applicable
Finance Laws” means, collectively, (a) each of the following federal laws and all regulations, rules and governmental
guidelines relating thereto: the Fair Credit Reporting Act, Fair Debt Collections Practices Act, Equal Credit Opportunity Act,
Truth in Lending Act, Truth in Savings Act, Credit Card Accountability Responsibility and Disclosure Act, Dodd-Frank Wall Street
Reform and Consumer Protection Act, Do-Not-Call Registry Legislation, Electronic Fund Transfer Act, Fair and Accurate Credit Transactions,
Fair Credit and Charge Card Disclosure Act, Fair Credit Billing Act, Federal Trade Commission Act, Identity Theft Assumption and
Deterrence Act, and Magnuson Moss Warranty-Federal Trade Commission Improvements Act, each as amended, and (b) all state and federal
laws relating to unfair or deceptive trade practices, usury, consumer protection, truth-in-lending, fair credit billing, fair credit
reporting, equal credit opportunity, fair debt collection practices, privacy, consumer finance transactions, rent-to-own transactions,
retail loans or retail installment sales, each as amended.

“Applicable
Healthcare Laws” means all applicable statutes, laws, ordinances, rules, and regulations of any governmental authority:
(a) with respect to regulatory matters relating to patient healthcare, healthcare providers, healthcare services, or pediatric
behavioral health services clinics (including: Medicaid, TRICARE/CHAMPUS, Section 1128B(b) of the Social Security Act, as amended,
42 U.S.C. § 1320a 7(b) (Criminal Penalties Involving Medicare or State Health Care Programs), commonly referred to as the
“Federal Anti-Kickback Statute;” HIPAA, and the Social Security Act, as amended, Section 1877, 42 U.S.C. § 1395nn
(Prohibition Against Certain Referrals), commonly referred to as “Stark Statute”; 31 U.S.C. §§ 3729-3722,
commonly referred to as the federal ” “False Claims Act”, 31 U.S.C. §§ 3801-3812, commonly referred
to as the “Program Fraud Civil Remedies Act”, 42 U.S.C. §§ 1320a-7a and 1320a-7b, commonly referred to as
the “Civil Monetary Penalties Law”, and 42 U.S.C. § 1320a-7, commonly referred to as the “Exclusion Laws”);
(b) with respect to patient healthcare, healthcare providers, healthcare services, or pediatric behavioral health services clinics
pertaining to the provision of, billing, collection, and reimbursement for, administration of, and payment for services which are
reimbursed with federal, state or local governmental funds through or on behalf of any governmental authority, including Medicaid
or TRICARE/CHAMPUS; and (c) any and all other applicable federal, state or local health care laws, rules, codes, statutes, regulations,
orders and ordinances, in each case as amended from time to time applicable to the activities referenced in subsections (a)-(b)
above.

“Applicable
Law” means all laws, rules, regulations and governmental guidelines applicable to the Person, conduct, transaction, agreement
or matter in question, including all applicable statutory law (including the Occupational Safety and Hazard Act of 1970, ERISA
and the Fair Labor Standards Act of 1938), ordinances, common law and equitable principles, and all provisions of constitutions,
treaties, statutes, rules, regulations, orders and decrees of all governmental authorities, including, to the extent applicable
to such Person, conduct, transaction, agreement or matter in question, all Applicable Finance Laws, all Applicable Healthcare Laws,
all Environmental Laws, the Occupational Safety and Hazard Act of 1970, ERISA, the Fair Labor Standards Act of 1938, and any other
laws regarding the collection, payment and deposit of Taxes.

“Applicable
Margin” means with respect to the applicable Type of Loan, (i) 0.30% with respect to Base Rate Loans, and (ii) 3.25% with
respect to LIBOR Index Loans.

“Approved
Fund” means any Fund that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender (c) an entity or an
Affiliate of an entity that administers or manages a Lender, or (d) the same investment advisor or an advisor under common control
with such Lender, Affiliate or advisor, as applicable.

    	 	-2-	 

     

    

“Assignment
and Acceptance” means an assignment agreement between a Lender and Eligible Assignee, and accepted by Agent, in the form
of Exhibit A.

“Availability”
means the Borrowing Base minus the principal balance of all Revolver Loans.

“Availability
Reserve” means, at any time, the sum (without duplication) of (a) the aggregate of (i) all past due rent and other amounts
owing by an Obligor to any landlord or other Person who possesses any Collateral or could assert a Lien on any Collateral and (ii)
a reserve at least equal to three (3) months’ rent and other charges that could be payable to any such Person, unless it has executed
a Lien Waiver; (b) the Bank Product Reserve; (c) all accrued Royalties (but not Royalty Payments payable to a Borrower in respect
of a Borrower Royalty Receivable), whether or not then due and payable by an Obligor; (d) the aggregate amount of liabilities secured
by Liens upon Collateral that are senior to Agent’s Liens (but imposition of any such reserve shall not waive an Event of Default
arising therefrom); (e) any amounts which any Obligor is obligated to pay pursuant to the provisions of any of the Loan Documents
that Agent elects to pay for the account of such Obligor in accordance with authority contained in any of the Loan Documents; (f)
any reserves established pursuant to any other provision of this Agreement; and (g) such additional reserves, in such amounts and
with respect to such matters, as Agent in its reasonable credit judgment may elect to impose from time to time.

“Bank Product”
means any of the following products, services or facilities extended to any Obligor or Subsidiary by State Bank or any of its Affiliates
or another Lender or any of its Affiliates: (a) Cash Management Services; (b) products under Hedging Agreements; (c) commercial
credit card and merchant card services; and (d) other banking products or services as may be requested by any Obligor or Subsidiary.

“Bank Product
Reserve” means the aggregate amount of reserves established by Agent from time to time in its reasonable credit judgment
in respect of Secured Bank Product Obligations.

“Bankruptcy
Code” means Title 11 of the United States Code.

“Base Rate”
means, on any day, a per annum rate equal to the greater of (a) the Prime Rate and (b) the Federal Funds Rate for such day, plus
0.50%. As used herein, the “Prime Rate” means the U.S. prime rate as shown in The Wall Street Journal on such
day, or, if such day is not a Business Day, on the immediately preceding Business Day (and, if The Wall Street Journal for any
reason ceases to publish a U.S. prime rate, then the Prime Rate shall be such prime rate as published from time to time in any
other publication or reference source designated by Agent in its discretion); provided, that the prime rate is a reference
rate and does not necessarily represent the best or lowest rate charged by any Lender. As used herein, “Federal Funds Rate”
means (a) the weighted average of interest rates on overnight federal funds transactions with members of the Federal Reserve System
arranged by federal funds brokers on the applicable Business Day (or on the preceding Business Day, if the applicable day is not
a Business Day), as published by the Federal Reserve Bank of New York on the next Business Day; or (b) if no such rate is published
on the next Business Day, the average rate (rounded up, if necessary, to the nearest 1/8 of 1%) charged to AloStar on the applicable
day on such transactions, as determined by Agent.

“Base Rate
Loan” means a Loan during any period in which it bears interest at a rate based upon the Base Rate.

    	 	-3-	 

     

    

“Besivance
Transaction Document” means that certain Royalty Purchase Agreement dated as of April 2, 2013, among InSite Vision Incorporated,
Bess Royalty, L.P. and SWK, and each other Transaction Document entered into in connection therewith, as the same are in effect
on the Closing Date.

“Board
of Governors” means the Board of Governors of the Federal Reserve System.

“Borrowed
Money” means with respect to any Obligor, without duplication, its (a) Debt that (i) arises from the lending of money
by any Person to such Obligor, (ii) is evidenced by notes, drafts, bonds, debentures, credit documents or similar instruments,
(iii) accrues interest or is a type upon which interest charges are customarily paid (excluding trade payables owing in the Ordinary
Course of Business), or (iv) was issued or assumed as full or partial payment for Property; (b) Capitalized Lease Obligations and
Debt for the deferred payment by one year or more of any purchase money obligation; (c) reimbursement obligations with respect
to letters of credit; (d) guaranties of any Debt of the foregoing types owing by another Person; and (e) any Debt payable by any
Obligor or a Subsidiary which is subordinate in right of payment to the Obligations or with respect to which the Liens securing
such Debt are subordinated to Agent’s Liens.

“Borrower
Advance” means, individually or collectively, as the context so implies, (i) a Borrower Loan Advance or (ii) a Borrower
Royalty Receivable Advance.

“Borrower
Advance Eligibility Requirements” means, with respect to a Borrower Advance, each of the following requirements:

(i)       such
Borrower Advance is made to an Eligible Customer;

(ii)       with
respect to a Borrower Loan Advance, such Borrower Loan Advance is a full recourse obligation of an Eligible Customer;

(iii)       such
Borrower Advance is not made to a Customer primarily for such Customer’s personal, family or household use or based on the value
of any healthcare insurance receivables payable to such Customer or any payments due or to become due to such Customer from Medicare
or Medicaid;

(iv)       with
respect to a Borrower Loan Advance, (A) such Borrower Loan Advance and the applicable Borrower’s Liens on the related Customer
Collateral have been pledged and assigned to Agent to secure the Obligations pursuant to the Borrower Assignment Agreement and
other documentation satisfactory to Agent, and (B) Agent holds a valid, enforceable and duly perfected first priority security
interest in, and Lien on, such Borrower Loan Advance and all of such Borrower’s right, title and interest in and to the related
Customer Collateral, subject only to (I) Permitted Intercreditor Arrangements, (II) Liens that are approved by Agent in writing
from time to time on a case-by-case basis, and (III) in the case of Borrower Advances that are Eligible Borrower Second Lien Advances,
Liens expressly permitted under the definition of Eligible Borrower Second Lien Advance;

(v)       with
respect to a Borrower Royalty Receivable Advance, (A) such Borrower Royalty Receivable Advance, related Borrower Royalty Receivables
and related Customer Collateral have been pledged and assigned to Agent to secure the Obligations pursuant to the Borrower Assignment
Agreement and other documentation satisfactory to Agent, and (B) Agent holds a valid, enforceable and duly perfected first priority
security interest in, and Lien on, such Borrower Royalty Receivable Advance, related Borrower Royalty Receivables and all of such
Borrower’s right, title and interest in and to the related Customer Collateral, subject only to Liens that are approved by
Agent in writing from time to time on a case-by-case basis;

    	 	-4-	 

     

    

(vi)       the
Transaction Documents evidencing or securing such Borrower Advance (A) constitute legal, valid, binding obligations of the applicable
Borrower(s) and Customer(s) and are in full force and effect; (B) comply with all Applicable Laws; (C) are on standard forms previously
approved by Agent and attached to the Certificate Regarding Forms of Transaction Documents or are otherwise accepted by Agent in
its discretion; (D) have not been amended, extended or modified without Agent’s prior written consent, provided that the
Transaction Documents evidencing or securing a given Borrower Advance may be amended in a manner that is not material without Agent’s
prior written consent no more than twice in any calendar year or four times during the term of this Agreement; and (E) are assignable
to Agent without consent from any Person and have been collaterally assigned to Agent pursuant to the Borrower Assignment Agreement;

(vii)       there
is no pending or overtly threatened litigation respecting the validity or enforceability of any of the Transaction Documents applicable
to such Borrower Advance or, in the case of a Borrower Royalty Receivable Advance, the license agreement, marketing agreement or
similar documentation between the applicable licensee or other Person obligated to make payments in respect of the applicable Borrower
Royalty Receivable and the Royalty Seller from which the applicable Borrower purchased such Borrower Royalty Receivable;

(viii)       such
Borrower Advance is in compliance in all respects with all Applicable Law;

(ix)       a
Borrower is the sole legal and beneficial owner of such Borrower Advance and, in the case of a Borrower Royalty Receivable Advance,
the related Borrower Royalty Receivable;

(x)       except
as Agent may agree to in writing in its discretion, as of such date of determination, (A) with respect to a Borrower Loan Advance,
the Customer to which such Borrower Loan Advance is made is not currently the subject of an Insolvency Proceeding and (B) with
respect to a Borrower Royalty Receivable Advance, neither the Customer to which such Borrower Royalty Receivable Advance is made
nor the licensee or other Person obligated to make Royalty Payments in respect of the related Borrower Royalty Receivable, in either
case, is currently the subject of an Insolvency Proceeding;

(xi)       (A)
no default or event of default has occurred under any Transaction Documents with respect to such Borrower Advance that has not
been waived by the applicable Borrower other than defaults and events of default (I) with respect to which Agent has received written
notice within five (5) Business Days of the occurrence or the applicable Borrower’s knowledge thereof, (II) that have existed
for less than ten (10) Business Days (or, in the case of defaults or events of default related to the payment of any amounts owing
under the applicable Transaction Documents, six (6) Business Days), and (III) with respect to which the applicable Borrower is
in good faith negotiating a resolution acceptable to such Borrower in its reasonable credit judgment; and (B) no portion of such
Borrower Advance or, if applicable, the related Borrower Royalty Receivable is or would be required to be written off (as bad debt
or otherwise pursuant to such Borrower’s established and documented underwriting, documentation and collection procedures);

(xii)       no
part of such Borrower Advance or any Lien in favor of the applicable Borrower securing such Borrower Advance (including any Lien
of such Borrower in a related Borrower Royalty Receivable or any Royalty Payments in respect of a related Borrower Royalty Receivable)
has been contractually subordinated to other Debt or Liens other than pursuant to a Permitted Intercreditor Arrangement unless
such Borrower Advance constitutes an Eligible Borrower Second Lien Advance, and no part of such Borrower Advance or, if applicable,
the related Borrower Royalty Receivable is subject to a potential offset, counterclaim, dispute, deduction, discount, recoupment,
reserve, defense, chargeback, credit or allowance (but ineligibility shall be limited to the amount thereof);

    	 	-5-	 

     

    

(xiii)       the
Customer to whom such Borrower Advance is made does not participate in any financing program with the Ex-Im Bank;

(xiv)       the
Customer to whom such Borrower Advance is made has not instituted any legal action to compel performance or payment of any amounts
due in respect of such Borrower Advance and, in the case of a Borrower Royalty Receivable Advance, neither such Customer nor the
Borrower making such Borrower Advance has instituted any legal action to compel performance or payment of the Borrower Royalty
Receivable or any amounts (including any Royalty Payments) due in respect thereof;

(xv)       such
Borrower Advance and, in the case of a Borrower Royalty Receivable Advance, the related Borrower Royalty Receivable, and all payments
due in respect thereof under the applicable Transaction Documents, are denominated in Dollars; and

(xvi)       such
Borrower Advance is not otherwise deemed ineligible hereunder by Agent in its reasonable credit judgment.

“Borrower
Agent” is as defined in Section 4.4.

“Borrower
Assignment Agreement” means the Collateral Assignment of Transaction Documents and Agency Agreement dated the date hereof
pursuant to which each Borrower assigns to Agent, for the benefit of the Secured Parties, (i) all of its right, title and interest
in and to all Transaction Documents (including any Royalty Purchase Documents) now existing or hereafter created or acquired, (ii)
all Borrower Advances made by such Borrower to the applicable Customer(s) pursuant to such Transaction Documents from time to time,
all of Borrower’s right, title and interest in and to the Customer Collateral securing or otherwise relating to such Borrower
Advances from time to time and, in the case of any Borrower Royalty Receivable Advances, all related Borrower Royalty Receivables,
(iii) the UCC-1 financing statement naming each such Customer as debtor and such Borrower as secured party and identifying the
collateral described in the applicable Transaction Documents, as amended from time to time, and (iv) if requested by Agent from
time to time, UCC-3 financing statement amendments that assign to Agent all financing statements naming a Customer as debtor and
such Borrower as secured party, which financing statement amendments may be filed of record by Agent as provided in Section
7.6.

“Borrower
Loan Advance” means a secured loan or similar financial accommodation (including any secured loan (a) that is required
to be repaid using the proceeds of royalties or similar payments and (b) with respect to which the related Transaction Documents
clearly indicate an intent by the parties thereto that such financial accommodation be characterized as a loan and not a purchase
of a Borrower Royalty Receivable) (i) that is made by a Borrower directly to a Customer in the Ordinary Course of Business of such
Borrower, (ii) that was originated by such Borrower, and (iii) that is owned absolutely by such Borrower. If a Borrower is one
of multiple Persons providing financial accommodations to a Customer under a given set of Transaction Documents (e.g., as part
of a syndicated loan transaction), then the portion of such financial accommodations actually made or held by the applicable Borrower
(and not any portion of such financial accommodations made or held by any Person other than such Borrower) shall be the Borrower
Loan Advance made pursuant to the applicable Transaction Documents. For the avoidance of doubt, no Borrower Royalty Receivable
Advance shall be a Borrower Loan Advance.

“Borrower
Royalty Receivable” means all right, title and interest in and to Royalty Payments of a Royalty Seller which are purchased
by a Borrower pursuant to Royalty Purchase Documents pursuant to which such Borrower bears the risk of non-payment of the applicable
Royalty Payment due to the licensee’s inability to pay Royalty Payments, together with all rights to payment and enforcement
thereof, all proceeds thereof (including any cash, checks, instruments and other items of payment in respect thereof) and any other
payment intangible, contract right or other monetary obligation at any time due or payable to such Borrower under or in connection
with the Royalty Payments (or portions thereof) that give rise to such Borrower Royalty Receivable.

    	 	-6-	 

     

    

“Borrower
Royalty Receivable Advance” means an advance (i) that is made by a Borrower directly to a Customer in the Ordinary Course
of Business of such Borrower and (ii) that is made in payment of the net purchase price of a Borrower Royalty Receivable pursuant
to a Royalty Purchase Agreement between such Borrower and such Customer. If a Borrower purchases less than 100% of the applicable
Customer’s interests in a given Borrower Royalty Receivable, then the net purchase price paid by such Borrower in respect
of the portion of the Borrower Royalty Receivable acquired by such Borrower (and not any portion of the Borrower Royalty Receivable
acquired or otherwise held or owned by any Person other than such Borrower) shall be the Borrower Royalty Receivable Advance made
in respect of such Borrower Royalty Receivable.

“Borrower
Second Lien Advance” means a Borrower Loan Advance that is secured by a valid, enforceable and duly perfected second
priority security interest in, and Lien on, the Customer Collateral serving as the primary underwritten collateral for such Borrower
Loan Advance (subject only to Liens expressly permitted by the applicable Transaction Documents that satisfy the requirements of
clause (vi)(C) of the definition of Borrower Advance Eligibility Requirements and Liens that are approved by Agent in writing from
time to time on a case-by-case basis).

“Borrowing”
means a borrowing consisting of Loans made on the same day by Lenders (or by Agent in the case of a Borrowing funded by Swingline
Loans).

“Borrowing
Base” means, on any date of determination, an amount equal to the lesser of:

(a) the aggregate
amount of Revolver Commitments; or

(b) the sum of:

(i) 85% (or
such lesser percentage as Agent may in its discretion determine from time to time) of the Net Amount of Eligible Borrower First
Lien Advances outstanding on such date, plus

(ii) 70%
(or such lesser percentage as Agent may in its discretion determine from time to time) of the Net Amount of Eligible Borrower Second
Lien Advances outstanding on such date, plus

(iii) 50%
(or such lesser percentage as Agent may in its discretion determine from time to time) of the Net Amount of Eligible Borrower Royalty
Receivable Advances outstanding on such date, minus

(iv) the
Availability Reserve;

provided, that,
without duplication:

(A)       at
any time that the Maximum Weighted Average Remaining Term of all Eligible Borrower Loan Advances (prior to giving effect to this
proviso) outstanding exceeds seven (7) years, the Net Amount of one or more Eligible Borrower First Lien Advances or Eligible Borrower
Second Lien Advances, as applicable, included in clauses (b)(i) and (b)(ii) above shall be excluded from clauses (b)(i) and (b)(ii)
above to the extent necessary to cause the Maximum Weighted Average Remaining Term of all Eligible Borrower Loan Advances included
under clauses (b)(i) and (b)(ii) (before application of the advance rates therein) to be not more than seven (7) years;

    	 	-7-	 

     

    

(B)       at
any time that the aggregate Net Amount of Eligible Borrower Advances (prior to giving effect to this proviso) to any Customer exceeds
ten percent (10%) of the aggregate Net Amount of all Eligible Borrower Advances (prior to giving effect to this proviso), the amount
of such excess shall be excluded from the calculation in clause (b) above (before application of the advance rates therein);

(C)       at
any time that the Net Amount of Eligible Borrower Second Lien Advances (prior to giving effect to this proviso) exceeds twenty-five
(25%) of the aggregate Net Amount of all Eligible Borrower Advances (prior to giving effect to this proviso), the Net Amount of
Eligible Borrower Second Lien Advances included in clause (b)(ii) above (before application of the advance rate therein) shall
be reduced by the amount of such excess;

(D)       at
any time that the Net Amount of Eligible Borrower Royalty Receivable Advances (prior to giving effect to this proviso) exceeds
twenty-five (25%) of the aggregate Net Amount of all Eligible Borrower Advances (prior to giving effect to this proviso), the Net
Amount of Eligible Borrower Royalty Receivable Advances included in clause (b)(iii) above (before application of the advance rate
therein) shall be reduced by the amount of such excess;

(E)       at
any time that the Net Amount of Eligible Borrower Royalty Receivable Advances consisting of Royalty Payments payable to a Borrower
arising primarily from the sale of generic pharmaceutical products (calculated prior to giving effect to this proviso) exceeds
fifty (50%) of the aggregate Net Amount of all Eligible Borrower Royalty Receivable Advances (prior to giving effect to this proviso),
the Net Amount of Eligible Borrower Royalty Receivable Advances included in clause (b)(iii) above (before application of the advance
rate therein) shall be reduced by the amount of such excess;

(F)       the
Net Amount of Eligible Borrower First Lien Advances and Eligible Borrower Second Lien Advances included in clauses (b)(i) and (b)(ii)
above (before application of the advance rates therein), as applicable, may include:

(I)       the
Net Amount of Eligible Borrower First Lien Advances or Eligible Borrower Second Lien Advances, as applicable, made pursuant to
Transaction Documents that provide for a syndicated loan transaction so long as the applicable Borrower’s consent is needed
for all amendments, waivers or other actions under such Transaction Documents requiring any lender’s, required lender’s
or majority lender’s consent and, unless otherwise consented to by Agent on a case-by-case basis, the applicable Borrower
is the agent for the lenders under such Transaction Documents; or

(II)       the
Net Amount of all other Eligible Borrower First Lien Advances or Eligible Borrower Second Lien Advances, as applicable, made pursuant
to Transaction Documents that provide for a syndicated loan transaction, so long as the aggregate Net Amount of such Eligible Borrower
First Lien Advances or Eligible Borrower Second Lien Advances included in clauses (b)(i) or (b)(ii) above (before application of
the advance rate therein), as applicable, does not exceed twenty-five percent (25%) of the aggregate Net Amount of all Eligible
Borrower First Lien Advances or Eligible Borrower Second Lien Advances (prior to giving effect to this proviso), as applicable;
and

    	 	-8-	 

     

    

(G)       the
Net Amount of Eligible Borrower Royalty Receivable Advances included in clause (b)(iii) above (before application of the advance
rate therein) may include the Net Amount of Eligible Borrower Royalty Receivable Advances made pursuant to Transaction Documents
under which the applicable Collections Paying Parties remit Collections into a Joint Royalty Account so long as the aggregate Net
Amount of such Eligible Borrower Royalty Receivable Advances included in clause (b)(iii) above (before application of the advance
rate therein) does not exceed twenty-five percent (25%) of the aggregate Net Amount of all Eligible Borrower Royalty Receivable
Advances (prior to giving effect to this proviso).

“Borrowing
Base Certificate” means a certificate, in form and substance satisfactory to Agent, by which Borrowers certify calculation
of the Borrowing Base, with appropriate insertions, and which is submitted to Agent by Borrowers pursuant to this Agreement and
certified as true and correct by a Senior Officer (which certificate may be submitted electronically subject to the limitations
set forth in Section 13.2.2).

“Business
Day” means any day other than a Saturday, Sunday, each day on which Agent is otherwise closed for transacting business
with the public or other day on which commercial banks are authorized to close under the laws of, or are in fact closed in, Georgia
or Texas, and if such day relates to a LIBOR Index Loan, any such day on which dealings in Dollar deposits are conducted between
banks in the London interbank Eurodollar market.

“Cambia
Transaction Documents” mean, collectively, that certain Royalty Purchase Agreement dated as of July 31, 2014, between
APR Applied Pharma Research S.A. and SWK, that certain Royalty Purchase Agreement dated as of December 2, 2015, between APR Applied
Pharma Research S.A. and SWK, and each other Transaction Document entered into in connection therewith, as the same are in effect
on the Closing Date.

“Capital
Expenditures” means all liabilities incurred or expenditures made by a Borrower or Subsidiary for the acquisition of fixed
assets, or any improvements, replacements, substitutions or additions thereto with a useful life of more than one year, including
the total principal portion of Capitalized Lease Obligations.

“Capitalized
Lease Obligation” means any Debt represented by obligations under a lease that is required to be capitalized for financial
reporting purposes in accordance with GAAP.

“Cash Collateral”
means cash, and any interest or other income earned thereon, that is delivered to Agent to Cash Collateralize any Obligations and
all interest and other income earned (if any) on such cash.

“Cash Collateral
Account” means a demand deposit, money market or other account maintained with Agent and subject to Agent’s Liens.

“Cash Collateralize”
means the delivery of cash to Agent, as security for the payment of Obligations, in an amount equal to, with respect to any inchoate,
contingent or other Obligations (including Secured Bank Product Obligations), Agent’s good faith estimate of the amount that is
due or could become due, including all fees and other amounts relating to such Obligations. “Cash Collateralization”
has a correlative meaning.

“Cash Management
Services” means any services provided from time to time by any Lender or any of its Affiliates to any Obligor or Subsidiary
in connection with operating, collections, payroll, trust, or other depository or disbursement accounts, including automated clearinghouse,
e-payable, electronic funds transfer, wire transfer, controlled disbursement, overdraft, depository, information reporting, lockbox
and stop payment services.

    	 	-9-	 

     

    

“Certificate
Regarding Forms of Transaction Documents” means that certain Certificate Regarding Forms of Transaction Documents dated
on or about the Closing Date and delivered by Borrowers to Agent.

“Change
in Law” means (i) the adoption of any applicable law, rule or regulation after the date of this Agreement, (ii) any change
in any applicable law, rule or regulation, or any change in the interpretation, implementation or application thereof, by any governmental
authority after the date of this Agreement, or (iii) compliance by Lender with any request, guideline or directive (whether or
not having the force of law) of any governmental authority made or issued after the date of this Agreement; provided that for purposes
of this Agreement, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives
in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements,
the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities,
in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law”, regardless of the date enacted,
adopted or issued.

“Change
of Control” means (a) Holdings ceases to own and control, beneficially and of record, directly or indirectly, all Equity
Interests in SWK; (b) Carlson Capital, L.P. ceases to own and control, beneficially and of record, directly or indirectly, fifty-one
percent (51%) of the Equity Interests in Holdings; (c) a change in the majority of directors or managers of a Borrower during any
24 month period, unless approved by the majority of directors or managers serving at the beginning of such period (excluding from
such determination, for purposes of this clause (c), any single change in a director or manager each year appointed by Carlson
Capital, L.P.); or (d) the sale or transfer of all or substantially all of a Borrower’s or Obligor’s assets, except
to another Borrower.

“Closing
Date” is as defined in Section 6.1.

“Code”
means the Internal Revenue Code of 1986.

“Collateral”
means all Property described in Section 7.1, all Property described in any Security Documents as security for any Obligations,
and all other Property that now or hereafter secures (or is intended to secure) any Obligations.

“Collections”
is as defined in Section 5.2.

“Collections
Paying Party” means (i) a Person who is or becomes obligated under or on account of an Account, Chattel Paper or General
Intangible or (ii) a Customer or other Person who is or becomes obligated under or on account of a Borrower Advance (including
any licensee, marketer, Royalty Seller or depository institution that has agreed or been instructed to remit any Collections to
or for the benefit of a Borrower).

“Commitment”
means for any Lender, the aggregate amount of such Lender’s Revolver Commitment. “Commitments” means the aggregate
amount of all Revolver Commitments.

“Commitment
Termination Date” means the earliest to occur of (a) the Revolver Termination Date; (b) the date on which Borrowers terminate
the Revolver Commitments pursuant to Section 2.1.4; or (c) the date on which the Revolver Commitments are terminated pursuant
to Section 10.2.

    	 	-10-	 

     

    

“Commodity
Exchange Act” means the Commodity Exchange Act (7 U.S.C. § 1 et seq.).

“Compliance
Certificate” means a compliance certificate, in the form of Exhibit B attached hereto, with appropriate insertions,
to be submitted to Agent by Borrowers pursuant to this Agreement and certified as true and correct by a Senior Officer.

“Contingent
Obligation” means with respect to any Person, any obligation of such Person arising from any guaranty, indemnity or other
assurance of payment or performance of any Debt, lease, dividend or other obligation of any other Person in any manner, whether
directly or indirectly.

“Credit
and Collection Policy” means Borrowers’ established and documented underwriting, documentation and collection policies
attached hereto as Exhibit E, as the same may be updated from time to time with Agent’s written consent.

“Credit
Support” means any guaranty, indemnity, security or other assurance of payment or performance provided by Agent to induce
a Person to extend credit to or for the benefit of any Obligor.

“Customer”
means (i) with respect to a Borrower Loan Advance, a Person to whom a Borrower makes one or more loans or other extensions of credit,
or (ii) with respect to a Borrower Receivable Advance, the Royalty Seller from which the applicable Borrower purchased the applicable
Borrower Royalty Receivable.

“Customer
Asset” means an item of Property owned by a Customer, and “Customer Assets” means all of the Property owned
by a Customer.

“Customer
Collateral” means (i) with respect to a Borrower Loan Advance, the Customer Assets in which the applicable Customer grants
a Lien in favor of a Borrower as security for one or more Borrower Loan Advances to such Customer and (ii) with respect to a Borrower
Royalty Receivable Advance made for the purpose of purchasing a Borrower Royalty Receivable, the Borrower Royalty Receivable and
any related assets, in each case, sold or assigned (including any such assets collaterally assigned) to such Borrower under the
applicable Royalty Purchase Agreement and related Transaction Documents, regardless of whether the transactions contemplated pursuant
to the applicable Royalty Purchase Documents do or do not result in a “true sale” of a Borrower Royalty Receivable
to the applicable Borrower (it being understood that it is the intent of Borrowers that the Royalty Purchase Documents result in
a “true sale” of the applicable Borrower Royalty Receivables).

“Customer
Credit Agreement” means a Credit Agreement, substantially in the form attached to the Certificate Regarding Forms of
Transaction Documents, or another agreement in form and substance satisfactory to Agent in all respects, pursuant to which a Borrower
makes one or more Borrower Loan Advances to a Customer.

“Daily
LIBOR Rate” means, on any day, the greater of (a) 1.00% and (b) the LIBOR Rate as shown in the Wall Street Journal on
such day for United States dollar deposits for the one month delivery of funds in amounts approximately equal to the principal
amount of the Loan for which such rate is being determined or, if such day is not a Business Day on the immediately preceding Business
Day. If The Wall Street Journal for any reason ceases to publish a LIBOR Rate, then the Daily LIBOR Rate shall be as published
from time to time and any other publication or reference source designated by Agent in its discretion (but, in any event, not less
than 1.00% per annum at any time). The Daily LIBOR Rate is a reference rate and does not necessarily represent the best or lowest
rate charged by Lender.

    	 	-11-	 

     

    

“Debt”
means, as applied to any Person, without duplication, (a) all items that would be included as liabilities on a balance sheet in
accordance with GAAP, including Capitalized Lease Obligations; (b) all Contingent Obligations; (c) all reimbursement obligations
in connection with letters of credit issued for the account of such Person; and (d) in the case of an Obligor, the Obligations.
The Debt of a Person shall include any recourse Debt of any partnership in which such Person is a general partner or joint venturer.

“Default”
means an event or condition that, with the lapse of time or giving of notice, or both, would constitute an Event of Default.

“Default
Rate” means for any Obligation (including, to the extent permitted by law, interest not paid when due), 2.0% plus the
interest rate otherwise applicable thereto.

“Defaulting
Lender” means any Lender that, as determined by Agent, (a) has failed to perform any funding obligations hereunder, and
such failure is not cured within three Business Days; (b) has notified Agent or any Borrower that such Lender does not intend to
comply with its funding obligations hereunder or has made a public statement to the effect that it does not intend to comply with
its funding obligations hereunder or under any other credit facility; (c) has failed, within three Business Days following request
by Agent, to confirm in a manner satisfactory to Agent that such Lender will comply with its funding obligations hereunder; or
(d) has, or has a direct or indirect parent company that has, become the subject of an Insolvency Proceeding or taken any action
in furtherance thereof; provided, however, that a Lender shall not be a Defaulting Lender solely by virtue of a governmental
authority’s ownership of an equity interest in such Lender or parent company.

“Distribution”
means any declaration or payment of a distribution, interest or dividend on any Equity Interest (other than payment-in-kind); any
distribution, advance or repayment of Debt to a holder of Equity Interests; or any purchase, redemption, or other acquisition,
surrender or retirement for value of any Equity Interest, sinking fund or similar payment.

“Dollars”
and the sign “$” mean lawful money of the United States.

“Dominion
Account” means that certain deposit account number ending in 4797 established by SWK at State Bank, or another deposit
account acceptable to Agent, over which Agent has exclusive control for withdrawal purposes.

“EBITDA”
means, on a consolidated basis for Borrowers and their Subsidiaries, net income, calculated before interest expense, provision
for income taxes, depreciation and amortization expense, gains or losses arising from the sale of capital assets, gains arising
from the write-up of assets, and any extraordinary gains (in each case, to the extent included in determining net income).

“Eligible
Assignee” means a Person that is (a) a Lender or an Affiliate of a Lender; (b) an Approved Fund; (c) any Person to whom
a Lender assigns its rights and obligations under this Agreement as part of an assignment and transfer of such Lender’s rights
in and to a material portion of such Lender’s portfolio of asset based credit facilities; (d) any other financial institution,
which extends revolving credit facilities of this type in its ordinary course of business approved by Agent and, unless an Event
of Default has occurred, Borrower Agent (which approval by Borrower Agent shall not be unreasonably withheld or delayed, and shall
be deemed given if no objection is made within five (5) Business Days after notice of the proposed assignment); and (e) during
any Event of Default, any Person acceptable to Agent in its discretion; provided, that in no event shall an Obligor or an
Affiliate of an Obligor be deemed to be an Eligible Assignee.

    	 	-12-	 

     

    

“Eligible
Borrower Advance” means, individually and collectively as the context so implies, each Eligible Borrower First Lien Advance,
Eligible Borrower Second Lien Advance and Eligible Borrower Royalty Receivable Advance.

“Eligible
Borrower First Lien Advance” means, on any date of determination, a Borrower Loan Advance that, in Agent’s reasonable
credit judgment, is an Eligible Borrower First Lien Advance and, in any event, that:

(i)       is
not a Borrower Royalty Receivable Advance;

(ii)       satisfies
all of the Borrower Advance Eligibility Requirements applicable to a Borrower Loan Advance on such date;

(iii)       is
secured by a valid, enforceable and duly perfected first priority security interest in, and Lien on, the Customer Collateral serving
as the primary underwritten collateral for such Borrower Loan Advance (subject only to Permitted Intercreditor Arrangements, Liens
expressly permitted by the applicable Transaction Documents that satisfy the requirements of clause (vi)(C) of the definition of
Borrower Advance Eligibility Requirements and Liens that are approved by Agent in writing from time to time on a case-by-case basis),
and such Customer Collateral includes the income stream arising from the sale of one or more products or devices and/or the provision
of services, in each case within the healthcare industry, that have been offered for sale or provided (and continue to be sold
or provided) to consumers in accordance with Applicable Law and that have a proven track record of sales and/or service to customers
that is sufficient to be able to be evaluated by the applicable Borrower as part of its underwriting process;

(iv)       as
it relates to any Borrower Loan Advance that was primarily underwritten based on the sales of one or more branded pharmaceutical
products, is scheduled, and reasonably expected by the applicable Borrower, to be repaid in full pursuant to the applicable Transaction
Documents during a period of no more than the lesser of (I) the remaining period of exclusivity granted by the FDA with respect
to the applicable patented drug product from which the income stream constituting Customer Collateral is derived and (II) the remaining
term of the patent on the applicable patented drug from which the income stream constituting Customer Collateral is derived;

(v)       as
it relates to any Borrower Loan Advance that was primarily underwritten based on the sales of one or more generic pharmaceutical
products, is scheduled, and reasonably expected by the applicable Borrower, to be repaid in full pursuant to the applicable Transaction
Documents during a period of no more than seven (7) years;

(vi)       is
made in accordance with the Credit and Collection Policy;

(vii)       has
not been placed on non-accrual by the applicable Borrower;

(viii)       is
in an amount that, together with the aggregate Net Amount of all Eligible Borrower Advances to the applicable Customer, does not
exceed 40% (or such greater percentage as Agent may agree to in its discretion on a case-by-case basis) of the aggregate value
of the Customer Collateral securing such Borrower Advance (provided that such Borrower Loan Advance shall be ineligible only to
the extent of such excess); and

(ix)       satisfies
all of the additional requirements applicable to such Borrower Advance as set forth on Schedule 1-A hereto.

    	 	-13-	 

     

    

“Eligible
Borrower Loan Advance” means, individually and collectively as the context so implies, each Eligible Borrower First Lien
Advance and Eligible Borrower Second Lien Advance.

“Eligible
Borrower Royalty Receivable Advance” means, on any date of determination, a Borrower Royalty Receivable Advance that,
in Agent’s reasonable credit judgment, is an Eligible Borrower Royalty Receivable Advance and, in any event, that:

(i)       satisfies
all of the Borrower Advance Eligibility Requirements applicable to a Borrower Royalty Receivable Advance on such date;

(ii)       is
made by the applicable Borrower to purchase a Borrower Royalty Receivable with an estimated original Expected Repayment Period
of no more than (A) the lesser of (I) the remaining period of exclusivity granted by the FDA with respect to the applicable patented
drug product from which the applicable Royalty Payments are derived and (II) the remaining term of the patent on the applicable
patented drug from which the applicable Royalty Payments are derived, or (B) with respect to a Borrower Royalty Receivable Advance
made to acquire an interest in a Borrower Royalty Receivable arising from the sale of a generic drug product, seven (7) years;

(iii)       is
made in accordance with the Credit and Collection Policy;

(iv)       the
value of the applicable Royalty Payments when discounted at a rate of not less than 9.0% is greater than or equal to the lesser
of (a) net purchase price paid by the applicable Borrower with respect to the related Borrower Royalty Receivable or (b) the book
carrying value of such Borrower Royalty Receivable as determined in accordance with GAAP;

(v)       is
made by the applicable Borrower to purchase a Borrower Royalty Receivable consisting of a right to receive Royalty Payments with
respect to one or more drug products that have been offered for sale (and continue to be sold) to consumers in accordance with
Applicable Law and that have a proven track record of sales to customers that is sufficient to be able to be evaluated by the applicable
Borrower as part of its underwriting process;

(vi)       is
made pursuant to Transaction Documents that provide for all Collections in respect of such Borrower Royalty Receivable Advance
to be paid directly into a Dominion Account unless (A) the applicable Borrower’s share of Collections are paid directly into
a Joint Royalty Account pursuant to arrangements described on Schedule 5.4, (B) no Person has the power to direct the transfer
of any amounts held in such Joint Royalty Account without such Borrower’s written consent, and (C) Borrowers have complied
with the provisions of Section 5.4(b) with respect to such Joint Royalty Account;

(vii)       is
held by a Borrower as the sole purchaser of the applicable right to receive Royalty Payments or, if the applicable Transaction
Documents provide for a Borrower and one or more other Persons to acquire interests in the same Royalty Payments, unless otherwise
consented to by Agent on a case-by-case basis, no Person other than a Borrower is authorized or empowered to act as agent for the
purchasers under the applicable Transaction Documents (it being understood that Agent consents to Bess Royalty, L.P. being the
agent under the Besivance Transaction Documents) and the applicable Borrower’s consent is necessary for all amendments, waivers
or other actions requiring any purchaser’s, required purchaser’s, or majority purchaser’s consent; and

(viii)       is
in an amount not exceeding (A) the net purchase price specified in such Royalty Purchase Documents or (B) the maximum net purchase
price that the applicable Borrower could pay without violating the required ratio described in clause (iv) above (provided, that
such Borrower Royalty Receivable Advance shall be ineligible only to the extent of such excess).

    	 	-14-	 

     

    

“Eligible
Borrower Second Lien Advance” means, on any date of determination, a Borrower Loan Advance that, in Agent’s reasonable
credit judgment, is an Eligible Borrower Second Lien Advance and, in any event, that:

(i)       is
not a Borrower Royalty Receivable Advance;

(ii)       satisfies
all of the Borrower Advance Eligibility Requirements applicable to a Borrower Loan Advance on such date;

(iii)       is
secured by a valid, enforceable and duly perfected second priority security interest in, and Lien on, the Customer Collateral serving
as the primary underwritten collateral for such Borrower Loan Advance (subject only to Liens expressly permitted by the applicable
Transaction Documents that satisfy the requirements of clause (vi)(C) of the definition of Borrower Advance Eligibility Requirements
and Liens that are approved by Agent in writing from time to time on a case-by-case basis), and such Customer Collateral includes
the income stream arising from the sale of one or more products or devices and/or the provision of services, in each case within
the healthcare industry, that have been offered for sale or provided (and continue to be sold or provided) to consumers in accordance
with Applicable Law and that have a proven track record of sales and/or service to customers that is sufficient to be able to be
evaluated by the applicable Borrower as part of its underwriting process;

(iv)       as
it relates to any Borrower Loan Advance that was primarily underwritten based on the sales of one or more branded pharmaceutical
products, is scheduled, and reasonably expected by the applicable Borrower, to be repaid in full pursuant to the applicable Transaction
Documents during a period of no more than the lesser of (I) the remaining period of exclusivity granted by the FDA with respect
to the applicable patented drug product from which the income stream constituting Customer Collateral is derived and (II) the remaining
term of the patent on the applicable patented drug from which the income stream constituting Customer Collateral is derived;

(v)       as
it relates to any Borrower Loan Advance that was primarily underwritten based on the sales of one or more generic pharmaceutical
products, is scheduled, and reasonably expected by the applicable Borrower, to be repaid in full pursuant to the applicable Transaction
Documents during a period of no more than seven (7) years;

(vi)       is
made in accordance with the Credit and Collection Policy;

(vii)       is
held by a Borrower as the sole lender or with respect to which more than fifty percent (50%) of the aggregate percentage of the
commitments to lend (or, after such commitments have been terminated, all loans made) under the applicable Transaction Documents
are held by a Borrower and, unless otherwise consented to by Agent on a case-by-case basis, in the case of any Borrower Advance
that is made pursuant to a syndicated loan transaction, such Borrower is the agent for the lenders under the applicable Transaction
Documents;

(viii)       has
not been placed on non-accrual by the applicable Borrower;

(ix)       is
in an amount that, together with the aggregate Net Amount of all Eligible Borrower Advances to the applicable Customer, does not
exceed 40% (or such greater percentage as Agent may agree to in its discretion on a case-by-case basis) of the aggregate value
of the Customer Collateral securing such Borrower Advance (provided that such Borrower Loan Advance shall be ineligible only to
the extent of such excess); and

(x)       satisfies
all of the additional requirements applicable to such Borrower Advance as set forth on Schedule 1-A hereto.

    	 	-15-	 

     

    

“Eligible
Customer” means, on any date, a Customer that meets all of the following criteria on such date:

(i)       such
Customer is domiciled in, is a resident of, has its principal place of business and assets located in and is organized under the
laws of a State of the United States, the District of Columbia, Canada or a Province of Canada;

(ii)       such
Customer is in good standing in all jurisdictions in which such Customer is required to be qualified to do business if the failure
to be qualified might restrict or limit the ability of Borrowers or Agent to enforce its rights and remedies against such Customer,
any Customer Collateral or, if Borrower Royalty Receivable Advances are made to such Customer, the related Borrower Royalty Receivables;

(iii)       such
Customer is not in liquidation nor has it dissolved or ceased to do business;

(iv)       such
Customer and its business are in compliance, in all material respects, with all Applicable Law;

(v)       such
Customer is not an Affiliate of any Borrower or an agency, branch or other component of any federal, state, local or other government;

(vi)       less
than twenty percent (20%) of the issued and outstanding Equity Interests of such Customer are owned by any Borrower; and

(vii)       less
than twenty percent (20%) of the issued and outstanding Equity Interests of such Customer are owned by an Affiliate of any Borrower.

“Environmental
Laws” means all Applicable Laws (including all programs, permits and guidance promulgated by regulatory agencies and all
implementing regulations), relating to public health (but excluding occupational safety and health, to the extent regulated by
the Occupational Safety and Hazard Act of 1970) or the protection or pollution of the environment, including the Clean Water Act
(33 U.S.C. §§ 1251 et seq.), the Comprehensive Environmental Response Compensation and Liability Act (42 U.S.C.
§ 9601 et seq.) and the Resource Conservation and Recovery Act (42 U.S.C. §§ 6991-6991i).

“Equity
Interest” means the interest of any (a) shareholder in a corporation; (b) partner in a partnership (whether general, limited,
limited liability or joint venture); (c) member in a limited liability company; or (d) other Person having any other form of equity
security or ownership interest in any other type of legal entity.

“ERISA”
means the Employee Retirement Income Security Act of 1974 and all rules and regulations from time to time promulgated thereunder.

“ERISA
Affiliate” means any trade or business (whether or not incorporated) under common control with an Obligor within the meaning
of Section 414(b) or (c) of the Code (and Sections 414(m) and (o) of the Code for purposes of provisions relating to Section 412
of the Code).

“Event
of Default” is as defined in Section 10.

    	 	-16-	 

     

    

“Excluded
Swap Obligation” means with respect to any Obligor, each Swap Obligation as to which, and only to the extent that, such
Obligor’s guaranty of or grant of a Lien as security for such Swap Obligation is or becomes illegal under the Commodity Exchange
Act because such Obligor does not constitute an “eligible contract participant” as defined in the act (determined after
giving effect to Section 5.12.3(c) and any other keepwell, support or other agreement for the benefit of such Obligor, and
all guarantees of Swap Obligations by other Obligors) when such guaranty or grant of Lien becomes effective with respect to the
Swap Obligation. If a Hedging Agreement governs more than one Swap Obligation, only the Swap Obligation(s) or portions thereof
described in the foregoing sentence shall be Excluded Swap Obligation(s).

“Excluded
Tax” means with respect to Agent, any Lender or any other recipient of a payment to be made by or on account of any Obligation,
(a) taxes imposed on or measured by its overall net income (however denominated), and franchise taxes imposed on it (in lieu of
net income taxes), by the jurisdiction (or any political subdivision thereof) under the laws of which such recipient is organized
or in which its principal office is located or, in the case of any Lender, in which its applicable Lending Office is located; (b)
any branch profits taxes imposed by the United States or any similar tax imposed by any other jurisdiction in which Borrower Agent
is located; (c) any backup withholding tax required by the Code to be withheld from amounts payable to a Lender that has failed
to comply with Section 5.10; (d) in the case of a Foreign Lender, any United States withholding tax that is (i) required
pursuant to laws in force at the time such Lender becomes a Lender (or designates a new Lending Office) hereunder, or (ii) attributable
to such Lender’s failure or inability (other than as a result of a Change in Law) to comply with Section 5.10, except
to the extent that such Foreign Lender (or its assignor, if any) was entitled, at the time of designation of a new Lending Office
(or assignment), to receive additional amounts from Obligors with respect to such withholding tax; and (e) U.S. federal withholding
taxes imposed pursuant to FATCA.

“Executive
Order No. 13224” means Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001, as the same has
been, or shall hereafter be, renewed, extended, amended or replaced.

“Expected
Repayment Period” means, with respect to any Borrower Royalty Receivable, the period of time after the effective date
of the Royalty Purchase Agreement giving rise to such Borrower Royalty Receivable during which the applicable Borrower could reasonably
be expected to receive Royalty Payments in respect of such Borrower Royalty Receivable under such Royalty Purchase Agreement.

“Extraordinary
Expenses” means all costs, expenses or advances that Agent or Lenders may suffer or incur during a Default or Event of
Default, or during the pendency of an Insolvency Proceeding of an Obligor, including those relating to (a) any audit, inspection,
repossession, storage, repair, appraisal, insurance, manufacture, preparation or advertising for sale, sale, collection, or other
preservation of or realization upon any Collateral; (b) any action, arbitration or other proceeding (whether instituted by or against
Agent, any Lender, any Obligor, any representative of creditors of an Obligor or any other Person) in any way relating to any Collateral
(including the validity, perfection, priority or avoidability of Agent’s Liens with respect to any Collateral), Loan Documents
or Obligations, including any lender liability and all other claims, liabilities, costs, expenses and other amounts of any kind
in any way related to the Loan Documents or Collateral at any time; (c) the exercise, protection or enforcement of any rights or
remedies of Agent and Lenders, in, or the monitoring of, any Insolvency Proceeding; (d) settlement or satisfaction of any taxes,
charges or Liens with respect to any Collateral; (e) any enforcement action or exercise of rights or remedies, of any kind, in
connection with the Obligations, the Collateral or the Loan Documents; (f) negotiation and documentation of any modification, waiver,
workout, restructuring or forbearance with respect to any Loan Documents or Obligations; and (g) Protective Advances. Such costs,
expenses and advances include transfer fees, Other Taxes, storage fees, insurance costs, permit fees, utility reservation and standby
fees, legal fees, appraisal fees, brokers’ fees and commissions, auctioneers’ fees and commissions, accountants’ fees, environmental
study fees, wages and salaries paid to employees of any Obligor or independent contractors in liquidating any Collateral, and travel
expenses.

    	 	-17-	 

     

    

“FATCA”
means Sections 1471 through 1474 of the Code (including any amended or successor version of substantively comparable and not materially
more onerous to comply with), and any agreements entered into pursuant to Section 1471(b)(1) of the Code.

“Fee Letter”
means the Fee Letter dated the Closing Date among Borrowers and Agent.

“Fiscal
Quarter” means each period of three months, commencing on the first day of a Fiscal Year.

“Fiscal
Year” means the fiscal year of Borrowers and Subsidiaries for accounting and tax purposes, ending on December 31 of each
year.

“Foreign
Lender” means any Lender that is organized under the laws of a jurisdiction other than the laws of the United States,
or any state or district thereof.

“Fronting
Exposure” means a Defaulting Lender’s Pro Rata share of Swingline Loans, as applicable, except to the extent allocated
to other Lenders under Section 4.2.

“Full Payment”
means with respect to any Obligations, (a) the full and indefeasible cash payment thereof, including any interest, fees and other
charges accruing during an Insolvency Proceeding (whether or not allowed in the proceeding); (b) if such Obligations are inchoate
or contingent in nature, Cash Collateralization thereof (or delivery of a standby letter of credit acceptable to Agent in its discretion,
in the amount of required Cash Collateral); and (c) termination of the Commitments and release by each Obligor (and by any representative
of creditors of such Obligor in any Insolvency Proceeding of such Obligor) of any claims that such Obligor has or asserts to have
against Agent, Lenders or any of their Affiliates. No Loans shall be deemed to have been paid in full until all Commitments related
to such Loans have expired or been terminated.

“Fund”
means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing
in commercial loans and similar extensions of credit in the Ordinary Course of its Business.

“GAAP”
means generally accepted accounting principles in effect in the United States from time to time.

“Guarantors”
means, collectively, each Person who guarantees (or has pledged assets to secure) payment or performance of any Obligations.

“Guaranty”
means each guaranty agreement executed by a Guarantor in favor of Agent.

“Hedging
Agreement” means any “swap agreement” as defined in Section 101(53B)(A) of the Bankruptcy Code.

“Indemnified
Taxes” means Taxes other than Excluded Taxes.

    	 	-18-	 

     

    

“Indemnitees”
means (i) Agent Indemnitees and (ii) the Lenders and State Bank and each of their respective officers, directors, employees, Affiliates,
agents and attorneys.

“Ineligible
Borrower Advance” means a Borrower Advance that is not an Eligible Borrower Advance.

“Insolvency
Proceeding” means any action, case or proceeding commenced by or against a Person under any state, federal or foreign
law for, or any agreement of such Person to, (a) the entry of an order for relief under the Bankruptcy Code, or any other insolvency,
debtor relief or debt adjustment law; (b) the appointment of a receiver, trustee, liquidator, administrator, conservator or other
custodian for such Person or any part of its Property; (c) an assignment or trust mortgage for the benefit of creditors; or (d)
the liquidation, dissolution or winding up of the affairs of such Person.

“Intellectual
Property” means all intellectual and similar Property of a Person, including inventions, designs, patents, copyrights,
trademarks, service marks, trade names, trade secrets, confidential or proprietary information, customer lists, know-how, software
and databases; all embodiments or fixations thereof and all related documentation, applications, registrations and franchises;
all licenses or other rights to use any of the foregoing; and all books and records relating to the foregoing.

“Investment
Policy” means Borrowers’ established and documented Investment Policy attached hereto as Exhibit F, as the
same may be updated from time to time with Agent’s written consent.

“IRS”
means the United States Internal Revenue Service.

“Joint
Royalty Account” means a Deposit Account maintained in the United States into which Collections in respect of a Borrower
Royalty Receivable Advance are paid (or to be paid) pursuant to the applicable Transaction Documents, which Deposit Account is
maintained in the name of a Person other than the Borrower and the applicable Customer (or is maintained in the name of such Borrower
and another Person (other than the applicable Customer) as joint owners).

“Lenders”
is as defined in the preamble to this Agreement, including Agent in its capacity as a provider of Swingline Loans and any other
Person who hereafter becomes a “Lender” pursuant to an Assignment and Acceptance.

“Lending
Office” means the office designated as such by the applicable Lender at the time it becomes party to this Agreement or
thereafter by notice to Agent and Borrower Agent.

“LIBOR
Index Loan” means a Loan during any period in which it bears interest at a rate based upon the Daily LIBOR Rate.

“Lien”
means any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, including any Lien, security
interest, pledge, hypothecation, trust, reservation, encroachment, easement, right-of-way, covenant, condition, restriction, leases,
or other title exception or encumbrance.

“Lien Waiver”
means an agreement, in form and substance satisfactory to Agent, by which for any Collateral located on leased premises, the lessor
waives or subordinates any Lien it may have on the Collateral, and agrees to permit Agent to enter upon the premises and remove
the Collateral or to use the premises to store or dispose of the Collateral.

    	 	-19-	 

     

    

“Loan”
means a Revolver Loan.

“Loan Account”
is as defined in Section 5.8.1.

“Loan Documents”
means this Agreement, each Guaranty, the Security Documents, any fee letter to which Agent is a party (including the Fee Letter),
Lien Waiver, each Borrowing Base Certificate, each Compliance Certificate, any flow of funds agreement or disbursement letter delivered
in connection with this Agreement or the transactions contemplated hereby or other note (including any notes issued pursuant to
Section 2.1.2 of this Agreement), each document, instrument, certificate (including any information certificate, solvency
certificate, incumbency certificate, closing certificate, or certificate with respect to Material Contracts)) or agreement now
or hereafter delivered by an Obligor or other Person to Agent or a Lender in connection with any transactions relating hereto,
all Borrowing Base information, reports, financial statements and other materials delivered by Borrowers hereunder to Agent or
any Lender.

“Loan Year”
means each 12 month period commencing on the Closing Date and on each anniversary of the Closing Date.

“Margin
Stock” is as defined in Regulation U of the Board of Governors.

“Material
Adverse Effect” means the effect of any event or circumstance that, taken alone or in conjunction with other events or
circumstances, (a) has or could be reasonably expected to have a material adverse effect on the business, operations, Properties,
assets, liabilities or condition (financial or otherwise) of any Obligor, on the value of any material Collateral, on the enforceability
of any Loan Documents, or on the validity or priority of Agent’s Liens on any Collateral; (b) impairs the ability of an Obligor
to perform its obligations under the Loan Documents, including repayment of any Obligations; or (c) otherwise impairs the ability
of Agent or any Lender to enforce or collect any Obligations or to realize upon any Collateral.

“Material
Contract” means any agreement or arrangement to which an Obligor or Subsidiary is party (other than the Loan Documents
and Transaction Documents) (a) for which breach, termination, nonperformance or failure to renew could reasonably be expected to
have a Material Adverse Effect; or (b) that relates to Debt incurred by an Obligor in an aggregate amount of $250,000 or more.

“Maximum
Weighted Average Remaining Term” means, on any date of determination, the amount obtained by dividing (i) the sum of,
for each Eligible Borrower First Lien Advance and Eligible Borrower Second Lien Advance outstanding on such date, (A) the Net Amount
of such Borrower Advance on such date multiplied by (B) the remaining term (measured in years and partial years) of such Borrower
Advance as provided in the applicable Transaction Documents, divided by (ii) the aggregate Net Amount of all Eligible Borrower
First Lien Advances and Eligible Borrower Second Lien Advances outstanding on such date. As an example, on a given date, assume
there are two Eligible Borrower First Lien Advances outstanding and no Eligible Borrower Second Lien Advances outstanding. One
Eligible Borrower First Lien Advance has a Net Amount of $100 and a remaining term of 1.5 years; the other Eligible Borrower First
Lien Advance has a Net Amount of $50 and a remaining term of 3.4 years. The Maximum Weighted Average Remaining Term on such date
would be calculated as follows: [($100 x 1.5 years) + ($50 x 3.4 years)] / $150 = 2.13 years.

“Mortgage
Assignments” is as defined in Section 7.4.3.

    	 	-20-	 

     

    

“Multiemployer
Plan” means any employee benefit plan of the type described in Section 4001(a)(3) of ERISA, to which any Obligor or ERISA
Affiliate makes or is obligated to make contributions, or during the preceding five plan years, has made or been obligated to make
contributions.

“Net Amount”
means, with respect to Borrower Advances by a Borrower to a Customer outstanding on any date of determination:

(a)       with
respect to any Borrower Loan Advances, the sum of (i) the aggregate unpaid principal balance of such Borrower Loan Advances on
such date (excluding any interest, fees or deferred expenses in respect of such Borrower Loan Advances that are paid in kind by
capitalizing such interest or fees and adding the same to the principal balance of such Borrower Loan Advances), minus (ii)
the aggregate amount of participations (whether or not funded) in such Borrower Advances that have been sold by such Borrower on
or before such date (it being understood that no such participations are permitted under this Agreement), minus (iii) the
amount of Collections in respect of such Borrower Advances that have not yet been applied to reduce the Net Amount of such Borrower
Advances on or before such date, or

(b)       with
respect to any Borrower Royalty Receivable Advances, the lesser of (i) the GAAP carrying value for such Borrower Royalty Receivable
Advance set forth in the most recent financial statements delivered to Agent by Borrowers pursuant to this Agreement and (ii) (A)
the aggregate purchase price paid by a Borrower to acquire the applicable Borrower Royalty Receivable, minus (B) the aggregate
amount of participations (whether or not funded) in such Borrower Advances that have been sold by such Borrower on or before such
date (it being understood that no such participations are permitted under this Agreement).

“Notice
of Borrowing” means a Notice of Borrowing to be provided by Borrower Agent to request a Borrowing of Revolver Loans, in
form satisfactory to Agent.

“Obligations”
means all (a) principal of and premium, if any, on the Loans, (b) interest, expenses, fees, indemnification obligations, reimbursement
obligations, Extraordinary Expenses and other amounts payable by Obligors under the Loan Documents, (c) Secured Bank Product Obligations,
and (d) all other Debts, covenants, duties, obligations and liabilities of any kind (including Contingent Obligations) owing by
Obligors pursuant to the Loan Documents, whether now existing or hereafter arising, whether evidenced by a note or other writing,
whether allowed in any Insolvency Proceeding, whether arising from an extension of credit, issuance of a letter of credit, acceptance,
loan, guaranty, indemnification or otherwise, and whether direct or indirect, absolute or contingent, due or to become due, primary
or secondary, or joint or several; provided, that Obligations of an Obligor shall not include its Excluded Swap Obligations.

“Obligor”
means each Borrower, each Guarantor, or other Person that is liable for payment of any Obligations or that has granted a Lien in
favor of Agent on its assets to secure any Obligations.

“OFAC”
means the U.S. Department of the Treasury’s Office of Foreign Assets Control.

“Operating
Account” means a Deposit Account maintained by a Borrower into which no Collections are remitted or received. On the
Closing Date, the Borrowers maintain the following Operating Accounts: those certain account numbers ending in 9158 and 7614 maintained
by Holdings at Wells Fargo Bank, National Association) and that certain account number ending in 4789 maintained by SWK at State
Bank.

    	 	-21-	 

     

    

“Ordinary
Course of Business” means, with respect to any transaction involving any Person, the ordinary course of such Person’s
business, as conducted by such Person in accordance with past practices and undertaken by such Person in good faith and not for
the purpose of evading any covenant or restriction in any Loan Document.

“Organic
Documents” means with respect to any Person, its charter, certificate or articles of incorporation, bylaws, articles of
organization, limited liability agreement, operating agreement, members agreement, shareholders agreement, partnership agreement,
certificate of partnership, certificate of formation, voting trust agreement, or similar agreement or instrument governing the
formation or operation of such Person.

“Osphena
Transaction Documents” means, collectively, those certain Note Purchase Agreements, dated July 9, 2013, among QuatRx
Pharmaceuticals Company, Ospemefine Royalty Sub LLC and certain note purchasers, including SWK, and each other Transaction Document
entered into in connection therewith, as the same are in effect on the Closing Date.

“Other
Taxes” means all present or future stamp or documentary taxes or any other excise or property taxes, charges or similar
levies arising from any payment made under any Loan Document or from the execution, delivery or enforcement of, or otherwise with
respect to, any Loan Document.

“Overadvance”
is as defined in Section 2.1.5.

“Overadvance
Loan” means a Revolver Loan made when an Overadvance exists or is caused by the funding thereof.

“Participant”
is as defined in Section 12.2.

“PATRIOT
Act” means the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism
Act of 2001, Pub. L. No. 107-56, 115 Stat. 272 (2001).

“Payment
Right” means all rights of Borrowers to the payment of money from one or more Customers (whether any of such rights constitutes
or is evidenced by an Account, Chattel Paper, Instrument, Document, General Intangible, Supporting Obligation, Payment Intangible
or Letter-of- Credit Right), including all rights to the repayment of Borrower Advances and all rights to payment in respect of
Borrower Royalty Receivables.

“Permitted
Intercreditor Arrangement” means, with respect to any Eligible Borrower First Lien Advance, an arrangement pursuant to
which a Borrower permits the Customer with respect to an Eligible Borrower First Lien Advance to obtain accounts receivable and/or
inventory financing on terms satisfactory to Agent (and in all events with advance rates of no more than 85% with respect to the
accounts receivable or inventory of such Customer) from a financial institution other than a Borrower, provided that (i) such arrangement
(including the terms of the proposed financing to be provided by such other financial institution) has been approved by Agent in
writing, (ii) such Borrower and such other financial institution have entered into an intercreditor agreement on a form previously
approved by Agent or otherwise in form and substance satisfactory to Agent, and (iii) such other financial institution has a lien
senior to the lien of the applicable Borrower only on accounts receivable, inventory and related assets and the applicable Borrower
has a lien on all other Customer Collateral that is senior to the liens of such other financial institution.

“Permitted
Liens” is as defined in Section 9.2.2.

    	 	-22-	 

     

    

“Permitted
Purchase Money Debt” means Purchase Money Debt of a Borrower that is unsecured or secured only by a Purchase Money Lien,
not to exceed $250,000 in the aggregate for all Borrowers at any time and subject to the limitations set forth in Section 9.3.

“Person”
means any individual, corporation, limited liability company, partnership, limited liability partnership, joint stock company,
joint venture, association, trust, unincorporated organization, governmental authority or other entity.

“Plan”
means any employee benefit plan (as defined in Section 3(3) of ERISA) established by an Obligor or, with respect to any such plan
that is subject to Section 412 of the Code or Title IV of ERISA, an ERISA Affiliate.

“Pledge
Agreement” means that certain Pledge Agreement dated the Closing Date by and between Agent and Holdings and acknowledged
by SWK.

“Pro Rata”
means with respect to any Lender, a percentage (rounded to the ninth decimal place) determined (a) while Revolver Commitments are
outstanding, by dividing the amount of such Lender’s Revolver Commitment by the aggregate amount of all Revolver Commitments; and
(b) at any other time, by dividing the amount of such Lender’s Loans by the aggregate amount of all outstanding Loans.

“Properly
Contested” means with respect to any obligation of an Obligor, (a) the obligation is subject to a bona fide dispute regarding
amount or the Obligor’s liability to pay; (b) the obligation is being properly contested in good faith by appropriate proceedings
promptly instituted and diligently pursued; (c) appropriate reserves have been established in accordance with GAAP; (d) non-payment
could not have a Material Adverse Effect, nor result in forfeiture or sale of any assets of the Obligor; (e) no Lien is imposed
on assets of the Obligor, unless bonded and stayed to the satisfaction of Agent; and (f) if the obligation results from entry of
a judgment or other order, such judgment or order is stayed pending appeal or other judicial review; and (g) if such contest is
abandoned, settled, or determined adversely (in whole or in part) to such Obligor, such Obligor forthwith pays such amounts and
all penalties, interest, and other amounts due in connection therewith. Only that portion of a Debt or Tax which is in dispute
may be deemed Properly Contested.

“Property”
means any interest in any kind of property or asset, whether real, personal or mixed, or tangible or intangible.

“Protective
Advances” is as defined in Section 2.1.6.

“Purchase
Money Debt” means Debt (including Capitalized Lease Obligations and excluding the Obligations) for payment of any of the
purchase price of fixed assets and Debt (including Capitalized Lease Obligations and excluding the Obligations) incurred within
10 days before or after acquisition of any fixed assets for the purpose of financing such purchase price.

“Purchase
Money Lien” means a Lien that secures Purchase Money Debt and that encumbers only the fixed assets acquired with such
Purchase Money Debt and that constitutes a capital lease or a purchase money security interest under the UCC.

“Qualified
ECP” means an Obligor that constitutes an “eligible contract participant” under the Commodity Exchange Act and
can cause another Person to qualify as an “eligible contract participant” under Section 1 a(18)(A)(v)(II) of such act.

“Remedies”
means all remedies, privileges and powers of Borrowers that are exercisable by Borrowers under the Transaction Documents or Applicable
Law to enforce any rights of the applicable Borrowers under such Transaction Documents, including, in the case of Borrower Royalty
Receivable Advances, all remedies, privileges and powers of Borrowers that are exercisable by Borrowers under the underlying Royalty
Purchase Documents and license agreements with respect to which the related Royalty Payments are due.

    	 	-23-	 

     

    

“Report”
is as defined in Section II(c) on Exhibit D.

“Required
Lenders” means two or more Lenders (subject to Section 4.2) having (a) Revolver Commitments in excess of 50% of
the aggregate Revolver Commitments; and (b) if the Revolver Commitments have terminated, Loans in excess of 50% of all outstanding
Loans; provided, however, that the Commitments and Loans of any Defaulting Lender shall be excluded from such calculation
and at any time there is one Lender only, such Lender shall constitute the Required Lenders.

“Required
Supermajority Lenders” means two or more Lenders (subject to Section 4.2) having (a) Revolver Commitments in excess
of 66 2/3% of the aggregate Revolver Commitments; and (b) if the Revolver Commitments have terminated, Loans in excess of 66 2/3%
of all outstanding Loans; provided, however, that the Commitments and Loans of any Defaulting Lender shall be excluded from such
calculation and at any time there is one Lender only, such Lender shall constitute the Required Supermajority Lenders.

“RESPA”
means the Real Estate Settlement Procedures Act, 12 U.S.C. §§ 2601-2617, as amended.

“Restrictive
Agreement” means an agreement (other than a Loan Document) that conditions or restricts the right of any Borrower, Subsidiary
or other Obligor to incur or repay Borrowed Money, to grant Liens on any assets, to declare or make Distributions, to modify, extend
or renew any agreement evidencing Borrowed Money, or to repay any intercompany Debt.

“Revolver
Commitment” means, for any Lender, its obligation to make Revolver Loans up to the maximum principal amount shown on Schedule
1-B, as hereafter modified pursuant to Section 2.1.7 or an Assignment and Acceptance to which it is a party. “Revolver
Commitments” means the aggregate amount of such commitments of all Lenders.

“Revolver
Loan” means a loan made pursuant to Section 2.1, and any Swingline Loan, Overadvance Loan or Protective Advance.

“Revolver
Termination Date” means June 29, 2021.

“Royalties”
means all royalties, fees, expense reimbursements and other amounts payable by an Obligor under a license.

“Royalty
Payments” means, collectively, all royalties, fees, expense reimbursements and other amounts payable to a particular
Royalty Seller (or a Borrower as assignee of a Royalty Seller) under a license.

“Royalty
Purchase Agreement” means a Royalty Purchase Agreement, substantially in the form attached to the Certificate Regarding
Forms of Transaction Documents, or another agreement in form and substance satisfactory to Agent in all respects, pursuant to which
a Borrower acquires from a Royalty Seller, and such Royalty Seller sells and assigns to such Borrower, all or a specified portion
of its right, title and interest in and to certain Royalty Payments payable to such Royalty Seller.

    	 	-24-	 

     

    

“Royalty
Purchase Documents” means, with respect to any Royalty Payments (or any percentage of Royalty Payments) acquired by a
Borrower from a Royalty Seller, (i) the Royalty Purchase Agreement between such Borrower and such Royalty Seller, (ii) the UCC-1
financing statement naming each applicable Royalty Seller as debtor and such Borrower as secured party and identifying the “Collateral”
as all of the Borrower Royalty Receivables acquired by such Borrower pursuant to such Royalty Purchase Agreement, and (iii) each
other document or agreement evidencing or relating to the Borrower Royalty Receivables of such Royalty Payments (or percentages
thereof) from such Royalty Seller.

“Royalty
Seller” means any Person from which a Borrower acquires any right, title or interest in any Royalty Payments.

“Sanctioned
Country” means, at any time, a country, region or territory that is, or whose government is, the subject or target of
any Sanctions.

“Sanctioned
Person” means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by OFAC,
the U.S. Department of State, the United Nations Security Council, the European Union or any EU member state, (b) any Person located,
organized, incorporated or resident in a Sanctioned Country or (c) any Person controlled by any such Person.

“Sanctions”
means economic or financial sanctions or trade embargoes administered or enforced from time to time by (a) the U.S. government,
including those administered by OFAC or the U.S. Department of State or (b) the United Nations Security Council, the European Union
or Her Majesty’s Treasury of the United Kingdom.

“Secured
Bank Product Obligations” means Debt, obligations and other liabilities with respect to Bank Products owing by an Obligor
or Subsidiary to a Secured Bank Product Provider; provided, that Secured Bank Product Obligations of an Obligor shall not
include its Excluded Swap Obligations.

“Secured
Bank Product Provider” means (a) State Bank or any of its Affiliates; and (b) any other Lender or Affiliate of a Lender
that is providing a Bank Product, provided such provider delivers written notice to Agent, in form and substance satisfactory to
Agent, within 10 days following the later of the Closing Date or creation of the Bank Product, (i) describing the Bank Product
and setting forth the maximum amount to be secured by the Collateral and the methodology to be used in calculating such amount,
and (ii) agreeing to be bound by Section XII of Exhibit D.

“Secured
Parties” means Agent, Lenders and Secured Bank Product Providers.

“Security
Documents” means the Borrower Assignment Agreement, the Guaranties, deposit account control agreements, the Pledge Agreement,
securities account control agreements, any commodity account control agreements (or, without limitation, other agreements providing
Agent “control” (as contemplated by Section 9-104 of the UCC) of a deposit account, securities account, commodity account
or similar account), and all other documents, instruments and agreements now or hereafter securing or perfecting (or given with
the intent to secure or perfect) any Obligations.

“Senior
Officer” means the chairman of the board, president, chief executive officer, chief financial officer or treasurer of
Borrower or, if the context requires, an Obligor.

“Settlement
Report” means a report summarizing Revolver Loans outstanding as of a given settlement date, allocated to Lenders on a
Pro Rata basis in accordance with their Revolver Commitments.

    	 	-25-	 

     

    

“Solvent”
means, as to any Person, such Person (a) owns Property whose fair salable value is greater than the amount required to pay all
of its debts (including contingent, subordinated, unmatured and unliquidated liabilities); (b) owns Property whose present fair
salable value (as defined below) is greater than the probable total liabilities (including contingent, subordinated, unmatured
and unliquidated liabilities) of such Person as they become absolute and matured; (c) is able to pay all of its debts as they mature;
(d) has capital that is not unreasonably small for its business and is sufficient to carry on its business and transactions and
all business and transactions in which it is about to engage; (e) is not “insolvent” within the meaning of Section 101(32)
of the Bankruptcy Code; and (f) has not incurred (by way of assumption or otherwise) any obligations or liabilities (contingent
or otherwise) under any Loan Documents, or made any conveyance in connection therewith, with actual intent to hinder, delay or
defraud either present or future creditors of such Person or any of its Affiliates. “Fair salable value” means
the amount that could be obtained for assets within a reasonable time, either through collection or through sale under ordinary
selling conditions by a capable and diligent seller to an interested buyer who is willing (but under no compulsion) to purchase.

“State
Bank” means State Bank and Trust Company, a Georgia banking corporation, and its successors and assigns.

“Subsidiary”
means, with respect to any Person, a corporation, partnership, limited liability company or other entity in which that Person directly
or indirectly owns or controls more than 50% of the Equity Interests or more than 50% of the voting power of such corporation,
partnership, limited liability company or other entity. In the context of the Obligors, Subsidiary also means any entity at least
50% of whose voting power or Equity Interests are owned by an Obligor or any combination of Obligors (including indirect ownership
by an Obligor through other entities in which such Obligor directly or indirectly owns 50% of the voting power or Equity Interests).

“Swap Obligations”
means, with respect to any Obligor, its obligations under a Hedging Agreement that constitutes a “swap” within the meaning
of Section 1a(47) of the Commodity Exchange Act.

“Swingline
Loan” means any Borrowing of Revolver Loans funded with Agent’s funds, until such Borrowing is settled among Lenders or
repaid by Borrowers.

“Taxes”
means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments,
fees or other charges imposed by any governmental authority, including any interest, additions to tax or penalties applicable thereto.

“Transaction
Documents” means, collectively, all instruments, agreements, documents and other writings that now or hereafter (i) evidence
any Borrower Advance or other Payment Right, including all promissory notes and loan agreements, (ii) secure (whether by the grant
or conveyance of a security interest, Lien or other encumbrance) or perfect any Borrower’s Lien in any Payment Right, including
all security agreements, UCC-1 financing statements, mortgages, security deeds, trust deeds, pledge agreements, lease agreements,
conditional sales agreements, negative pledge agreements, and assignments, (iii) guarantee the payment or performance of all or
any part of any Payment Right owing by a Customer, including all guaranties, support or contribution agreements, letters of credit,
indemnifications and repurchase agreements and (iv) are at any time executed and delivered by any Person in connection with or
relating to any Payment Right. Without limiting the generality of the foregoing, the term “Transaction Documents” shall
mean and include all Customer Credit Agreements, all Royalty Purchase Documents (if applicable), all documents assigned pursuant
to the Borrower Assignment Agreement (including UCC financing statements), all landlord waivers or agreements, mortgagee waivers
or agreements, warehousemen agreements, processor agreements, lockbox, deposit account control agreements or other dominion account
agreements, intercreditor or subordination agreements and estoppel certificates, whether the foregoing are executed and delivered
by a Customer, any guarantor or surety of a Payment Right or any other Person.

    	 	-26-	 

     

    

“Transferee”
means any actual or potential Eligible Assignee, Participant or other Person acquiring an interest in any Obligations.

“TRT Transaction
Document” means that certain Royalty Purchase Agreement dated as of June ___, 2013, between Tissue Regeneration Therapeutics,
Inc. and SWK, and each other Transaction Document entered into in connection therewith, as the same are in effect on the Closing
Date.

“Type”
means any type of a Loan (i.e., Base Rate Loan or LIBOR Index Loan) that has the same interest option.

“UCC”
means the Uniform Commercial Code as in effect in the State of Georgia or, when the laws of any other jurisdiction govern the perfection
or enforcement of any Lien, the Uniform Commercial Code of such jurisdiction.

“UFCA”
is as defined in Section 5.12.3.

“UFTA”
is as defined in Section 5.12.3.

“Upstream
Payment” means a Distribution by a Subsidiary of a Borrower to such Borrower.

1.2              
Accounting Terms. Under the Loan Documents (except as otherwise specified herein), all accounting terms shall
be interpreted, all accounting determinations shall be made, and all financial statements shall be prepared, in accordance with
GAAP applied on a basis consistent with the most recent audited financial statements of Borrowers delivered to Agent before the
Closing Date and using the same inventory valuation method as used in such financial statements, except for any change required
or permitted by GAAP if Borrowers’ certified public accountants concur in such change, the change is disclosed to Agent,
and Section 9.3 is amended in a manner satisfactory to Required Lenders to take into account the effects of the change.

1.3              
Uniform Commercial Code. All other terms contained in this Agreement shall have, when the context so indicates,
the meanings provided for by the UCC to the extent the same are used or defined therein. Without limiting the generality of the
foregoing, the following terms shall have the meaning ascribed to them in the UCC: Account, Chattel Paper, Commercial Tort Claim,
Commodity Account, Deposit Account, Document, Electronic Chattel Paper, Equipment, Fixtures, Goods, General Intangible, Instrument,
Inventory, Investment Property, Letter-of-Credit Right, Payment Intangible, Proceeds, Securities Account, Software and Supporting
Obligations.

1.4              
Certain Matters of Construction. The terms “herein,” “hereof,” “hereunder” and
other words of similar import refer to this Agreement as a whole and not to any particular section, paragraph or subdivision. Any
pronoun used shall be deemed to cover all genders. In the computation of periods of time from a specified date to a later specified
date, “from” means “from and including,” and “to” and “until” each mean “to but excluding.”
The terms “including” and “include” shall mean “including, without limitation” and, for purposes
of each Loan Document, the parties agree that the rule of ejusdem generis shall not be applicable to limit any provision.
Section titles appear as a matter of convenience only and shall not affect the interpretation of any Loan Document. All references
to (a) laws or statutes include all related rules, regulations, interpretations, amendments and successor provisions; (b) any document,
instrument or agreement include any amendments, waivers and other modifications, extensions or renewals (to the extent permitted
by the Loan Documents); (c) any section mean, unless the context otherwise requires, a section of this Agreement; (d) any exhibits
or schedules mean, unless the context otherwise requires, exhibits and schedules attached hereto, which are hereby incorporated
by reference; (e) any Person include successors and assigns; (f) time of day means time of day at Agent’s notice address under
Section 13.3.1; or (g) discretion of Agent or any Lender mean the sole and absolute discretion of such Person. The recitals
and preamble hereto are incorporated by reference and shall be deemed an integral part of this Agreement. All calculations of value,
fundings of Loans and payments of Obligations shall be in Dollars and, unless the context otherwise requires, all determinations
(including calculations of Borrowing Base and financial covenants) made from time to time under the Loan Documents shall be made
in light of the circumstances existing at such time. Borrowing Base calculations shall be consistent with historical methods of
valuation and calculation, and otherwise satisfactory to Agent (and not necessarily calculated in accordance with GAAP). Borrowers
shall have the burden of establishing any alleged negligence, misconduct or lack of good faith by Agent or any Lender under any
Loan Documents. No provision of any Loan Documents shall be construed against any party by reason of such party having, or being
deemed to have, drafted the provision. Whenever the phrase “to the best of Borrowers’ knowledge” or words of similar
import are used in any Loan Documents, it means actual knowledge of a Senior Officer, or knowledge that a Senior Officer would
have obtained if he or she had engaged in good faith and diligent performance of his or her duties, including reasonably specific
inquiries of employees or agents and a good faith attempt to ascertain the matter to which such phrase relates.

    	 	-27-	 

     

    

SECTION
2.            
CREDIT FACILITIES

2.1              
Revolver Commitment

2.1.1         
Revolver Loans. Each Lender agrees, severally on a Pro Rata basis up to its Revolver Commitment, on the terms set
forth herein, to make Revolver Loans to Borrowers from time to time through the Commitment Termination Date. The Revolver Loans
may be repaid and reborrowed as provided herein. In no event shall Lenders have any obligation to honor a request for a Revolver
Loan if the unpaid balance of Revolver Loans outstanding at such time (including the requested Loan) would exceed the Borrowing
Base.

2.1.2         
Revolver Notes. The Revolver Loans made by each Lender and interest accruing thereon shall be evidenced by the records
of Agent and such Lender. At the request of any Lender, Borrowers shall deliver a promissory note to such Lender evidencing the
Borrowers obligations in respect of the Revolver Commitments of such Lender.

2.1.3         
Use of Proceeds. The proceeds of Revolver Loans shall be used by Borrowers solely (a) to make Borrower Advances on
and after the Closing Date in the Ordinary Course of Business of Borrowers; (b) to pay fees and transaction expenses associated
with the closing of this credit facility; (c) to pay Obligations in accordance with this Agreement; and (d) for working capital
and other lawful corporate purposes of Borrowers not inconsistent with the terms of this Agreement. Borrowers will not request
any Loan, and Borrower will not use, and its directors, officers, employees and agents will not use, the proceeds of any Loan (a)
in the furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of
value, to any Person in violation of any Anti-Corruption Laws, (b) for the purpose of funding, financing or facilitating any activities,
business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, to the extent such activities, businesses
or transaction would be prohibited by Sanctions if conducted by a corporation incorporated in the United States or in an European
Union member state or (c) in any manner that would result in the violation of any Sanctions applicable to any party hereto.

    	 	-28-	 

     

    

2.1.4         
Termination of Revolver Commitments.

(a)       The
Revolver Commitments shall terminate on the Revolver Termination Date, unless sooner terminated in accordance with this Agreement.
Upon at least 15 Business Days prior written notice to Agent, Borrowers may, at their option, terminate the Revolver Commitments
and this credit facility. Any notice of termination given by Borrowers shall be irrevocable. On the termination date, Borrowers
shall make Full Payment of all Obligations.

(b)       Concurrently
with any termination of the Revolver Commitments, for whatever reason (including an Event of Default), Borrowers shall pay to Agent,
for the Pro Rata benefit of Lenders, and as liquidated damages for loss of bargain (and not as a penalty), an amount equal to (i)
if the termination occurs during the first or second Loan Year, 1.0% (less 4.17 basis points per month for each month during the
first two Loan Years that has passed prior to such termination) of the Revolver Commitments; and (ii) if it occurs thereafter,
0.5% (less 4.17 basis points per month for each month after the end of the second Loan Year that has passed prior to such termination)
of the Revolver Commitments. No termination charge shall be payable if (x) termination occurs on the Revolver Termination Date
or (y) termination occurs in connection with Full Payment of the Obligations using proceeds of a refinancing credit facility with
a commitment amount of not less than $60,000,000 and in which State Bank is given the opportunity but declines to participate.

(c)       Notwithstanding
the forgoing, Borrowers may terminate the Revolver Commitments and this credit facility, upon not less than 15 Business Days prior
written notice to Agent, without the payment of the liquidated damages provided for in Section 2.1.4, in the event that Agent exercises
its discretion (in lieu of relying on specific exclusionary or reserve language in this Agreement) in relation to the imposition
of any Availability Reserve, the determination of eligibility of Borrower Advances for inclusion in the Borrowing Base, or any
reduction in the advance rates applicable under the definition of Borrowing Base, the result of which on any date of such exercise
of reasonable credit judgment is to reduce the Borrowing Base by an amount greater than twenty-five percent (25%) of the aggregate
Revolver Commitments on such date.

2.1.5         
Overadvances. If the aggregate Revolver Loans exceed the Borrowing Base (“Overadvance”) at any time,
the excess amount shall be payable by Borrowers on demand by Agent, but all such Revolver Loans shall nevertheless constitute
Obligations secured by the Collateral and entitled to all benefits of the Loan Documents. Agent may require Lenders to honor requests
for Overadvance Loans and to forbear from requiring Borrowers to cure an Overadvance, (a) when no other Event of Default is known
to Agent, as long as (i) the Overadvance does not continue for more than 30 consecutive days (and no Overadvance may exist for
at least five consecutive days thereafter before further Overadvance Loans are required), and (ii) the Overadvance is not known
by Agent to exceed an amount equal to the greater of (x) $3,000,000 or (y) ten percent (10%) of the Commitments at such time; and
(b) regardless of whether an Event of Default exists, if Agent discovers an Overadvance not previously known by it to exist, as
long as from the date of such discovery the Overadvance (i) is not increased by more than an amount equal to the greater of (x)
$1,500,000 or (y) five percent (5%) of the Commitments at such time, and (ii) does not continue for more than 30 consecutive days.
In no event shall Overadvance Loans be required that would cause the outstanding Revolver Loans to exceed the aggregate Revolver
Commitments. Any funding of an Overadvance Loan or sufferance of an Overadvance shall not constitute a waiver by Agent or Lenders
of the Event of Default caused thereby. In no event shall any Borrower or other Obligor be deemed a beneficiary of this Section
or authorized to enforce any of its terms.

    	 	-29-	 

     

    

2.1.6         
Protective Advances. Agent shall be authorized, in its discretion, notwithstanding whether any conditions in Section
6 have been satisfied and without regard to the aggregate Commitments, to make Revolver Loans (“Protective Advances”)
(a) up to an aggregate amount of the greater of (x) $2,000,000 or (y) ten percent (10%) of the Commitments at any time, if Agent
deems such Loans necessary or desirable to preserve or protect Collateral, or to enhance the collectibility or repayment of Obligations;
or (b) to pay any other amounts chargeable to Obligors under any Loan Documents, including costs, fees and expenses. Each Lender
shall participate in each Protective Advance on a Pro Rata basis. Required Lenders may at any time revoke Agent’s authority to
make further Protective Advances under clause (a) by written notice to Agent. Absent such revocation, Agent’s determination
that funding of a Protective Advance is appropriate shall be conclusive.

2.1.7         
Increase in Revolver Commitments. Borrowers may request an increase in Revolver Commitments from time to time upon
notice to Agent, as long as (a) the requested increase is in a minimum amount of $5,000,000 and is offered on the same terms as
existing Revolver Commitments, except for fees specified in the Fee Letter, (b) total increases under this Section do not exceed
$15,000,000 and no more than three (3) increases are made, and (c) Required Lenders consent in writing to such increase. Agent
shall promptly notify Lenders of the requested increase and, within 10 Business Days thereafter, each Lender shall notify Agent
if and to what extent such Lender commits to increase its Revolver Commitment. Any Lender not responding within such period shall
be deemed to have declined an increase. If Lenders fail to commit to the full requested increase, Eligible Assignees may issue
additional Revolver Commitments and become Lenders hereunder. Agent may allocate, in its discretion, the increased Revolver Commitments
among committing Lenders and, if necessary, Eligible Assignees. Provided the conditions set forth in Section 6.2 are satisfied,
total Revolver Commitments shall be increased by the requested amount (or such lesser amount committed by Lenders and Eligible
Assignees) on a date agreed upon by Agent and Borrowers. Agent, Borrowers, and the new and existing Lenders shall execute and deliver
such documents and agreements as Agent deems appropriate to evidence the increase in and allocations of Revolver Commitments. On
the effective date of an increase, the exposures under the Revolver Commitments shall be reallocated among Lenders, and settled
by Agent as necessary, in accordance with Lenders’ adjusted shares of such commitments.

2.2              
[Reserved]

SECTION
3.            
INTEREST, FEES AND CHARGES

3.1              
Interest

3.1.1         
Rates and Payment of Interest.

(a)               
Subject to Section 3.1.1(b) below, the Obligations shall bear interest at the Daily LIBOR Rate in effect from time
to time, plus the Applicable Margin, or in Agent’s discretion at any time that Agent determines that (i) it is not reasonably
possible to determine the Daily LIBOR Rate, (ii) that the Daily LIBOR Rate is no longer available, or (iii) it is no longer lawful
for any Lender to make Loans at any rate based on the Daily LIBOR Rate, the Base Rate in effect from time to time, plus the Applicable
Margin. Interest shall accrue from the date the Loan is advanced or the Obligation is incurred or payable, until paid by Borrowers.
If a Loan is repaid on the same day made, one day’s interest shall accrue. The Daily LIBOR Rate on the date hereof is 2.09213%
per annum and, therefore, the rate of interest in effect on the date hereof, expressed in simple interest terms, is 5.34213% per
annum for LIBOR Index Loans.

(b)              
During an Insolvency Proceeding with respect to any Obligor, or during any other Event of Default if Agent or Required Lenders
in their discretion so elect, Obligations shall bear interest at the Default Rate (whether before or after any judgment). Each
Borrower acknowledges that the cost and expense to Agent and Lenders due to an Event of Default are difficult to ascertain and
that the Default Rate is a fair and reasonable estimate to compensate Agent and Lenders for this.

    	 	-30-	 

     

    

(c)               
Interest accrued on the Loans shall be due and payable in arrears, (i) on the first day of each calendar month; (ii) on
any date of prepayment, with respect to the principal amount of Loans being prepaid; and (iii) on the Commitment Termination Date
or the date the Obligations are accelerated pursuant to the terms of this Agreement. Interest accrued on any other Obligations
shall be due and payable as provided in the Loan Documents and, if no payment date is specified, shall be due and payable on
demand. Notwithstanding the foregoing, interest accrued at the Default Rate shall be due and payable on demand.

(d)              
Without limiting the generality of Section 4.1.1(b), unless payment is otherwise timely made by Borrowers, the becoming
due of any Obligations constituting interest shall be deemed to be a request for Revolver Loans on the due date, in the amount
of such Obligations. The proceeds of such Revolver Loans shall be disbursed as direct payment of the relevant Obligation. In addition,
Agent may, at its option, charge such Obligations against any operating, investment or other account of a Borrower maintained with
Agent or any of its Affiliates.

3.1.2         
[Reserved]

3.1.3         
Types of Loans. Except as otherwise provided in this Agreement, including pursuant to Section 3.1.4, 3.5
or 3.6, all Loans shall be made as LIBOR Index Loans.

3.1.4         
Interest Rate Not Ascertainable. If Agent shall determine that on any date for determining LIBOR, due to any circumstance
affecting the London interbank market, adequate and fair means do not exist for ascertaining such rate on the basis provided herein,
then Agent shall immediately notify Borrower Agent of such determination and all LIBOR Index Loans shall be converted to Base Rate
Loans. Until Agent notifies Borrower Agent that such circumstance no longer exists, all future Loans will be Base Rate Loans.

3.2              
Fees

3.2.1         
Unused Line Fee. Borrowers shall pay to Agent, for the Pro Rata benefit of Lenders, a fee equal to 0.50% per annum
times the amount by which the Revolver Commitments exceed the average daily balance of Revolver Loans during any month. Such fee
shall be payable in arrears, on the first day of each month and on the Commitment Termination Date.

3.2.2         
Agent Fees. Borrowers shall pay to Agent, for its own account, the fees described in the Fee Letter. Borrowers shall
also pay to Agent its standard wire fee for each outgoing wire made by Agent at the request of Borrowers.

3.3              
Computation of Interest, Fees, Yield Protection. All interest, as well as fees and other charges calculated on
a per annum basis, shall be computed for the actual days elapsed, based on a year of 360 days. Each determination by Agent of any
interest, fees or interest rate hereunder shall be final, conclusive and binding for all purposes, absent manifest error. All fees
shall be fully earned when due and shall not be subject to rebate, refund or proration. All fees payable under Section 3.2
are compensation for services and are not, and shall not be deemed to be, interest or any other charge for the use, forbearance
or detention of money. A certificate as to amounts payable by Borrowers under Section 3.4, 3.6, 3.7, 3.8 or 5.9,
submitted to Borrower Agent by Agent or the affected Lender, as applicable, shall be final, conclusive and binding for all purposes,
absent manifest error, and Borrowers shall pay such amounts to the appropriate party within 10 days following receipt of the certificate.

    	 	-31-	 

     

    

3.4              
Reimbursement Obligations. Obligors shall reimburse Agent and Lenders for all Extraordinary Expenses. Obligors
shall also reimburse Agent for all legal (to the extent reasonable), accounting, appraisal, consulting, and other fees, costs and
expenses incurred by any of them in connection with (a) negotiation and preparation of any Loan Documents, including any amendment
or other modification thereof; (b) administration of and actions relating to any Collateral, Loan Documents and transactions contemplated
thereby, including any actions taken to perfect or maintain priority of Agent’s Liens on any Collateral, to maintain any insurance
required hereunder or to verify Collateral; and (c) subject to the limits of Section 9.1.2(b), each inspection, audit or appraisal
with respect to any Obligor or Collateral, whether prepared by Agent’s personnel or a third party. All legal (to the extent reasonable),
accounting and consulting fees shall be charged to Borrowers by Agent’s and Lenders’ respective professionals at their full hourly
rates, regardless of any reduced or alternative fee billing arrangements that Agent, any Lender or any of their Affiliates may
have with such professionals with respect to this or any other transaction; provided, that the foregoing shall in no way
limit Obligors’ obligations to reimburse Agent or Lenders as provided for elsewhere in the Loan Documents, including reimbursement
of Extraordinary Expenses pursuant to this Section 3.4 and reimbursements contemplated pursuant to Section 9.1.2.
All amounts payable by Obligors under this Section shall be due on demand. All amounts payable by Obligors under this Section
shall be due on demand.

3.5              
Illegality. If any Lender determines that any Applicable Law has made it unlawful, or that any governmental authority
has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund LIBOR Index Loans,
or to determine or charge interest rates based upon the Daily Libor Rate, or any governmental authority has imposed material restrictions
on the authority of such Lender to purchase or sell, or to take deposits of, Dollars in the London interbank market, then, on notice
thereof by such Lender to Agent, all LIBOR Index Loans shall immediately be converted to Base Rate Loans and all future Loans shall
be Base Rate Loans. Upon any such conversion, Borrowers shall also pay accrued interest on the amount so prepaid or converted.

3.6              
Inability to Determine Rates. If Required Lenders notify Agent for any reason in connection with a request for
a Borrowing of a LIBOR Index Loan that (a) Dollar deposits are not being offered to banks in the London interbank Eurodollar market
for the applicable amount for a one-month period, (b) adequate and reasonable means do not exist for determining LIBOR for a one-month
period, or (c) LIBOR for a one-month period does not adequately and fairly reflect the cost to such Lenders of funding such Loan,
then Agent will promptly so notify Borrower Agent and each Lender. Thereafter, all LIBOR Index Loans of Lenders shall immediately
be converted to Base Rate Loans and all future Loans shall be Base Rate Loans. Upon receipt of such notice, Borrower Agent may
revoke any pending request for a Borrowing of a LIBOR Index Loan or, failing that, will be deemed to have submitted a request for
a Base Rate Loan.

3.7              
Increased Costs; Capital Adequacy

3.7.1         
Change in Law. If any Change in Law shall:

(a)               
impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement
against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender (including any reserve
requirement);

(b)              
subject any Lender to any Tax with respect to any Loan or Loan Document, or change the basis of taxation of payments to
such Lender in respect thereof (except for Indemnified Taxes or Other Taxes covered by Section 5.9 and the imposition of,
or any change in the rate of, any Excluded Tax payable by such Lender); or

    	 	-32-	 

     

    

(c)               
impose on any Lender or interbank market any other condition, cost or expense affecting any Loan, Loan Document, or Commitment;

and the result thereof
shall be to increase the cost to such Lender of making or maintaining any Loan or Commitment, or to reduce the amount of any sum
received or receivable by such Lender hereunder (whether of principal, interest or any other amount) then, upon request of such
Lender, Borrowers will pay to such Lender such additional amount or amounts as will compensate such Lender for such additional
costs incurred or reduction suffered.

3.7.2         
Capital Adequacy. If any Lender determines that any Change in Law affecting such Lender or any Lending Office of
such Lender or such Lender’s holding company, if any, regarding capital or liquidity requirements has or would have the effect
of reducing the rate of return on such Lender’s or holding company’s capital as a consequence of this Agreement, or such Lender’s
Commitments or Loans, to a level below that which such Lender or holding company could have achieved but for such Change in Law
(taking into consideration such Lender’s and holding company’s policies with respect to capital adequacy and liquidity), then from
time to time Borrowers will pay to such Lender such additional amount or amounts as will compensate it or its holding company for
any such reduction suffered.

3.7.3         
Compensation. Failure or delay on the part of any Lender to demand compensation pursuant to this Section shall not
constitute a waiver of its right to demand such compensation, but Borrowers shall not be required to compensate a Lender for any
increased costs incurred or reductions suffered more than 180 days prior to the date that the Lender notifies Borrower Agent of
the Change in Law giving rise to such increased costs or reductions and of such Lender’s intention to claim compensation therefor
(except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine-month period
referred to above shall be extended to include the period of retroactive effect thereof).

3.8              
Mitigation. If any Lender gives a notice under Section 3.5 or requests compensation under Section 3.7,
or if Borrowers are required to pay additional amounts with respect to a Lender under Section 5.9, then such Lender shall
use reasonable efforts to designate a different Lending Office or to assign its rights and obligations hereunder to another of
its offices, branches or Affiliates, if, in the judgment of such Lender, such designation or assignment (a) would eliminate the
need for such notice or reduce amounts payable or to be withheld in the future, as applicable; and (b) would not subject the Lender
to any unreimbursed cost or expense and would not otherwise be disadvantageous to it or unlawful. Borrowers shall pay all reasonable
costs and expenses incurred by any Lender in connection with any such designation or assignment. Notwithstanding anything to the
contrary set forth herein, no Participant shall be entitled to receive additional amounts under Section 3.7 or Section
5.9 or indemnification in amounts in excess of those the participating Lender would have been entitled to receive in respect
of the amount of participation transferred to such Participant had no such participation occurred.

3.9              
[Reserved]

3.10           
Maximum Interest. Notwithstanding anything to the contrary contained in any Loan Document, the interest paid
or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by Applicable
Law (“maximum rate”). If Agent or any Lender shall receive interest in an amount that exceeds the maximum rate, the excess
interest shall be applied to the principal of the Obligations or, if it exceeds such unpaid principal, refunded to Borrowers. In
determining whether the interest contracted for, charged or received by Agent or a Lender exceeds the maximum rate, such Person
may, to the extent permitted by Applicable Law, (a) characterize any payment that is not principal as an expense, fee or premium
rather than interest; (b) exclude voluntary prepayments and the effects thereof; and (c) amortize, prorate, allocate and spread
in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations hereunder.

    	 	-33-	 

     

    

SECTION
4.            
LOAN ADMINISTRATION

4.1              
Manner of Borrowing and Funding Revolver Loans

4.1.1         
Notice of Borrowing.

(a)               
Whenever Borrowers desire funding of a Borrowing of Revolver Loans, Borrower Agent shall give Agent a Notice of Borrowing
signed by a Senior Officer, which shall be in such form as may be required by Agent (and which notice may be given electronically
subject to the limitations set forth in Section 13.3.2) and which shall specify the account of Borrowers into which the
proceeds of such Revolver Loans should be disbursed. Such notice must be received by Agent no later than 11:00 a.m. on the Business
Day of the requested funding date. Notices received after 11:00 a.m. shall be deemed received on the next Business Day. Each Notice
of Borrowing shall be irrevocable and shall specify (A) the amount of the Borrowing and (B) the requested funding date (which must
be a Business Day).

(b)              
Unless payment is otherwise timely made by Borrowers, the becoming due of any Obligations (whether principal, interest,
fees or other charges, including Extraordinary Expenses, Cash Collateral and Secured Bank Product Obligations) shall be deemed
to be a request for Revolver Loans on the due date, in the amount of such Obligations. The proceeds of such Revolver Loans shall
be disbursed as direct payment of the relevant Obligation. In addition, Agent may, at its option, charge such Obligations against
any operating, investment or other account of a Borrower maintained with Agent or any of its Affiliates.

(c)               
If Borrowers establish a controlled disbursement account with Agent or any Affiliate of Agent, then the presentation for
payment of any check, ACH or electronic debit, or other payment item at a time when there are insufficient funds to cover it shall
be deemed to be a request for Revolver Loans on the date of such presentation, in the amount of such payment item. The proceeds
of such Revolver Loans may be disbursed directly to the controlled disbursement account or other appropriate account.

4.1.2         
Fundings by Lenders. Each Lender shall timely honor its Revolver Commitment by funding its Pro Rata share of each
Borrowing of Revolver Loans that is properly requested hereunder. Except for Borrowings to be made as Swingline Loans, Agent shall
endeavor to notify Lenders of each Notice of Borrowing (or deemed request for a Borrowing) by 12:00 noon on the proposed funding
date for Base Rate Loans or LIBOR Index Loans. Each Lender shall fund to Agent such Lender’s Pro Rata share of the Borrowing to
the account specified by Agent in immediately available funds not later than 2:00 p.m. on the requested funding date, unless Agent’s
notice is received after the times provided above, in which case Lender shall fund its Pro Rata share by 11:00 a.m. on the next
Business Day. Subject to its receipt of such amounts from Lenders, Agent shall disburse the proceeds of the Revolver Loans as directed
by Borrower Agent. Unless Agent shall have received (in sufficient time to act) written notice from a Lender that it does not intend
to fund its Pro Rata share of a Borrowing, Agent may assume that such Lender has deposited or promptly will deposit its share with
Agent, and Agent may disburse a corresponding amount to Borrowers. If a Lender’s share of any Borrowing or of any settlement pursuant
to Section 4.1.3(b) is not received by Agent, then Borrowers agree to repay to Agent on demand the amount of such
share, together with interest thereon from the date disbursed until repaid, at the rate applicable to the Borrowing.

    	 	-34-	 

     

    

4.1.3         
Swingline Loans; Settlement.

(a)               
Agent may, but shall not be obligated to, advance Swingline Loans to Borrowers, up to an aggregate outstanding amount of
$5,000,000, unless the funding is specifically required to be made by all Lenders hereunder. Each Swingline Loan shall constitute
a Revolver Loan for all purposes, except that payments thereon shall be made to Agent for its own account. The obligation of Borrowers
to repay Swingline Loans shall be evidenced by the records of Agent and need not be evidenced by any promissory note.

(b)              
Settlement of Swingline Loans and other Revolver Loans among Lenders and Agent shall take place on a date determined from
time to time by Agent (but at least weekly), in accordance with the Settlement Report delivered by Agent to Lenders. Between settlement
dates, Agent may in its discretion apply payments on Revolver Loans to Swingline Loans, regardless of any designation by Borrower
Agent or any provision herein to the contrary. Each Lender’s obligation to make settlements with Agent is absolute and unconditional,
without offset, counterclaim or other defense, and whether or not the Commitments have terminated, an Overadvance exists or the
conditions in Section 6 are satisfied. If, due to an Insolvency Proceeding with respect to a Borrower or otherwise, any
Swingline Loan may not be settled among Lenders hereunder, then each Lender shall be deemed to have purchased from Agent a Pro
Rata participation in such Loan and shall transfer the amount of such participation to Agent, in immediately available funds, within
one Business Day after Agent’s request therefor.

4.1.4         
Notices. Borrowers may request Loans and transfer funds based on telephonic or e-mailed instructions to Agent (subject
to the limitations set forth in Section 13.3.2). Borrowers shall confirm each such request by prompt delivery to Agent of
a Notice of Borrowing but if it differs materially from the action taken by Agent or Lenders, the records of Agent and Lenders
shall govern. Neither Agent nor any Lender shall have any liability for any loss suffered by a Borrower as a result of Agent or
any Lender acting upon its understanding of telephonic or e-mailed instructions (subject to the limitations set forth in Section
13.3.2) from a person believed in good faith by Agent or any Lender to be a person authorized to give such instructions on
a Borrower’s behalf.

4.2              
Defaulting Lender

4.2.1         
Reallocation of Pro Rata Share; Amendments. For purposes of determining Lenders’ obligations to fund or participate
in Loans, to share in fees or for any other determination permitted hereunder, Agent may exclude the Commitments and Loans of any
Defaulting Lender(s) from the calculation of Pro Rata shares. A Defaulting Lender shall have no right to vote on any amendment,
waiver or other modification of a Loan Document, except as provided in Section 13.1.1(b).

4.2.2         
Payments; Fees. Agent may, in its discretion, receive and retain any amounts payable to a Defaulting Lender under
the Loan Documents, and a Defaulting Lender shall be deemed to have assigned to Agent such amounts until all Obligations owing
to Agent, non-Defaulting Lenders and other Secured Parties have been paid in full. Agent may apply such amounts to the Defaulting
Lender’s defaulted obligations, use the funds to Cash Collateralize such Lender’s Fronting Exposure, or readvance the amounts to
Borrowers hereunder. A Lender shall not be entitled to receive any fees accruing hereunder during the period in which it is a Defaulting
Lender, and the unfunded portion of its Commitment shall be disregarded for purposes of calculating the unused line fee under Section
3.2.1.

    	 	-35-	 

     

    

4.2.3         
Cure. Borrowers and Agent may agree in writing that a Lender is no longer a Defaulting Lender. At such time, Pro
Rata shares shall be reallocated without exclusion of such Lender’s Commitments and Loans, and all outstanding Revolver Loans and
other exposures under the Revolver Commitments shall be reallocated among Lenders and settled by Agent (with appropriate payments
by the reinstated Lender) in accordance with the readjusted Pro Rata shares. Unless expressly agreed by Borrowers and Agent, no
reinstatement of a Defaulting Lender shall constitute a waiver or release of claims against such Lender. The failure of any Lender
to fund a Loan or otherwise to perform its obligations hereunder shall not relieve any other Lender of its obligations, and no
Lender shall be responsible for default by another Lender.

4.3              
[Reserved]

4.4              
Borrower Agent. Each Borrower and each other Obligor hereby designates SWK (“Borrower Agent”)
as its representative and agent for all purposes under the Loan Documents, including requests for Loans, delivery or receipt of
communications, preparation and delivery of Borrowing Base and financial reports, receipt and payment of Obligations, requests
for waivers, amendments or other accommodations, actions under the Loan Documents (including in respect of compliance with covenants),
and all other dealings with Agent or any Lender. Borrower Agent hereby accepts such appointment. Agent and Lenders shall be entitled
to rely upon, and shall be fully protected in relying upon, any notice or communication (including any notice of borrowing) delivered
by Borrower Agent on behalf of any Borrower. Agent and Lenders may give any notice or communication with an Obligor hereunder to
Borrower Agent on behalf of such Obligor. Each of Agent and Lenders shall have the right, in its discretion, to deal exclusively
with Borrower Agent for any or all purposes under the Loan Documents. Each Obligor agrees that any notice, election, communication,
representation, agreement or undertaking made on its behalf by Borrower Agent shall be binding upon and enforceable against it.

4.5              
One Obligation. The Loans and other Obligations constitute one general obligation of Borrowers and the other
Obligors and are secured by Agent’s Lien (for the benefit of the Secured Parties) on all Collateral.

4.6              
Effect of Termination. On the effective date of any termination of the Commitments, all Obligations shall be
immediately due and payable. All undertakings of Borrowers contained in the Loan Documents shall survive any termination, and Agent
shall retain its Liens in the Collateral for the benefit of the Secured Parties and all of its rights and remedies under the Loan
Documents until Full Payment of the Obligations. Notwithstanding Full Payment of the Obligations, Agent shall not be required to
terminate its Liens in any Collateral unless, with respect to any damages Agent may incur as a result of the dishonor or return
of any check, draft or other item of payment applied to Obligations, Agent receives (a) a written agreement satisfactory to Agent,
executed by Borrowers and any Person whose advances are used in whole or in part to satisfy the Obligations, indemnifying Agent
and Lenders from such damages; and (b) such Cash Collateral as Agent, in its discretion, deems appropriate to protect against such
damages. Sections 3.4, 3.6, 3.7, 3.8, 3.10, 5.5, 5.9, 5.10, 11, 13.2 and this Section 4.6, and the obligation
of each Obligor and Lender with respect to each indemnity given by it in any Loan Document, shall survive Full Payment of the Obligations
and any release relating to this credit facility.

SECTION
5.            
PAYMENTS

5.1              
General Payment Provisions. All payments of Obligations shall be made in Dollars, without offset, counterclaim
or defense of any kind, free of (and without deduction for) any Taxes, and in immediately available funds, not later than 1:00
p.m. on the due date. Any payment after such time shall be deemed made on the next Business Day.

    	 	-36-	 

     

    

5.2              
Repayment of Revolver Loans. Revolver Loans shall be due and payable in full on the Revolver Termination Date,
unless payment is sooner required hereunder. Revolver Loans may be prepaid from time to time, without penalty or premium. Payments
with respect to Borrower Advances, payments in respect of Borrower Royalty Receivables, collections from proceeds of Customer Collateral
securing Borrower Advances, collections from proceeds of Collateral and the net proceeds of any asset disposition (collectively,
“Collections”), whether paid or received in cash or in the form of a check, draft or other item of payment,
shall be applied to the Revolver Loans. Notwithstanding anything herein to the contrary, if an Overadvance exists, Borrowers shall,
on the sooner of Agent’s demand or the first Business Day after any Borrower has knowledge thereof, repay the outstanding Revolver
Loans in an amount sufficient to reduce the principal balance of Revolver Loans to the Borrowing Base. Borrowers will direct all
payments made by any Customer with respect to Borrower Advances or licensee or other payor with respect to any Borrower Royalty
Receivables to a Dominion Account on a daily basis. Agent will apply all proceeds received in each Dominion Account to the Obligations
each Business Day in accordance with Section 5.7.

5.3              
Payment of Other Obligations. Obligations other than Loans, including Extraordinary Expenses, shall be paid by
Borrowers (and the other Obligors, as applicable) as provided in the Loan Documents or, if no payment date is specified, on
demand.

5.4              
Payments on Borrower Advances; Dominion Accounts; Joint Royalty Accounts.

(a)       Subject
to Section 9.1.15, Borrowers have advised Agent and Lenders that all Collections in respect of Borrower Loan Advances will
be made directly to a Dominion Account and that, except as described on Schedule 5.4-A and Schedule 5.4-B, all Collections
in respect of Borrower Royalty Receivable Advances will be made directly to a Dominion Account. Borrowers shall request in writing
and otherwise take all necessary steps to ensure that all Collections (other than Collections in respect of the Borrower Royalty
Receivable Advances described on Schedule 5.4-B, which shall be governed by Section 5.4(a)(i) below) are made directly
(or, in the case of Collections in respect of the Borrower Royalty Receivable Advances described on Schedule 5.4-A, pursuant
to a standing wire transfer instructions from the Joint Royalty Account into which such Collections are directly paid) to a Dominion
Account (or a lockbox relating to a Dominion Account). Agent shall have the right, at any time and whether or not an Event of Default
exists, to contact directly any or all Collections Paying Parties to ensure that all Collections paid or to be paid by such Collections
Paying Parties are directed to Agent or as provided in this Section. If any Borrower or Subsidiary receives any Collections, it
shall hold the same in trust and as agent for Agent (and the same shall not be commingled with Borrowers’ other funds) and
promptly (and in all events within ten (10) Business Days) deposit same into a Dominion Account. All such Collections shall be
the exclusive property of Agent upon the earlier of the receipt thereof by Agent or by Borrowers. All funds in each Dominion Account
shall be swept on a daily basis to Agent. Agent shall be entitled to apply immediately to the Obligations any wire transfer, check
or other item of payment received by Agent. Interest shall continue accruing on the amount of any wire transfer, check, draft or
other item of payment for one (1) Business Day after the date that the proceeds of such wire transfer, check, draft or other item
of payment become good, collected funds received by Agent and are applied to the Obligations. Borrowers irrevocably waive the right
to direct the application of any and all payments and collections at any time or times hereafter received by Agent from or on behalf
of Borrowers, and Borrowers do hereby irrevocably agree that Agent shall have the continuing exclusive right to apply and reapply
any and all such payments and collections received at any time or times hereafter by Agent or its agent against the Obligations
in such manner as set forth herein (or otherwise as Agent elects). Notwithstanding the foregoing, Borrowers shall be permitted
to:

    	 	-37-	 

     

    

(i)       allow
Collections payable pursuant to the Cambia Transaction Documents to be remitted to and maintained in that certain deposit account
no. 1317607-22 jointly maintained by SWK and APR Applied Pharma Research S.A. with Credit Suisse (Switzerland) Ltd., and Borrowers
hereby covenant to remit any Collections payable to Borrowers that are deposited into such deposit account to a Dominion Account
maintained at State Bank within ten (10) Business Days of the day that such Collections are received; and

(ii)       allow
Collections payable to or for the benefit of Borrowers pursuant to the Osphena Transaction Documents to be remitted to and maintained
in that certain Securities Account no. 5574-5588 maintained by SWK with Wells Fargo Clearing Services, LLC so long as (A) such
Securities Account is subject to a springing Securities Account control agreement satisfactory to Agent in all respects and (B)
any Collections remitted into such Securities Account are deposited or otherwise transferred by Borrowers to a Dominion Account
maintained at State Bank within ten (10) Business Days of the day that such Collections are received. Following the occurrence
and continuance of an Event of Default, Agent is authorized to provide a notice of full dominion and control in relation to such
Securities Account, and Borrowers shall cooperate with Agent in relation to any request to move the underlying securities on deposit
in such account to a replacement securities or deposit account designated by Agent.

(b)       Without
limiting the generality of the foregoing subsection in any respect, Borrowers shall issue (or cause the appropriate Person to issue)
an irrevocable standing instruction to the applicable depository institution to wire transfer to a Dominion Account maintained
at State Bank on each Business Day all Collections owned by Borrowers that are received in each Joint Royalty Account. Borrowers
shall not change (or permit any Person to change) any standing instructions governing any Joint Royalty Account without the prior
written consent of Agent. To the extent that the agreements governing a Joint Royalty Account do not permit for such an instruction
to be irrevocable, or if Borrowers obtain knowledge that any such instruction has been changed or is not being complied with on
a timely basis, Borrowers shall, on each Business Day, manually wire transfer to a Dominion Account maintained at State Bank all
such Collections. If the agreements governing a Joint Royalty Account do not permit Borrowers to initiate such wire transfers or
if the owner or co-owner of any Joint Royalty Account fails to take such action as is required to allow Borrowers to initiate such
transfers, then Borrowers will promptly notify Agent of the same and shall provide sufficient detail with respect thereto as Agent
may request.

(c)       Borrowers
shall maintain the Dominion Accounts pursuant to lockbox or other arrangements acceptable to Agent. Borrowers shall obtain an agreement
(in form and substance satisfactory to Agent) from each lockbox servicer and Dominion Account bank, establishing Agent’s control
over and Lien in (for the benefit of the Secured Parties) the applicable lockbox or Dominion Account, requiring immediate deposit
of all remittances received in the lockbox to a Dominion Account, and waiving offset rights of such servicer or bank, except for
customary administrative charges. Agent may require immediate transfer of all funds in any Dominion Account not maintained with
State Bank to the Dominion Account maintained with State Bank. Agent and Lenders assume no responsibility to Borrowers for any
lockbox arrangement or any Dominion Account or Joint Royalty Account, including any claim of accord and satisfaction or release
with respect to any check, draft or other item of payment accepted by any bank. Borrowers hereby grant to Agent (for the benefit
of the Secured Parties) a Lien upon all items and balances held in any lockbox and any Dominion Account as security for the payment
of the Obligations, in addition to and cumulative with the general security interest in all other assets of Obligors (including
all Deposit Accounts) as provided elsewhere in this Agreement or any other Loan Document.

    	 	-38-	 

     

    

5.5              
Marshaling; Payments Set Aside. None of Agent or Lenders shall be under any obligation to marshal any assets
in favor of any Obligor or against any Obligations. If any payment by or on behalf of Borrowers is made to Agent or any Lender,
or Agent or any Lender exercises a right of setoff, and such payment or the proceeds of such setoff or any part thereof is subsequently
invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into
by Agent or such Lender in its discretion) to be repaid to a trustee, receiver or any other Person, then to the extent of such
recovery, the Obligation originally intended to be satisfied, and all Liens, rights and remedies relating thereto, shall be revived
and continued in full force and effect as if such payment had not been made or such setoff had not occurred.

5.6              
Post-Default Allocation of Payments

5.6.1         
Allocation. Notwithstanding anything herein to the contrary, during an Event of Default, monies to be applied to
the Obligations, whether arising from payments by Obligors, realization on Collateral, setoff or otherwise, shall be allocated
as follows:

(a)               
first, to all costs and expenses, including Extraordinary Expenses, owing to Agent;

(b)              
second, to all amounts owing to Agent on Swingline Loans;

(c)               
third, to all Obligations constituting fees (other than Secured Bank Product Obligations);

(d)              
fourth, to all Obligations constituting interest (other than Secured Bank Product Obligations);

(e)              
fifth, to all Loans and Secured Bank Product Obligations, including Cash Collateralization of Secured Bank Product
Obligations; and

(f)                
last, to all other Obligations.

Amounts shall be applied to each category
of Obligations set forth above until Full Payment thereof and then to the next category. If amounts are insufficient to satisfy
a category, they shall be applied on a pro rata basis among the Obligations in the category. Amounts distributed with respect to
any Secured Bank Product Obligations shall be the lesser of the maximum Secured Bank Product Obligations last reported to Agent
or the actual Secured Bank Product Obligations as calculated by the methodology reported to Agent for determining the amount due.
Agent shall have no obligation to calculate the amount to be distributed with respect to any Secured Bank Product Obligations,
and may request a reasonably detailed calculation of such amount from the applicable Secured Party. If a Secured Party fails to
deliver such calculation within five days following request by Agent, Agent may assume the amount to be distributed is zero. The
allocations set forth in this Section are solely to determine the rights and priorities of Agent and Secured Parties as among themselves,
and may be changed by agreement among them without the consent of any Obligor. This Section is not for the benefit of or enforceable
by any Obligor.

5.6.1         
Erroneous Application. Agent shall not be liable for any application of amounts made by it in good faith and, if
any such application is subsequently determined to have been made in error, the sole recourse of any Lender or other Person to
which such amount should have been made shall be to recover the amount from the Person that actually received it (and, if such
amount was received by any Lender, such Lender hereby agrees to return it).

    	 	-39-	 

     

    

5.7              
Application of Payments

5.7.1         
Dominion Account. The entire ledger balance in each Dominion Account shall, on each Business Day, be directed to
Agent and applied by Agent to the Obligations at the beginning of the next Business Day. If, as a result of such application, a
credit balance exists, the balance shall not accrue interest in favor of Borrowers and shall be made available to Borrowers within
one (1) Business Day of request therefor by Borrowers. Each Borrower irrevocably waives the right to direct the application of
any payments or Collateral proceeds, and agrees that Agent shall have the continuing, exclusive right to apply and reapply same
against the Obligations, in such manner as Agent deems advisable.

5.7.2         
Insurance and Condemnation Proceeds. Any proceeds of insurance (other than proceeds from workers’ compensation or
D&O insurance) and any awards arising from condemnation of any Collateral shall be paid to Agent unless (i) such proceeds or
awards are received by a Borrower in connection with an insurable event with respect to, or a condemnation of, Customer Collateral,
(ii) such Borrower is required to remit such proceeds or awards to the applicable Customer pursuant to the applicable Transaction
Documents, and (iii) such Borrower promptly remits such proceeds or awards to such Customer in compliance with such Transaction
Documents. Any such proceeds or awards that relate to Inventory (whether constituting assets of a Borrower or Customer Collateral)
shall be applied to payment of the Revolver Loans, and then to any other Obligations outstanding. Any proceeds or awards that relate
to Equipment, real estate or business interruption insurance shall be applied to Revolver Loans and then to other Obligations.

5.7.3         
Reinvestment. If requested by Borrowers in writing within 15 days after Agent’s receipt of any insurance proceeds
or condemnation awards relating to any loss or destruction of Equipment or real estate (whether constituting assets of a Borrower
or Customer Collateral), Borrowers may, or may permit the applicable Customer to, use such proceeds or awards to repair or replace
such Equipment or real estate (and until so used, the proceeds shall be held by Agent as Cash Collateral or applied to the Revolver
Loans) as long as (i) no Default or Event of Default exists; (ii) no default or event of default exists under the underlying Transaction
Documents; (iii) such repair or replacement is promptly undertaken and concluded, in accordance with plans satisfactory to Agent
(but in any event concluded within 180 days after the date of such loss); (iv) replacement buildings are constructed on the sites
of the original casualties and are of comparable size, quality and utility to the destroyed buildings; (v) the repaired or replaced
Property is free of Liens (except in favor of Agent); (vi) Borrowers (or such Customer, if applicable) comply with disbursement
procedures for such repair or replacement as Agent may reasonably require; and (vii) the aggregate amount of such proceeds or awards
from any single casualty or condemnation does not exceed $100,000.

5.8              
Loan Account; Account Stated

5.8.1         
Loan Account. Agent shall maintain in accordance with its usual and customary practices an account or accounts (“Loan
Account”) evidencing the Debt of Borrowers resulting from each Loan from time to time. Any failure of Agent to record
anything in the Loan Account, or any error in doing so, shall not limit or otherwise affect the obligation of Borrowers to pay
any amount owing hereunder. Agent may maintain a single Loan Account in the name of Borrower Agent, and each Borrower confirms
that such arrangement shall have no effect on the joint and several character of its liability for the Obligations.

5.8.2         
Entries Binding. Entries made in the Loan Account shall constitute presumptive evidence of the information contained
therein. If any information contained in the Loan Account is provided to or inspected by any Person, then such information shall
be conclusive and binding on such Person for all purposes absent manifest error, except to the extent such Person notifies Agent
in writing within 30 days after receipt or inspection that specific information is subject to dispute.

    	 	-40-	 

     

    

5.9              
Taxes

5.9.1         
Payments Free of Taxes. All payments by Obligors of Obligations shall be free and clear of and without reduction
for any Taxes. If Applicable Law requires any Obligor or Agent to withhold or deduct any Tax (including backup withholding or withholding
Tax), the withholding or deduction shall be based on information provided pursuant to Section 5.10 and Agent shall pay the
amount withheld or deducted to the relevant governmental authority. If the withholding or deduction is made on account of Indemnified
Taxes or Other Taxes, the sum payable by Obligors shall be increased so that Agent or Lenders, as applicable, receives an amount
equal to the sum it would have received if no such withholding or deduction (including deductions applicable to additional sums
payable under this Section) had been made. Without limiting the foregoing, Obligors shall timely pay all Other Taxes to the relevant
governmental authorities.

5.9.2         
Payment. Obligors shall indemnify, hold harmless and reimburse (within 10 days after demand therefor) Agent and Lenders
for any Indemnified Taxes or Other Taxes (including those attributable to amounts payable under this Section) withheld or deducted
by any Obligor or Agent, or paid by Agent or any Lender, with respect to any Obligations or Loan Documents, whether or not such
Taxes were properly asserted by the relevant governmental authority, and including all penalties, interest and reasonable expenses
relating thereto, as well as any amount that a Lender fails to pay indefeasibly to Agent under Section 5.10. A certificate
as to the amount of any such payment or liability delivered to Borrower Agent by Agent, or by a Lender (with a copy to Agent),
shall be conclusive, absent manifest error. As soon as practicable after any payment of Taxes by an Obligor, Borrower Agent shall
deliver to Agent a receipt from the governmental authority or other evidence of payment satisfactory to Agent.

5.10           
Lender Tax Information

5.10.1     
Status of Lenders. Each Lender shall deliver documentation and information to Agent and Borrower Agent, at the times
and in form required by Applicable Law or reasonably requested by Agent or Borrower Agent, sufficient to permit Agent or Borrowers
to determine (a) whether or not payments made with respect to Obligations are subject to Taxes, (b) if applicable, the required
rate of withholding or deduction, and (c) such Lender’s entitlement to any available exemption from, or reduction of, applicable
Taxes for such payments or otherwise to establish such Lender’s status for withholding tax purposes in the applicable jurisdiction.

5.10.2     
Documentation. If a Borrower is resident for tax purposes in the United States, any Lender that is a “United
States person” within the meaning of section 7701(a)(30) of the Code shall deliver to Agent and Borrower Agent IRS Form W-9
or such other documentation or information prescribed by Applicable Law or reasonably requested by Agent or Borrower Agent to determine
whether such Lender is subject to backup withholding or information reporting requirements. If any Foreign Lender is entitled to
any exemption from or reduction of withholding tax for payments with respect to the Obligations, it shall deliver to Agent and
Borrower Agent, on or prior to the date on which it becomes a Lender hereunder (and from time to time thereafter upon request by
Agent or Borrower Agent, but only if such Foreign Lender is legally entitled to do so), (a) IRS Form W-8BEN claiming eligibility
for benefits of an income tax treaty to which the United States is a party; (b) IRS Form W-8ECI; (c) IRS Form W-8IMY and all required
supporting documentation; (d) in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under
section 881(c) of the Code, IRS Form W-8BEN and a certificate showing such Foreign Lender is not (i) a “bank” within
the meaning of section 881(c)(3)(A) of the Code, (ii) a “10 percent shareholder” of any Obligor within the meaning of
section 881(c)(3)(B) of the Code, or (iii) a “controlled foreign corporation” described in section 881(c)(3)(C) of the
Code; or (e) any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in withholding tax,
together with such supplementary documentation necessary to allow Agent and Borrower Agent to determine the withholding or deduction
required to be made.

    	 	-41-	 

     

    

5.10.3     
Lender Obligations. Each Lender shall promptly notify Borrower Agent and Agent of any change in circumstances that
would change any claimed Tax exemption or reduction. Each Lender shall indemnify, hold harmless and reimburse (within 10 days after
demand therefor) Borrowers and Agent for any Taxes, losses, claims, liabilities, penalties, interest and expenses (including reasonable
attorneys’ fees) incurred by or asserted against Borrowers or Agent by any governmental authority due to such Lender’s failure
to deliver, or inaccuracy or deficiency in, any documentation required to be delivered by it pursuant to this Section. Each Lender
authorizes Agent to set off any amounts due to Agent under this Section against any amounts payable to such Lender under any Loan
Document.

5.10.4     
FATCA. If a payment made to a Lender under this Agreement would be subject to U.S. Federal withholding Tax imposed
by FATCA, such Lender shall deliver to Agent, at the time or times prescribed by law and at such time or times reasonably requested
by Agent, such documentation prescribed by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and
such additional documentation reasonably requested by Agent as may be necessary for Agent to comply with its obligations under
FATCA, to determine that such Lender has complied with such Lender’s obligations under FATCA, applicable reporting requirements
of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable) or to determine the amount to deduct
and withhold from such payment. Solely for purposes of this paragraph, “FATCA” shall include any amendments made to FATCA
after the Closing Date.

5.11           
Nature and Extent of Each Borrower’s Liability.

5.11.1     
Joint and Several Liability. Each Borrower (and each other Obligor) agrees that it is jointly and severally liable
for, and absolutely and unconditionally guarantees to Agent and Lenders the prompt payment and performance of, all Obligations
and all agreements under the Loan Documents. Each Borrower (and each other Obligor) agrees that its guaranty obligations hereunder
constitute a continuing guaranty of payment and not of collection, that such obligations shall not be discharged until Full Payment
of the Obligations, and that such obligations are absolute and unconditional, irrespective of (a) the genuineness, validity, regularity,
enforceability, subordination or any future modification of, or change in, any Obligations or Loan Document, or any other document,
instrument or agreement to which any Obligor is or may become a party or be bound; (b) the absence of any action to enforce this
Agreement (including this Section) or any other Loan Document, or any waiver, consent or indulgence of any kind by Agent or any
Lender with respect thereto; (c) the existence, value or condition of, or failure to perfect a Lien or to preserve rights against,
any security or guaranty for the Obligations or any action, or the absence of any action, by Agent or any Lender in respect thereof
(including the release of any security or guaranty); (d) the insolvency of any Obligor; (e) any election by Agent or any Lender
in an Insolvency Proceeding for the application of Section 1111(b)(2) of the Bankruptcy Code; (f) any borrowing or grant of a Lien
by any other Obligor, as debtor-in-possession under Section 364 of the Bankruptcy Code or otherwise; (g) the disallowance of any
claims of Agent or any Lender against any Obligor for the repayment of any Obligations under Section 502 of the Bankruptcy Code
or otherwise; or (h) any other action or circumstances that might otherwise constitute a legal or equitable discharge or defense
of a surety or guarantor, except Full Payment of all Obligations.

5.11.2     
Waiver.

(a)               
Each Borrower expressly waives all rights that it may have now or in the future under any statute, at common law, in equity
or otherwise, to compel Agent or Lenders to marshal assets or to proceed against any Obligor, other Person or security for the
payment or performance of any Obligations before, or as a condition to, proceeding against such Borrower. Each Borrower waives
all defenses available to a surety, guarantor or accommodation co-obligor other than Full Payment of all Obligations. It is agreed
among each Borrower, Agent and Lenders that the provisions of this Section 5.11 are of the essence of the transaction contemplated
by the Loan Documents and that, but for such provisions, Agent and Lenders would decline to make Loans and other extensions of
credit. Each Borrower acknowledges that its guaranty pursuant to this Section is necessary to the conduct and promotion of its
business, and can be expected to benefit such business.

    	 	-42-	 

     

    

(b)              
Agent and Lenders may, in their discretion, pursue such rights and remedies as they deem appropriate, including realization
upon Collateral or any real estate by judicial foreclosure or non-judicial sale or enforcement, without affecting any rights and
remedies under this Section 5.11. If, in taking any action in connection with the exercise of any rights or remedies, Agent
or any Lender shall forfeit any other rights or remedies, including the right to enter a deficiency judgment against any Borrower
or other Person, whether because of any Applicable Laws pertaining to “election of remedies” or otherwise, each Borrower
consents to such action and waives any claim based upon it, even if the action may result in loss of any rights of subrogation
that any Borrower might otherwise have had. Any election of remedies that results in denial or impairment of the right of Agent
or any Lender to seek a deficiency judgment against any Borrower shall not impair any other Borrower’s obligation to pay
the full amount of the Obligations. Each Borrower waives all rights and defenses arising out of an election of remedies, such as
non-judicial foreclosure with respect to any security for the Obligations, even though that election of remedies destroys such
Borrower’s rights of subrogation against any other Person. Agent may bid all or a portion of the Obligations at any foreclosure
or trustee’s sale or at any private sale, and the amount of such bid need not be paid by Agent but shall be credited against
the Obligations. The amount of the successful bid at any such sale, whether Agent or any other Person is the successful bidder,
shall be conclusively deemed to be the fair market value of the Collateral, and the difference between such bid amount and the
remaining balance of the Obligations shall be conclusively deemed to be the amount of the Obligations guaranteed under this Section
5.11, notwithstanding that any present or future law or court decision may have the effect of reducing the amount of any deficiency
claim to which Agent or any Lender might otherwise be entitled but for such bidding at any such sale.

5.11.3     
Extent of Liability; Contribution.

(a)               
Upon payment by any Obligor of any Obligations, all rights of such Obligor against any other Obligor arising as a result
thereof by way of right of subrogation, contribution, reimbursement, indemnity or otherwise shall in all respects be subordinate
and junior in right of payment to the prior Full Payment of the Obligations. In addition, any Debt of any Obligor now or hereafter
held by any other Obligor is hereby subordinated in right of payment to the prior Full Payment of the Obligations and unless and
until Full Payment of the Obligations has occurred, no Obligor will demand, sue for or otherwise attempt to collect any such Debt.
If any amount shall erroneously be paid to any Obligor on account of (i) such subrogation, contribution, reimbursement, indemnity
or similar right or (ii) any such Debt of any Obligor, such amount shall be held in trust for the benefit of the Obligors and shall
forthwith be paid to Agent to be credited against the payment of the Obligations, whether matured or unmatured, in accordance with
the terms of this Agreement and the other Loan Documents. Subject to the foregoing, to the extent that any Borrower shall, under
this Agreement as a joint and several obligor, repay any of the Obligations constituting a portion of a Loan made to another Borrower
hereunder or other Obligations incurred directly and primarily by any other Borrower (an “Accommodation Payment”),
then the Borrower making such Accommodation Payment shall be entitled to contribution and indemnification from, and be reimbursed
by, each of the other Borrowers in an amount, for each of such other Borrowers, equal to a fraction of such Accommodation Payment,
the numerator of which fraction is such other Borrower’s Allocable Amount and the denominator of which is the sum of the Allocable
Amounts of all of the Borrowers. As of any date of determination, the “Allocable Amount” of each Borrower shall
be equal to the maximum amount of liability for Accommodation Payments which could be asserted against such Borrower hereunder
without (a) rendering such Borrower “insolvent” within the meaning of Section 101 (32) of the Bankruptcy Code, Section
2 of the Uniform Fraudulent Transfer Act (“UFTA”) or Section 2 of the Uniform Fraudulent Conveyance Act (“UFCA”),
(b) leaving such Borrower with unreasonably small capital or assets, within the meaning of Section 548 of the Bankruptcy Code,
Section 4 of the UFTA, or Section 5 of the UFCA, or (c) leaving such Borrower unable to pay its debts as they become due within
the meaning of Section 548 of the Bankruptcy Code or Section 4 of the UFTA, or Section 5 of the UFCA.

    	 	-43-	 

     

    

(b)              
Nothing contained in this Section 5.11 shall limit the liability of any Borrower to pay Loans made directly or indirectly
to that Borrower (including Loans advanced to any other Borrower and then re-loaned or otherwise transferred to, or for the benefit
of, such Borrower) and all accrued interest, fees, expenses and other related Obligations with respect thereto, for which such
Borrower shall be primarily liable for all purposes hereunder. Agent and Lenders shall have the right, at any time in their discretion,
to condition Loans and other extensions of credit upon a separate calculation of borrowing availability for each Borrower and to
restrict the disbursement and use of such Loans and other extensions of credit to such Borrower.

(c)               
Each Obligor that is a Qualified ECP when its guaranty of or grant of Lien as security for a Swap Obligation becomes effective
hereby jointly and severally, absolutely, unconditionally and irrevocably undertakes to provide such funds or other support to
each specified Obligor with respect to such Swap Obligation as may be needed by such specified Obligor from time to time to honor
all of its obligations under the Loan Documents in respect of such Swap Obligation (but, in each case, only up to the maximum amount
of such liability that can be hereby incurred without rendering such Qualified ECP’s obligations and undertakings under this Section
5.12 voidable under any applicable fraudulent transfer or conveyance act). The obligations and undertakings of each Qualified
ECP under this Section shall remain in full force and effect until Full Payment of the Obligations. Each Obligor intends this Section
to constitute, and this Section shall be deemed to constitute, a guarantee of the obligations of, and a “keepwell, support
or other agreement” for the benefit of, each Obligor for all purposes of the Commodity Exchange Act.

5.11.4     
Subordination. Each Borrower and each other Obligor hereby subordinates any claims, including any rights at law or
in equity to payment, subrogation, reimbursement, exoneration, contribution, indemnification or set off, that it may have at any
time against any other Obligor, howsoever arising, to the Full Payment of all Obligations.

SECTION
6.            
CONDITIONS PRECEDENT

6.1              
Conditions Precedent to Initial Loans. Upon each of the conditions set forth on Exhibit C attached hereto
having been satisfied or waived in writing by Agent, the closing date (the “Closing Date”) shall have occurred.
In addition to the conditions set forth in Section 6.2, Lenders shall not be required to fund any requested Loan, or otherwise
extend credit to Borrowers hereunder, until the Closing Date has occurred.

    	 	-44-	 

     

    

6.2              
Conditions Precedent to All Credit Extensions. Agent and Lenders shall not be required to fund any Loans, increase
the Revolver Commitments pursuant to Section 2.1.7 or grant any other accommodation to or for the benefit of Borrowers,
unless the following conditions are satisfied:

(a)               
No Default or Event of Default shall exist at the time of, or result from, such funding, increase or grant;

(b)              
The representations and warranties of each Obligor in the Loan Documents shall be true and correct on the date of, and upon
giving effect to, such funding, increase or grant (except for representations and warranties that expressly relate to an earlier
date);

(c)               
All conditions precedent in any other Loan Document shall be satisfied;

(d)              
No event shall have occurred or circumstance exist that has or could reasonably be expected to have a Material Adverse Effect
and no action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed before any
court, governmental authority or legislative body to enjoin, restrain or prohibit, or to obtain damages in respect of, or which
is related to or arises out of, this Agreement or any of the other Loan Documents or the consummation of the transactions contemplated
hereby or thereby; and

(e)              
Solely in connection with the first funding of Loans hereunder, (i) Agent shall have received a Borrowing Base Certificate
dated as of the date of the proposed funding prepared as of such date or a recent date prior thereto that is acceptable to Agent
and (ii) upon giving effect to the initial funding of the Loans, and the payment by Borrowers of all fees and expenses incurred
in connection herewith, the repayment of any Debt contemplated to occur on the date of the initial funding and any payables stretched
beyond their customary payment practices, Availability shall be at least $17,500,000.

Each request (or deemed request) by Borrowers for funding
of a Loan, increase to the Revolver Commitments or grant of an accommodation shall constitute a representation by Borrowers that
the foregoing conditions are satisfied on the date of such request and on the date of such funding, increase or grant. As an additional
condition to any funding, increase or grant, Agent shall have received such other information, documents, instruments and agreements
as it deems appropriate in connection therewith. Each representation and warranty contained in this Agreement and the other Loan
Documents shall be deemed to be reaffirmed by each Borrower on each day that Borrowers request or are deemed to have requested
an extension of credit hereunder, except for changes in the nature of a Borrower’s or, if applicable, any Subsidiary’s business
or operations that may occur after the date hereof in the Ordinary Course of Business so long as Agent has consented to such changes
or such changes are not violative of any provision of this Agreement.

SECTION
7.            
COLLATERAL

7.1              
Grant of Security Interest. To secure the prompt payment and performance of all Obligations, each Borrower hereby
grants to Agent, for the benefit of Secured Parties, a continuing security interest in and Lien upon all personal Property of such
Borrower, including all of the following Property, whether now owned or hereafter acquired, and wherever located: (a) all Accounts;
(b) all Chattel Paper, including electronic chattel paper; (c) all Commercial Tort Claims, including those shown on Schedule
7; (d) all Deposit Accounts; (e) all Documents; (f) all General Intangibles, including Intellectual Property; (g) all Goods,
including Inventory, Equipment and fixtures; (h) all Instruments; (i) all Investment Property; (j) all Letter-of-Credit Rights;
(k) all Supporting Obligations; (l) all monies, whether or not in the possession or under the control of Agent, a Lender, or a
bailee or Affiliate of Agent or a Lender, including any Cash Collateral; (m) all accessions to, substitutions for, and all replacements,
products, and cash and non-cash proceeds of the foregoing, including proceeds of and unearned premiums with respect to insurance
policies, and claims against any Person for loss, damage or destruction of any Collateral; and (n) all books and records (including
customer lists, files, correspondence, tapes, computer programs, print-outs and computer records) pertaining to the foregoing.
Without limiting the generality of the foregoing, “Collateral” shall include all of each Borrower’s right, title
and interest in, to and under all Borrower Advances, Transaction Documents, Payment Rights, Remedies and Borrower Royalty Receivables.

    	 	-45-	 

     

    

7.2              
Lien on Other Collateral

7.2.1         
Deposit and other Accounts. To further secure the prompt payment and performance of all Obligations, each Borrower
hereby grants to Agent, for the benefit of Secured Parties, a continuing security interest in and Lien upon all amounts credited
to any Deposit Account, Securities Account and Commodity Account of such Borrower, including any sums in any blocked or lockbox
accounts or in any accounts into which such sums are swept. Each Borrower hereby authorizes and directs each bank or other depository
to deliver to Agent, upon request, all balances in any Deposit Account, Securities Account and Commodity Account maintained by
such Borrower, without inquiry into the authority or right of Agent to make such request. Each Borrower shall take all actions
(including the delivery of one or more control agreements) necessary to establish Agent’s control (including through the execution
of a deposit account control agreement as required by Agent) of each such Deposit Account (including each Dominion Account and
each Operating Account), Securities Account and Commodity Account (other than a Deposit Account exclusively used for payroll, payroll
taxes or employee benefits, or an account containing not more than $10,000 at any time). Each Borrower shall be the sole account
holder of each Deposit Account (other than the Joint Royalty Accounts) and shall not allow any other Person (other than Agent or,
in the case of a Joint Royalty Account, the Person named as the owner or co-owner of such Joint Royalty Account) to have control
over a Deposit Account or any Property deposited therein (other than a Deposit Account exclusively used for payroll, payroll taxes
or employee benefits). Each Borrower shall promptly notify Agent of any opening or closing of a Deposit Account, Securities Account
or Commodities Account and, with the consent of Agent, will amend Schedule 2 to reflect same.

7.2.2         
Cash Collateral. Any Cash Collateral may be invested, at Agent’s discretion (and with the consent of Borrowers, as
long as no Event of Default exists), but Agent shall have no duty to do so, regardless of any agreement or course of dealing with
any Borrower, and shall have no responsibility for any investment or loss. Each Borrower hereby grants to Agent, for the benefit
of Secured Parties and as security for the Obligations, a security interest in all Cash Collateral held from time to time and all
proceeds thereof, whether held in a Cash Collateral Account or otherwise. Agent may apply Cash Collateral to the payment of Obligations
as they become due, in such order as Agent may elect. Each Cash Collateral Account and all Cash Collateral shall be under the sole
dominion and control of Agent, and no Borrower or any other Person shall have any right to any Cash Collateral, until Full Payment
of all Obligations.

7.3              
[Reserved].

7.4              
Other Collateral

7.4.1         
Commercial Tort Claims. Borrowers shall promptly notify Agent in writing if any Borrower has a Commercial Tort Claim
(other than, as long as no Default or Event of Default exists, a Commercial Tort Claim for less than $50,000), shall promptly amend
Schedule 7 to include such claim, and shall take such actions as Agent deems appropriate to subject such claim to a duly
perfected, first priority Lien in favor of Agent (for the benefit of Secured Parties).

    	 	-46-	 

     

    

7.4.2         
Certain After-Acquired Collateral. Borrowers shall promptly notify Agent in writing if, after the Closing Date, any
Borrower obtains any interest in any Collateral consisting of Deposit Accounts, Securities Accounts, Commodity Accounts, Chattel
Paper (including tangible Chattel Paper and Electronic Chattel Paper), Documents, Instruments, Intellectual Property, Investment
Property or Letter-of-Credit Rights and, upon Agent’s request, shall promptly take such actions as Agent deems appropriate to effect
Agent’s duly perfected, first priority Lien upon such Collateral, including obtaining any appropriate possession, control agreement
or Lien Waiver. If any Collateral is in the possession of a third party, at Agent’s request, Borrowers shall obtain an acknowledgment
that such third party holds the Collateral for the benefit of Agent.

7.4.3         
Real Estate. Upon request by Agent, the Obligations shall also be secured by collateral assignments of all mortgages,
deeds to secure debt or deeds of trust owned by Borrowers securing Borrower Advances, in form and substance satisfactory to Agent
in its discretion (collectively, the “Mortgage Assignments”). The Mortgage Assignments shall be duly recorded,
at Borrowers’ expense, in each office where such recording is required to constitute a fully perfected Lien on the Real Estate
covered thereby. To the extent any Lien on Real Estate is provided by a Customer to a Borrower, such Liens may be released only
upon payment in full of all Debts owing by such Customer to such Borrower and termination of any commitment by Borrower to provide
financing of any kind to such Customer.

7.5              
No Assumption of Liability. The Lien on Collateral granted hereunder is given as security only and shall not
subject Agent or any Lender to, or in any way modify, any obligation or liability of any Obligor relating to any Collateral (including
any Transaction Documents, Borrower Royalty Receivables or Customer Collateral).

7.6              
Further Assurances. Promptly upon request, Borrowers shall deliver to Agent or its designee, for the benefit
of the Secured Parties, (i) all Instruments and Chattel Paper evidencing a Debt of a Customer to any Borrower, and (ii) UCC-3 financing
statement amendments that assign to Agent all financing statements naming a Customer as debtor and any Borrower as secured party,
which financing statement amendments may be filed of record by Agent, at its election, at any time that a Default or Event of Default
exists. For so long as no Default or Event of Default exists, upon Borrowers’ request therefor, Agent or its designee will
deliver to Borrower Agent any Instrument or Chattel Paper evidencing a Debt of a Customer to a Borrower theretofore delivered by
Borrowers to Agent pursuant to this Section 7.6 for the purpose of enabling the applicable Borrower (a) to enforce payment
of, or otherwise exercise its rights and remedies with respect to, such Instrument or (b) to administer such Instrument or Chattel
Paper in the Ordinary Course of Business of such Borrower which, by way of example, may include the modification, amendment, extension,
renewal or consolidation of such Instrument or Chattel Paper.

7.7              
Continuation of Security Interest. Notwithstanding termination of this Agreement or of Lenders’ commitments
to extend Loans hereunder, until Full Payment of all Obligations, Agent shall retain its security interest in all presently owned
and hereafter arising or acquired Collateral.

SECTION
8.            
REPRESENTATIONS AND WARRANTIES

8.1              
General Representations and Warranties. To induce Agent and Lenders to enter into this Agreement and to make
available the Commitments and Loans, each Obligor represents and warrants that:

    	 	-47-	 

     

    

8.1.1         
Organization and Qualification. Each Obligor and Subsidiary is duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization. Each Obligor and Subsidiary is duly qualified, authorized to do business
and in good standing as a foreign corporation in each jurisdiction where failure to be so qualified could reasonably be expected
to have a Material Adverse Effect. No Obligor has changed its legal status or the jurisdiction in which it is organized or moved
its chief executive office within the five (5) years preceding the Closing Date.

8.1.2         
Power and Authority. Each Obligor is duly authorized to execute, deliver and perform its Loan Documents. The execution,
delivery and performance of the Loan Documents have been duly authorized by all necessary action, and do not (a) require any consent
or approval of any holders of Equity Interests of any Obligor, other than those already obtained; (b) contravene the Organic Documents
of any Obligor; (c) violate or cause a default under any Applicable Law or Material Contract; or (d) result in or require the imposition
of any Lien (other than Permitted Liens) on any Property of any Obligor.

8.1.3         
Enforceability. Each Loan Document is a legal, valid and binding obligation of each Obligor party thereto, enforceable
in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency or similar laws affecting the enforcement
of creditors’ rights generally.

8.1.4         
Capital Structure. Schedule 4 shows, for each Obligor and Subsidiary, its name, its jurisdiction of organization,
its authorized and issued Equity Interests, the holders of its Equity Interests, and all agreements binding on such holders with
respect to their Equity Interests. Except as disclosed on Schedule 4, in the five years preceding the Closing Date, no Obligor
or Subsidiary has acquired any substantial assets from any other Person nor been the surviving entity in a merger or combination.
Each Obligor has good title to its Equity Interests in its Subsidiaries, subject only to Agent’s Lien, and all such Equity Interests
are duly issued, fully paid and non-assessable. There are no outstanding purchase options, warrants, agreements to buy, subscription
rights, agreements to issue or sell, convertible interests, phantom rights or powers of attorney relating to Equity Interests of
any Obligor or Subsidiary other than as set forth on Schedule 4.

8.1.5         
Title to Properties; Priority of Liens. Each Obligor and Subsidiary has good and marketable title to (or valid leasehold
interests in) all of its real estate, and good title to all of its personal Property, including all Property reflected in any financial
statements delivered to Agent or Lenders, in each case free of Liens except Permitted Liens. Each Obligor and Subsidiary has paid
and discharged all lawful claims that, if unpaid, could become a Lien on its Properties, other than Permitted Liens. All Liens
of Agent in the Collateral are duly perfected, first priority Liens, subject only to Permitted Liens that are expressly allowed
to have priority over Agent’s Liens.

8.1.6         
Eligible Borrower Advances. Each Document, Instrument or other writing evidencing or relating to any Borrower Advance
included in the Eligible Borrower Advances or any Account or Payment Intangible (including any Borrower Royalty Receivable) included
in the Customer Collateral securing any such Borrower Advance (a) is genuine and enforceable in accordance with its terms except
for such limits thereon arising from bankruptcy or similar laws relating to creditors’ rights; (b) is not subject to any reduction
or discount (other than as stated in the invoice applicable thereto and disclosed to Agent), defense, setoff, claim or counterclaim
of a material nature against Borrowers or the applicable Customer except as to which Borrowers have notified Agent in writing;
(c) is not subject to any other circumstances that would impair the validity, enforceability or amount of such Collateral except
as to which Borrowers have notified Agent in writing; (d) is free of all Liens (other than Permitted Liens); and (e) is for a liquidated
amount maturing as stated in the applicable invoice or other document pertaining thereto. Each Borrower Advance included in any
Borrowing Base Certificate, report or other document as an Eligible Borrower Advance as of the date of such Borrowing Base Certificate
meets all of the requirements of an Eligible Borrower Advance as set forth in the definitions of Eligible Borrower First Lien Advance,
Eligible Borrower Royalty Receivable Advance or Eligible Borrower Second Lien Advance, as applicable.

    	 	-48-	 

     

    

8.1.7         
Financial Statements. The consolidated and consolidating balance sheets, and related statements of income, cash flow
and shareholder’s equity, of Borrowers, any other Obligor and their Subsidiaries that have been and are hereafter delivered to
Agent and Lenders, are prepared in accordance with GAAP, and fairly present the financial positions and results of operations of
Borrowers, such Obligors and Subsidiaries at the dates and for the periods indicated. All projections delivered from time to time
to Agent and Lenders have been prepared in good faith, based on reasonable assumptions in light of the circumstances at such time.
Since December 31, 2016, there has been no change in the condition, financial or otherwise, of any Obligor or Subsidiary that could
reasonably be expected to have a Material Adverse Effect. No financial statement delivered to Agent or Lenders at any time contains
any untrue statement of a material fact, nor fails to disclose any material fact necessary to make such statement not materially
misleading. Each Obligor and Subsidiary Solvent. No transfer of property has been or will be made by any Obligor and no obligation
has been or will be incurred by any Obligor in connection with the transactions contemplated by this Agreement or the other Loan
Documents with the intent to hinder, delay, or defraud either present or future creditors of any Obligor.

8.1.8         
Surety Obligations. No Obligor or Subsidiary is obligated as surety or indemnitor under any bond or other contract
that assures payment or performance of any obligation of any Person, except as permitted hereunder.

8.1.9         
Taxes. Each Obligor and Subsidiary has filed all federal, state and local tax returns and other reports that it is
required by law to file, and has paid, or made provision for the payment of, all Taxes upon it, its income and its Properties that
are due and payable, except to the extent being Properly Contested (and, in the case of matters being Properly Contested as of
the Closing Date, fully disclosed to Agent and Lenders on or before the Closing Date). The provision for Taxes on the books of
each Obligor and Subsidiary is adequate for all years not closed by applicable statutes, and for its current Fiscal Year.

8.1.10     
Brokers. There are no brokerage commissions, finder’s fees or investment banking fees payable in connection with
any transactions contemplated by the Loan Documents.

8.1.11     
Intellectual Property. Each Obligor and Subsidiary owns or has the lawful right to use all Intellectual Property
necessary for the conduct of its business, without conflict with any rights of others. There is no pending or, to any Obligor’s
knowledge, threatened Intellectual Property claim with respect to any Obligor, any Subsidiary or any of their Property (including
any Intellectual Property). Except as disclosed on Schedule 5, no Obligor or Subsidiary pays or owes any Royalty or other
compensation to any Person with respect to any Intellectual Property. All Intellectual Property owned, used or licensed by, or
(except for Borrower Royalty Receivables purchased from time to time in the Ordinary Course of Business pursuant to Royalty Purchase
Documents) otherwise subject to any interests of, any Obligor or Subsidiary is shown on Schedule 5.

8.1.12     
Governmental Approvals. Each Obligor and Subsidiary has, is in compliance with, and is in good standing with respect
to, all approvals from all governmental authorities necessary to conduct its business and to own, lease and operate its Properties.

8.1.13     
Compliance with Laws. Each Obligor and Subsidiary has duly complied, and its Properties and business operations are
in compliance, in all material respects with all Applicable Law, except where noncompliance could not reasonably be expected to
have a Material Adverse Effect. There have been no citations, notices or orders of material noncompliance issued to any Obligor
or Subsidiary under any Applicable Law.

    	 	-49-	 

     

    

8.1.14     
Burdensome Contracts. No Obligor or Subsidiary is a party or subject to any contract, agreement or charter restriction
that could reasonably be expected to have a Material Adverse Effect. No Obligor or Subsidiary is party or subject to any Restrictive
Agreement, except as shown on Schedule 6 and the agreement identified on Schedule 6 does not require any shareholder consent
for the execution and delivery of, or performance under, the Loan Documents. No such Restrictive Agreement prohibits the execution,
delivery or performance of any Loan Document by an Obligor.

8.1.15     
Litigation. Except as shown on Schedule 7, there are no proceedings or investigations pending or, to any Obligor’s
knowledge, threatened against any Obligor or Subsidiary or any of their businesses, operations, Properties, prospects or conditions,
that (a) relate to any Loan Documents or transactions contemplated thereby; or (b) could reasonably be expected to have a Material
Adverse Effect if determined adversely to any Obligor or Subsidiary. Except as shown on such Schedule, no Obligor has a Commercial
Tort Claim (other than, as long as no Default or Event of Default exists, a Commercial Tort Claim for less than $50,000). No Obligor
or Subsidiary is in default with respect to any order, injunction or judgment of any governmental authority.

8.1.16     
No Defaults. No event or circumstance has occurred or exists that constitutes a Default or Event of Default. No Obligor
or Subsidiary is in default, and no event or circumstance has occurred or exists that with the passage of time or giving of notice
would constitute a default, under any Material Contract or in the payment of any Borrowed Money. There is no basis upon which any
party (other than an Obligor or Subsidiary) could terminate a Material Contract prior to its scheduled termination date.

8.1.17     
ERISA. Except as disclosed on Schedule 8, no Obligor nor any of its Subsidiaries has any Plan on the date
hereof. Each Obligor and each of its Subsidiaries is in full compliance with the requirements of ERISA and the regulations promulgated
thereunder with respect to each Plan. No fact or situation that is reasonably likely to result in a Material Adverse Effect exists
in connection with any Plan. No Obligor nor any of its Subsidiaries has any withdrawal liability in connection with a Multiemployer
Plan.

8.1.18     
Trade Relations. There exists no actual or threatened termination, limitation or modification of any business relationship
between any Obligor or Subsidiary and any customer or supplier, or any group of customers or suppliers, who individually or in
the aggregate are material to the business of such Obligor or Subsidiary. There exists no condition or circumstance that could
reasonably be expected to impair the ability of any Obligor or Subsidiary to conduct its business at any time hereafter in substantially
the same manner as conducted on the Closing Date.

8.1.19     
Labor Relations. Except as described on Schedule 9, no Obligor or Subsidiary is party to or bound by any collective
bargaining agreement, management agreement or consulting agreement. There are no material grievances, disputes or controversies
with any union or other organization of any Obligor’s or Subsidiary’s employees, or, to any Obligor’s knowledge, any asserted or
threatened strikes, work stoppages or demands for collective bargaining. No goods or services have been or will be produced by
any Obligor or any Subsidiary in violation of any applicable labor laws or regulations or any collective bargaining agreement or
other labor agreements or in violation of any minimum wage, wage-and-hour or other similar laws or regulations.

    	 	-50-	 

     

    

8.1.20     
Payable Practices. No Obligor or Subsidiary has made any material change in its historical accounts payable practices
from those in effect on the Closing Date.

8.1.21     
Not a Regulated Entity. No Obligor or any Subsidiary (a) is subject to registration under or other regulation under
the Investment Company Act of 1940, or (b) subject to regulation under the Federal Power Act, the Interstate Commerce Act, any
public utilities code or any other Applicable Law regarding its authority to incur Debt.

8.1.22     
Margin Stock. No Obligor or Subsidiary is engaged, principally or as one of its important activities, in the business
of extending credit for the purpose of purchasing or carrying any Margin Stock. No Loan proceeds will be used by Obligors to purchase
or carry, or to reduce or refinance any Debt incurred to purchase or carry, any Margin Stock or for any related purpose governed
by Regulations T, U or X of the Board of Governors.

8.1.23     
Deposit and Other Accounts. Schedule 2 sets forth all Deposit Accounts, Securities Accounts and Commodity
Accounts maintained by Obligors and their Subsidiaries, including all Dominion Accounts and all Joint Royalty Accounts.

8.1.24     
Anti-Terrorism Laws, Anti-Corruption Laws and Sanctions.

(a)               
No Obligor, nor any Subsidiary or Affiliate thereof, is in violation of any Anti-Terrorism Law; engages in or conspires
to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the
prohibitions set forth in any Anti-Terrorism Law; or is a Sanctioned Person. No Obligor, nor any Subsidiary or Affiliate thereof
conducts any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any
Sanctioned Person or deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked
pursuant to Executive Order No. 13224.

(b)              
Obligors have implemented and maintain in effect policies and procedures designed to ensure compliance by Obligors, their
respective Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable
Sanctions, and Obligors, their respective Subsidiaries and their respective directors, officers and employees and, to the knowledge
of Borrowers, their agents, are in compliance with Anti-Corruption Laws and applicable Sanctions. None of (i) Obligors, any of
their respective Subsidiaries or any of their respective directors, officers or employees, or (ii) to the knowledge of Borrowers,
any agent of Obligors or any of their respective Subsidiaries that will act in any capacity in connection with or benefit from
the credit facilities established hereby, is a Sanctioned Person. No borrowing, use of proceeds or other transactions contemplated
herein will violate Anti-Corruption Laws or applicable Sanctions.

8.1.25     
Additional Collateral Matters.

(a)               
As of the Closing Date: (i) no amount payable under or in connection with any of the Collateral is evidenced by any Instrument
or tangible Chattel Paper unless the applicable Instrument or Chattel Paper is being held in trust by Borrowers for the benefit
of Agent or has been delivered to Agent; (ii) (1) no Obligor holds, owns, or has any interest in any certificated securities or
uncertificated securities other than those constituting Collateral with respect to which Agent has a perfected security interest
in such Collateral, and (2) it has entered into a duly authorized, executed and delivered control agreement in form and substance
satisfactory to Agent with respect to each Deposit Account, Securities Account and Commodity Account listed in Schedule 2
with respect to which Agent has a perfected security interest in such accounts by “control” (as contemplated by Section
9-104 of the UCC); (iii) no amount payable under or in connection with any of the Collateral is evidenced by any Electronic Chattel
Paper or any “transferable record” (as that term is defined in Section 201 of the Federal Electronic Signatures in
Global and National Commerce Act, or in Section 16 of the Uniform Electronic Transactions Act as in effect in any relevant jurisdiction);
and (iv) no amount payable under or in connection with any of the Collateral is evidenced by any Letter-of-Credit Rights.

    	 	-51-	 

     

    

(b)              
This Agreement and the other Security Documents create in favor of Agent, for the benefit of the Secured Parties referred
to therein, a legal, valid, continuing and enforceable security interest and Lien in the Collateral, the enforceability of which
is subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally
and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. The financing
statements, releases and other filings are in appropriate form and have been or will be filed in appropriate filing offices. Upon
such filings and/or the obtaining of “control” (as contemplated by Section 9-104 of the UCC), Agent will have a perfected
Lien on, and security interest in, to and under all right, title and interest of the grantors thereunder in all Collateral that
may be perfected under the UCC (in effect on the date this representation is made) by filing, recording or registering a financing
statement or analogous document (including the proceeds of such Collateral subject to the limitations relating to such proceeds
in the UCC) or by obtaining control. The Pledged Collateral (as defined in the Pledge Agreement) has been delivered to Agent (together
with stock powers or other appropriate instruments of transfer executed in blank form).

(c)               
If applicable, when a trademark security agreement or patent security agreement (or a short form thereof) is filed in the
United States Patent and Trademark Office and when financing statements, releases and other filings in appropriate form are filed
in the applicable filing offices, Agent shall have a fully perfected Lien on, and security interest in, all right, title and interest
of the applicable Obligor in trademarks, patents and related assets constituting trademark and patent Collateral (as set forth
in the applicable trademark security agreement or patent security agreement) in which a security interest may be perfected by filing,
recording or registering a security agreement, financing statement or analogous document in the United States Patent and Trademark
Office, as applicable. If applicable, when a copyright security agreement or patent security agreement is filed in the United States
Copyright Office and when financing statements, releases and other filings in appropriate form are filed in the applicable filing
offices, Agent shall have a fully perfected Lien on, and security interest in, all right, title and interest of the applicable
Obligor in copyrights and assets constituting copyright Collateral (as set forth in the applicable trademark security agreement
or patent security agreement) in which a security interest may be perfected by filing, recording or registering a security agreement,
financing statement or analogous document in the United States Copyright Office, as applicable.

(d)              
Neither the businesses nor the properties of any Obligor or any of its Subsidiaries are affected by any fire, explosion,
accident, strike, lockout or other labor dispute, drought, storm, hail, earthquake, embargo, act of God or of the public enemy
or other casualty (whether or not covered by insurance).

(e)              
No Obligor (and, to the extent applicable, its property) (i) has failed to comply with any Environmental Law or to obtain,
maintain or comply with any permit, license or other approval required under any Environmental Law, (ii) has become subject to
any liability under any Environmental Law, (iii) has received notice of any claim or investigation with respect to any material
liability or non-compliance under any Environmental Law or (iv) knows of any basis for any liability under any Environmental Law,
except, in each case, as could not, individually or in the aggregate, reasonably be expected to result in any material liability
under Environmental Laws or have a Material Adverse Effect. No Obligor is undertaking, and no Obligor has completed, either individually
or together with other potentially responsible parties, any investigation or assessment or remedial or response action relating
to any actual or threatened release, discharge or disposal of hazardous materials at any site, location or operation, either voluntarily
or pursuant to the order of any governmental authority or the requirements of any Environmental Law; and all hazardous materials
generated, used, treated, handled or stored at, or transported to or from, any property currently or formerly owned or operated
by any Obligor have been disposed of in a manner not reasonably expected to result in material liability to any Obligor.

(f)                
Each Borrower Advance has been originated and made by a Borrower.

    	 	-52-	 

     

    

8.2              
Complete Disclosure. No Loan Document, nor any other agreement, document, certificate, or statement, delivered
by or on behalf of an Obligor or a Subsidiary to Agent or any Lender contains any untrue statement of a material fact, nor fails
to disclose any material fact necessary to make the statements contained therein not misleading. There is no fact or circumstance
that any Obligor has failed to disclose to Agent in writing that could reasonably be expected to have a Material Adverse Effect.

8.3              
Updated Representations and Warranties. Each representation and warranty contained in this Agreement and the
other Loan Documents shall be deemed to be reaffirmed by each Obligor on each day that Borrowers deliver or are required to deliver
a Borrowing Base Certificate hereunder and on each day a Loan is made hereunder, except for changes in the nature of an Obligor’s
or, if applicable, any Subsidiary’s business or operations that may occur after the date hereof in the Ordinary Course of Business
so long as Agent has provided its prior written consent (in its sole discretion) to such changes or such changes are not violative
of any provision of this Agreement.

SECTION
9.            
COVENANTS AND CONTINUING AGREEMENTS

9.1              
Affirmative Covenants. As long as any Commitments or Obligations are outstanding, each Obligor shall, and shall
cause each other Obligor and each Subsidiary to, do the following:

9.1.1         
Collateral Reporting and Records..

(a)               
Borrowing Base. Borrowers shall deliver to Agent, by the 30th day of each month, a Borrowing Base Certificate prepared
as of the close of business of the previous month, and at such other times as Agent may request; provided that, while all calculations
of Availability in any Borrowing Base Certificate shall originally be made by Borrowers and certified by a Senior Officer, Agent
may from time to time review and adjust any such calculation (i) to reflect its reasonable estimate of declines in value of any
Collateral, due to collections received in the Dominion Accounts or otherwise; (ii) to adjust advance rates to reflect changes
in dilution, quality, mix and other factors affecting Collateral; and (iii) to the extent the calculation is not made in accordance
with this Agreement or does not accurately reflect the Availability Reserve; Borrowers, Agent and Lenders agree that the Borrowing
Base Certificate and other information required to be delivered to Agent pursuant to this Section 9.1.1 may be delivered
electronically utilizing Agent’s “Stucky Netlink” system or any other electronic transmission system approved
by Agent, and any such information delivered electronically shall be deemed to be delivered with the following certification: “As
of the date of this Certificate, no Event of Default exists or has occurred and is continuing. Obligors acknowledge that the Loans
made by Agent and Lenders to, or for the benefit of, Borrowers are based upon Agent’s and Lenders’ reliance on the
information contained herein and all representations and warranties with respect to Collateral in the Loan Agreement are applicable
to the Collateral included in this Certificate. The reliance by Agent and Lenders on this Certificate should not be deemed to limit
the right of Agent to establish or revise criteria of eligibility or Availability Reserves or otherwise limit, impair, or affect
in any manner the rights of Agent and Lenders under the Loan Agreement. In the event of any conflict between the determination
of Agent of the amount of the Loans to Borrowers in accordance with the terms of the Loan Agreement and the determination by Borrowers
of such amounts, the determination of Agent shall govern. All capitalized terms used in this Certificate shall have the meaning
assigned to them in the Loan Agreement.”

    	 	-53-	 

     

    

(b)              
Administration of Borrower Advances. Agent may rely, in determining which Borrower Advances are Eligible Borrower
Advances, on all statements and representations made by any Borrower with respect to any Borrower Advance. Each Borrower shall
keep accurate and complete records of its Borrower Advances, including all fundings and payments thereof, and shall submit to Agent
portfolio reviews and other reports in form satisfactory to Agent, on such periodic basis as Agent may request. At any time that
an Event of Default exists, Agent shall have the right, at any time, in the name of Agent, any designee of Agent or any Borrower,
to verify the validity, amount or any other matter relating to any Borrower Advances by mail, telephone, telegraph or otherwise.
Borrowers shall cooperate fully with Agent in an effort to facilitate and promptly conclude any such verification process. In addition,
Borrowers shall cause Agent to be given full access (including, at Agent’s election, by creating one or more separate accounts
in the name of Agent or by providing Agent with active user names, passwords and other information required to obtain such access)
to all electronic, computer or online databases and/or reports prepared or maintained by Borrowers describing Borrower Advances,
Borrower Royalty Receivables and Customer Collateral.

9.1.2         
Inspections; Appraisals

(a)               
Permit Agent from time to time, subject (except when a Default or Event of Default exists) to reasonable notice and normal
business hours, to visit and inspect the Properties of any Obligor or Subsidiary, inspect, audit and make extracts from any Obligor’s
or Subsidiary’s books and records, and discuss with its officers, employees, agents, advisors and independent accountants such
Obligor’s or Subsidiary’s business, financial condition, assets, prospects and results of operations. Lenders may participate in
any such visit or inspection, at their own expense. Agent may use all of each Obligor’s and Subsidiary’s electronic and non-electronic
books, files, accounts, and all other records, computer equipment and software at any time, without (a) any compensation to any
Obligor, (b) being deemed to have foreclosed on the same, or (c) being deemed to have exercised any other remedy under any Loan
Document, for the purposes of monitoring Borrowers’ servicing of the Collateral and to facilitate realization upon the Collateral.
Neither Agent nor any Lender shall have any duty to any Person to make any inspection, nor to share any results of any inspection,
appraisal or report with any Person. Obligors acknowledge that all inspections, appraisals and reports are prepared by Agent and
Lenders for their purposes, and Obligors shall not be entitled to rely upon them.

(b)              
Reimburse Agent for all charges, costs and expenses of Agent in connection with (i) examinations of any Obligor’s
books and records or any other financial or Collateral matters as Agent deems appropriate for each day that an employee or agent
of Agent shall be engaged in an examination or review of any of the Obligors’ properties), plus reasonable expenses; provided,
however, that Borrowers shall not be required to reimburse Lender for the costs and expenses of more than two (2) field
examinations in any 12-month period, unless an Event of Default exists, (ii) appraisals of Collateral deemed appropriate by Agent;
(iii) the establishment of electronic collateral reporting systems performed by employees or agents of Agent; and (iv) the actual
charges paid or incurred by Agent if it elects to employ the services of one or more third parties to perform financial audits
of Obligors, establish electronic collateral reporting of Obligors, appraise the Collateral or to assess Obligors’ business valuation.
Borrowers agree to pay Agent’s then standard charges for examination activities, including the standard charges of Agent’s internal
examination and appraisal groups ($1,000 per person per day as of the Closing Date), as well as the charges of any third party
used for such purpose.

    	 	-54-	 

     

    

9.1.3         
Financial and Other Information. Keep adequate records and books of account with respect to its business activities,
in which proper entries are made in accordance with GAAP reflecting all financial transactions; and furnish to Agent and Lenders:

(a)               
as soon as available, and in any event within 90 days after the close of each Fiscal Year, balance sheets as of the end
of such Fiscal Year and the related statements of income, cash flow and shareholders’ equity for such Fiscal Year, on consolidated
and consolidating bases for Obligors and Subsidiaries, together with all supporting schedules and footnotes, which consolidated
statements shall be audited and certified (without qualification) by a firm of independent certified public accountants of recognized
standing selected by Borrowers and acceptable to Agent (it being hereby acknowledged by Agent that BPM LLP are acceptable to Agent),
and shall set forth in comparative form corresponding figures for the preceding Fiscal Year and other information acceptable to
Agent;

(b)              
as soon as available, and in any event within 45 days after the end of each Fiscal Quarter (but within 60 days after the
last Fiscal Quarter in a Fiscal Year), unaudited balance sheets as of the end of such Fiscal Quarter and the related statements
of income and cash flow for such Fiscal Quarter and for the portion of the Fiscal Year then elapsed, on consolidated and consolidating
bases for Obligors and Subsidiaries, setting forth in comparative form corresponding figures for the preceding Fiscal Year and
certified by the chief financial officer of Holdings as prepared in accordance with GAAP and fairly presenting the financial position
and results of operations for such month and period, subject to normal year-end adjustments and the absence of footnotes;

(c)               
as soon as available, and in any event within 30 days after the end of each month (but within 45 days after the last month
in a Fiscal Quarter (other than the last Fiscal Quarter of a Fiscal Year) and 60 days after the last month in a Fiscal Year), unaudited
balance sheets as of the end of such month and the related statements of income and cash flow for such month and for the portion
of the Fiscal Year then elapsed, on consolidated and consolidating bases for Obligors and Subsidiaries, setting forth in comparative
form corresponding figures for the preceding Fiscal Year and certified by the chief financial officer of Holdings as prepared in
accordance with GAAP and fairly presenting the financial position and results of operations for such month and period, subject
to normal year-end adjustments and the absence of footnotes;

(d)              
concurrently with delivery of financial statements under clauses (a) and (b) above, or more frequently if requested by Agent
while a Default or Event of Default exists, a Compliance Certificate executed by the chief financial officer of Holdings;

(e)              
concurrently with delivery of financial statements under clause (a) above, copies of all management letters and other material
reports submitted to Obligors by their accountants in connection with such financial statements, and promptly upon receipt thereof,
copies of each report to Obligors (or any of them) concerning accounting practices and systems and any final comment letter submitted
by such accountants to management in connection with an annual audit;

(f)                
not later than 30 days after the end of each Fiscal Year, projections of Obligors’ consolidated and consolidating balance
sheets, results of operations, cash flow and Availability for the next Fiscal Year on a Fiscal Quarter by Fiscal Quarter basis;

    	 	-55-	 

     

    

(g)               
at Agent’s request, a listing of each Obligor’s trade payables, specifying the trade creditor (if applicable) and balance
due, and a detailed trade payable aging, all in form satisfactory to Agent;

(h)              
promptly after the sending or filing thereof, copies of any proxy statements, financial statements or reports that any Obligor
has made generally available to its shareholders; copies of any regular, periodic and special reports or registration statements
or prospectuses that any Obligor files with the Securities and Exchange Commission or any other governmental authority, or any
securities exchange; and copies of any press releases or other statements made available by an Obligor to the public concerning
material changes to or developments in the business of such Obligor;

(i)                 
promptly after the sending or filing thereof, copies of any annual report to be filed in connection with each Plan or any
employee benefit plan or similar employee benefit arrangement maintained or contributed to by any Obligor or Subsidiary that is
not subject to the laws of the United States or is mandated by a government other than the United States for employees of any Obligor
or Subsidiary;

(j)                
as soon as available, and in any event within 30 days after the initial funding of any Borrower Advance (or, in the case
of a Borrower Royalty Receivable Advance, the purchase of the related Borrower Royalty Receivable), a copy of Borrowers’
internally prepared written underwriting report with respect to such Borrower Advance along with such related information as Agent
may request in its reasonable discretion with respect to the underwriting rationale for such Borrower Advance;

(k)               
as soon as available, and in any event within thirty (30) days after receipt by Borrowers, copies of all reports prepared
for Borrowers by a firm of independent certified public accountants of recognized standing selected by Borrowers and acceptable
to Agent (it being hereby acknowledged by Agent that BPM LLP are acceptable to Agent), evaluating the performance of all Borrower
Advances outstanding during the prior Fiscal Quarter; and

(l)                 
such other reports and information (financial or otherwise) as Agent may request from time to time in its reasonable credit
judgment in connection with any Collateral or any Borrower’s Subsidiary’s or other Obligor’s financial condition or business.

9.1.4         
Notices. Notify Agent and Lenders in writing, promptly after an Obligor’s obtaining knowledge thereof, of any of
the following that affects an Obligor: (a) the threat or commencement of any proceeding or investigation, whether or not covered
by insurance, if an adverse determination could have a Material Adverse Effect; (b) any pending or threatened labor dispute, strike
or walkout, or the expiration of any material labor contract; (c) any default under or termination of a Material Contract; (d)
the existence of any Default or Event of Default (together with what action, if any, Obligors are taking to correct the same);
(e) any litigation involving an amount at issue in excess of $100,000 or changes in existing litigation or any judgment against
it or its Subsidiaries or their respective assets with an amount at issue or assets involved exceeding $100,000; (f) the assertion
of any Intellectual Property claim, if an adverse resolution could have a Material Adverse Effect; (g) any violation or asserted
violation of any Applicable Law by an Obligor or Subsidiary or with respect to the Collateral; (i) the occurrence of any event
or occurrence which could possibly, as a result of the passage of time or otherwise, result in any of the events described in Section
10.1(k); (j) the discharge of or any withdrawal or resignation by Obligors’ independent accountants; (k) any proposed opening
of a new office or place of business, at least 30 days prior to such opening; (l) any failure of any Obligor to pay rent at any
of its business locations; (m) the filing of any Lien against any Obligor or Subsidiary (other than the Lien of Agent or another
Permitted Lien) or against any Eligible Customer (other than the Lien of a Borrower or a lien permitted under the applicable Transaction
Documents), notice from any taxing authorities as to claimed deficiencies or any tax Lien or any notice relating to alleged ERISA
violations, the occurrence of any Reportable Event or the occurrence of any Termination Event; (n) any damage or loss to property
in excess of $100,000; (o) any rejection, return, offset, dispute, loss or other circumstance in an amount equal to or greater
than $100,000 or otherwise having a Material Adverse Effect on any Collateral; and (p) any acceleration of the maturity of any
Debt owed by any Obligor or the occurrence or existence of any event or circumstance which gives the holder of such Debt the right
to accelerate.

    	 	-56-	 

     

    

9.1.5         
Landlord Agreements. Upon request, provide Agent with copies of all existing agreements, and promptly after execution
thereof provide Agent with copies of all future agreements, between an Obligor and any landlord or other Person that owns any premises
at which any Collateral may be kept or that otherwise may possess or handle any Collateral. In connection with any such agreements
with landlords described in this Section 9.1.5 (including, for purposes of clarity, any existing agreements), Obligors shall
use commercially reasonable efforts to obtain Lien Waivers with respect to any corporate headquarters of the Obligors and each
other physical location of any tangible Collateral.

9.1.6         
Compliance with Laws; Taxes. Comply with all Applicable Laws, including laws regarding collection and payment of
Taxes, and pay and discharge all Taxes prior to the date on which they become delinquent or penalties attach (unless such Taxes
are being Properly Contested) and maintain all approvals from all governmental authorities necessary to the ownership of its Properties
or conduct of its business, and, without limiting the generality of the foregoing, act promptly and diligently to make appropriate
remedial actions with respect to any Environmental Laws and other Applicable Laws, whether or not directed to do so by any governmental
authority. If a Borrower Royalty Receivable or an Account that constitutes Customer Collateral includes a charge for any Taxes,
Agent is authorized, in its discretion, to pay the amount thereof to the proper taxing authority for the account of the applicable
Borrower and the applicable Customer and to charge Borrowers therefor; provided, however, that neither Agent nor
Lenders shall be liable for any Taxes that may be due from any Borrower or any Customer or with respect to any Collateral (including
any Borrower Royalty Receivables) or Customer Collateral.

9.1.7         
Insurance. Maintain general liability, umbrella liability insurance and property coverage with respect to the Collateral
with insurers reasonably satisfactory to Agent. Unless Agent shall agree otherwise, each policy shall include satisfactory endorsements
(i) showing Agent as lender’s loss payee or additional insured, as applicable; (ii) requiring 30 days prior written notice to Agent
in the event of cancellation of the policy for any reason whatsoever; and (iii) specifying that the interest of Agent shall not
be impaired or invalidated by any act or neglect of any Obligor or the owner of the Property, nor by the occupation of the premises
for purposes more hazardous than are permitted by the policy. If any Obligor fails to provide and pay for any insurance, Agent
may, at its option, but shall not be required to, procure the insurance and charge Borrowers therefor.

9.1.8         
Licenses and Other Rights. Keep each material license affecting any Collateral or any other material Property of
Obligors and Subsidiaries in full force and effect; promptly notify Agent of any proposed modification to any such license, or
entry into any new license granted to an Obligor (other than shrinkwrap software licenses), in each case at least 30 days prior
to its effective date; pay all Royalties under material licenses granted to an Obligor when due; notify Agent of any default or
breach asserted by any Person to have occurred under any such license; preserve and maintain its legal existence, authorities to
transact business, rights and franchises, trade names, patents, trademarks, and permit necessary to the proper conduct of its business;
and, except as could not reasonably be expected to have a Material Adverse Effect, remain in good standing and qualified to transact
business as a foreign entity in any state or other jurisdiction in which it is required to be qualified to transact business as
a foreign entity.

    	 	-57-	 

     

    

9.1.9         
Other Affirmative Covenants. (a) At any time that an Event of Default exists, permit Agent, and Agent shall have
the right at any time, in the name of Agent, any designee of Agent or any Obligor, to verify the validity, amount or any other
matter relating to any Borrower Advances, Collateral (including any Borrower Royalty Receivables) or Customer Collateral by mail,
telephone or otherwise; (b) cooperate fully with Agent in an effort to facilitate and promptly conclude any such verification process;
(c) maintain, preserve and protect all Collateral and the remainder of property used or useful in the conduct of its business,
keep the same in good repair, working order, and condition (normal wear and tear excepted), including ensuring that Equipment is
mechanically and structurally sound, and capable of performing the functions for which it was designed, in accordance with manufacturer
specifications and in good operating condition and repair, with all necessary replacements and repairs having been made so that
the value and operating efficiency of the Equipment is preserved at all times, and make, or cause to be made, all material needed
and proper repairs, renewals, replacements, betterments, and improvements thereto so that the business carried on in connection
therewith may be conducted properly and in accordance with standards generally accepted in businesses of a similar type and size;
(d) use, store and maintain all Inventory with reasonable care and caution, in accordance with applicable standards of any insurance
and in conformity with all Applicable Law, and shall make current rent payments (within applicable grace periods provided for in
leases) at all locations where any Collateral is located; (e) keep at all times, all tangible items of Collateral, other than Inventory
in transit, at the business locations set forth in Schedule 3, except that, subject to Section 9.2.11, Obligors may
(i) make sales or other dispositions of Collateral in accordance with Section 9.2.5; and (ii) move Collateral to another
location in the United States, upon 30 Business Days prior written notice to Agent; (f) bear and pay all expenses of protecting,
storing, warehousing, insuring, handling, maintaining and shipping any Collateral, all Taxes payable with respect to any Collateral
(including any sale thereof), and all other payments required to be made by Agent to any Person to realize upon any Collateral,
shall be borne and paid by Obligors (and Borrowers and the other Obligors agree Agent shall not be liable or responsible in any
way for the safekeeping of any Collateral, for any loss or damage thereto (except for reasonable care in its custody while Collateral
is in Agent’s actual possession), for any diminution in the value thereof, or for any act or default of any warehouseman, carrier,
forwarding agency or other Person whatsoever, but the same shall be at Borrowers’ and the other Obligors’ sole risk); (g) if any
amount payable under or in connection with any of the Collateral shall be evidenced by any Instrument or tangible Chattel Paper,
forthwith upon the request of Agent endorse, assign and deliver the same to Agent, accompanied by such instruments of transfer
or assignment duly executed in blank as Agent may reasonably request from time to time; and (h) at all times defend its title to
Collateral and Agent’s Liens therein against all Persons, claims and demands whatsoever, except Permitted Liens.

9.1.10     
[Reserved] 

9.1.11     
[Reserved] 

9.1.12     
Credit and Collection Policy. With respect to all Borrower Advances (other than Borrower Advances made under Section
9.2.4(b) and not included in the Borrowing Base), adhere to the Credit and Collection Policy without waiver of any of the underwriting,
documentation or collection policies contained therein (except to the extent Agent has consented in writing to such a waiver after
receipt and approval of such documentation and information as Agent may reasonably request (including copies of any credit committee
approvals related to the proposed waiver)); and not amend or otherwise modify the Credit and Collection Policy in any respect without
Agent’s prior written consent.

    	 	-58-	 

     

    

9.1.13     
Maintenance of Senior Security Interest. For so long as any Debt is owing by a Customer to any Borrower, take all
steps necessary or reasonably requested by Agent to maintain a first (or, in with respect to an Eligible Borrower Second Lien Advance,
second) priority perfected security interest in and Lien upon all Customer Collateral in connection with an Eligible Borrower Advance
(subject only to Liens expressly permitted by the applicable Transaction Documents (provided that such Transaction Documents are
in the forms attached to the Certificate Regarding Forms of Transaction Documents or in such other forms as are acceptable to Agent),
Liens that are approved by Agent in writing from time to time on a case-by-case basis and, in the case of an Eligible Borrower
First Lien Advance, Permitted Intercreditor Arrangements) except in connection with the settlement or liquidation of an Ineligible
Borrower Advance in the Ordinary Course of Business of such Borrower and not in violation of Section 9.2.13(b).

9.1.14     
Transaction Documents. Not enter into any Transaction Documents with any Customer unless such Transaction Documents
are substantially in the form of the applicable Transaction Documents attached to the Certificate Regarding Forms of Transaction
Documents or in such other forms as are acceptable to Agent.

9.1.15     
Post-Closing Obligations.

(a)               
On or before the date five (5) days following the Closing Date (or such later date as shall be agreed to in writing by Agent),
Borrowers shall deliver to Agent an account control agreement with respect to the securities accounts of Borrowers maintained at
Wells Fargo Clearing Services, LLC.

(b)              
On or before the date fifteen(15) days following the Closing Date (or such later date as shall be agreed to in writing by
Agent), Borrowers shall deliver to Agent a deposit account control agreement with respect to each Dominion Account maintained at
State Bank.

(c)               
On or before the date fifteen(15) days following the Closing Date (or such later date as shall be agreed to in writing by
Agent), Borrowers shall instruct all Collections Paying Parties who previously remitted Collections to a Deposit Account maintained
by Borrowers at Wells Fargo Bank, National Association, to make all payments to a Dominion Account maintained at State Bank; provided
that (i) any Collections paid to such Deposit Account at Wells Fargo Bank, National Association shall be transferred on a daily
basis to a Dominion Account maintained at State Bank, and (ii) if Collections Paying Parties continue to remit Collections to a
Deposit Account maintained by Borrowers at Wells Fargo Bank, National Association, after such date notwithstanding Borrowers’ instructions,
then on or before the date sixty (60) days following the Closing Date (or such later date as shall be agreed to in writing by Agent),
Borrowers shall either (A) cause all Collections Paying Parties who previously remitted Collections to a Deposit Account maintained
by Borrowers at Wells Fargo Bank, National Association to make all payments to a Dominion Account maintained at State Bank or (B)
cause such Deposit Account to be closed.

(d)              
On or before the date fifteen (15) days following the Closing Date (or such later date as shall be agreed to in writing
by Agent), Borrowers shall close all Deposit Accounts maintained by Borrowers at Pacific Western Bank and shall cause all Collections
Paying Parties who previously remitted Collections to a Deposit Account maintained by Borrowers at Pacific Western Bank to make
all payments to a Dominion Account maintained at State Bank; provided that any Collections paid to such Deposit Account at Wells
Fargo Bank, National Association prior to such Deposit Account being closed, shall be transferred on a daily basis to a Dominion
Account maintained at State Bank.

    	 	-59-	 

     

    

(e)              
On or before the date thirty (30) days following the Closing Date (or such later date as shall be agreed to in writing by
Agent), Borrowers shall deliver to Agent an additional insured endorsement with respect to Borrowers liability insurance.

(f)                
On or before the date thirty (30) days following the Closing Date (or such later date as shall be agreed to in writing by
Agent), Borrowers have used commercially reasonable efforts to cause the UCC-1 financing statement number 201400327886 filed by
SPUA6 Signature Place, LP in Dallas County, Texas to be amended in a manner acceptable to Agent in its Permitted Discretion.

(g)               
On or before the date sixty (60) days following the Closing Date (or such later date as shall be agreed to in writing by
Agent) or, in the case of a Royalty Purchase Agreement entered into after the Closing Date, on or before the date three (3) days
following the date such Royalty Purchase Agreement is entered into, Borrowers shall deliver to Agent copies of notices in form
and substance satisfactory to Agent pursuant to which (i) Borrowers and Royalty Sellers direct all related licensees to make payments
owing to Borrowers directly to the Dominion Account (except as provided in Sections 5.4(a)(i) and (ii)), and (ii) Borrowers give
notice to each Royalty Seller and related licensee of the collateral assignment to Agent of rights under the Royalty Purchase Agreement
to which the applicable Royalty Seller is a party, including, without limitation, the underlying Royalty Payments; provided, that
the failure to timely comply with such covenant with respect to any Royalty Purchase Agreement shall result in a Default under
this Agreement and, unless and until such consents and notices are given with respect to such Royalty Purchase Agreement, no Borrower
Royalty Receivable Advance made in connection with such Royalty Purchase Agreement shall be included in the Borrowing Base. In
addition, on or before the date sixty (60) days following the Closing Date (or such later date as shall be agreed to in writing
by Agent) or, in the case of a Royalty Purchase Agreement entered into after the Closing Date, on or before the date three (3)
days following the date such Royalty Purchase Agreement is entered into, Borrowers shall use commercially reasonable efforts to
obtain all consents needed for the collateral assignment to Agent of rights under the Royalty Purchase Agreements, including without
limitation, the underlying Royalty Payments; provided, that the failure to timely comply with such covenant with respect to any
Royalty Purchase Agreement shall result in a Default under this Agreement and, unless and until such consents and notices are given
with respect to such Royalty Purchase Agreement, no Borrower Royalty Receivable Advance made in connection with such Royalty Purchase
Agreement shall be included in the Borrowing Base; provider further, that Borrowers shall notify Agent in writing of any consent
that is required and is not obtained as required hereunder.

9.2              
Negative Covenants. As long as any Commitments or Obligations are outstanding, each Obligor shall not, and shall
cause each other Obligor and each Subsidiary not to do any of the following:

9.2.1         
Permitted Debt. Create, incur, guarantee or suffer to exist any Debt, except:

(a)               
the Obligations;

(b)              
obligations of a Borrower to extend credit to Customers under the Transaction Documents or to purchase Borrower Royalty
Receivables pursuant to Royalty Purchase Documents, in each case, pursuant to the terms, and subject to the conditions, thereof;

(c)               
the Permitted Purchase Money Debt; and

(d)              
other unsecured Debt incurred in the Ordinary Course of Business not to exceed $200,000 in the aggregate outstanding at
any time.

    	 	-60-	 

     

    

9.2.2         
Permitted Liens. Create or suffer to exist any Lien upon any of its Property, except the following (collectively,
“Permitted Liens”):

(a)               
Liens in favor of Agent;

(b)              
Purchase Money Liens securing Permitted Purchase Money Debt;

(c)               
Liens for Taxes (excluding any Lien imposed pursuant to any of the provisions of ERISA) not yet due or being Properly Contested;
and

(d)              
statutory Liens (other than Liens for Taxes or imposed under ERISA) arising in the Ordinary Course of Business, but only
if (i) payment of the obligations secured thereby is not yet due or is being Properly Contested, and (ii) such Liens do not materially
impair the value or use of the Property or materially impair operation of the business of any Borrower or Subsidiary.

9.2.3         
Distributions. Declare or make any Distributions, except Upstream Payments; or create or suffer to exist any encumbrance
or restriction on the ability of a Subsidiary to make any Upstream Payment.

9.2.4         
Restricted Investments. Make any investment in or to any Person, other than (a) making Borrower Advances and purchasing
Borrower Royalty Receivables pursuant to Transaction Documents in the Ordinary Course of Business and consistent with the Credit
and Collection Policy and Investment Policy; (b) other investments contemplated by the Investment Policy so long as, at the time
each such investment is made and after giving pro forma effect thereto, (i) no Default or Event of Default exists, (ii)
Borrowers are in compliance with the financial covenants set forth in Section 9.3 as set forth in a certificate to be delivered
by a Senior Officer of Borrower Agent at least five (5) Business Days prior to the making of such investment, and (iii) Availability
is at least $2,000,000; (c) investments in Subsidiaries existing on the Closing Date and SWK HP Holdings LP’s investment in Holmdel
Pharmaceuticals LP existing on the Closing Date; (d) investments by Holdings in SWK after the Closing Date; (e) investments by
Borrowers in other Subsidiaries to the extent approved by Agent and Required Lenders in writing from time to time; and (f) to the
extent subject to Agent’s Lien and control, pursuant to documentation in form and substance satisfactory to Agent, and no other
Liens, marketable direct obligations issued or unconditionally guaranteed by the United States government and backed by the full
faith and credit of the United States government having maturities of not more than 12 months from the date of acquisition, and
domestic certificates of deposit and time deposit having maturities of not more than 12 months from the date of acquisition.

9.2.5         
Disposition of Assets. Make (a) any disposition of any Borrower Advances, except, so long as no Event of Default
exists, dispositions of defaulted Borrower Advances in the Ordinary Course of Business so long as (i) prior and immediately after
giving effect to such disposition, an Overadvance does not exist and (ii) all net proceeds of such disposition are deposited into
a Dominion Account maintained at State Bank; or (b) any disposition of any other assets (including a sale, lease, license, consignment
or other transfer or disposition of assets (real or personal, tangible or intangible) or a disposition of property in connection
with a sale-leaseback transaction or synthetic lease, and including any sale or disposition of Equity Interests by any Subsidiary),
except dispositions of Equipment so long as all net proceeds of such disposition are deposited into a Dominion Account maintained
at State Bank.

    	 	-61-	 

     

    

9.2.6         
Restrictions on Payment of Certain Debt. Make any payments (whether voluntary or mandatory, or a prepayment, redemption,
retirement, defeasance or acquisition and whether consisting of principal, interest, fees or any other amounts, however categorized)
with respect to any Borrowed Money (other than the Obligations) prior to its due date under the agreements evidencing such Debt
as in effect on the Closing Date (or as amended thereafter with the consent of Agent).

9.2.7         
Fundamental Changes. Merge, combine, reorganize, or consolidate with any Person, or liquidate, wind up its affairs
or dissolve itself, in each case whether in a single transaction or in a series of related transactions, except for (a) a merger
of SWK with and into Holdings with Holdings continuing as the surviving entity and (b) mergers or consolidations of a wholly-owned
Subsidiary that is not an Obligor with another wholly-owned Subsidiary that is not an Obligor; change its name or conduct business
under any fictitious name; change its tax, charter or other organizational identification number or federal employer identification
number (or equivalent); or change its form or state of organization.

9.2.8         
Restrictive Agreements. Become a party to any Restrictive Agreement, except a Restrictive Agreement (a) in effect
on the Closing Date; (b) relating to secured Debt permitted hereunder, as long as the restrictions apply only to collateral for
such Debt; or (c) constituting customary restrictions on assignment in leases and other contracts (other than Transaction Documents
entered into in connection with Eligible Borrower Advances).

9.2.9         
Conduct of Business. Engage in any business other than its business as conducted on the Closing Date and any activities
incidental thereto and, to the extent permitted by Section 9.2.4(b), other activities contemplated by the Investment Policy;
make any loans or other advances of money to any Person, except Borrower Advances to Customers in the Ordinary Course of Business
of a Borrower pursuant to the terms, and subject to the conditions, set forth in the applicable Transaction Documents; form or
acquire any Subsidiary after the Closing Date except in connection with an investment permitted under Section 9.2.4(b) and,
unless and to the extent waived in writing by Agent in its discretion on a case-by-case basis, only if such Subsidiary becomes
a Guarantor and pledges its assets to Agent and the Equity Interests of such Subsidiary are pledged to Agent, in each case, pursuant
to documentation in form and substance satisfactory to Agent and with delivery of such certificates and opinions as shall be required
by Agent in connection therewith; permit any existing Subsidiary to issue any additional Equity Interests except to its parent;
acquire any business, line of business, division, license rights or brand of another Person, or all or substantially all of another
Person’s assets; amend, modify or otherwise change any of its Organic Documents as in effect on the Closing Date, unless consented
to in writing by Agent; file or consent to the filing of any consolidated income tax return with any Person other than Obligors
and Subsidiaries; make any change in accounting methods or treatment or reporting practices; change its Fiscal Year; enter into
any Hedging Agreement, except to hedge risks arising in the Ordinary Course of Business and not for speculative purposes; become,
or permit any Subsidiary to become a party to a Multiemployer Plan or any employee benefit plan or arrangement maintained or contributed
to by any Obligor or Subsidiary that is not subject to the laws of the United States or mandated by a government other than the
United States for employees of any Obligor or Subsidiary.

9.2.10     
Affiliate Transactions. Enter into or be party to any transaction with an Affiliate, except (a) transactions contemplated
by the Loan Documents; (b) payment of reasonable compensation to officers and employees for services actually rendered; (c) payment
of customary directors’ fees and indemnities; (d) transactions solely among Borrowers; (e) transactions with Affiliates that were
consummated prior to the Closing Date, as shown on Schedule 10; and (f) transactions with Affiliates in the Ordinary Course
of Business, upon fair and reasonable terms fully disclosed to Agent and no less favorable than would be obtained in a comparable
arm’s-length transaction with a non-Affiliate.

    	 	-62-	 

     

    

9.2.11     
Other Collateral Negative Covenants. (a) Keep, store or otherwise maintain any books and records at any location,
unless (i) a Borrower is the owner of such location, or (ii) a Borrower leases such location and the landlord has executed in favor
of Agent a Lien Waiver (or, if Agent agrees in its discretion, Agent has established an Availability Reserve with respect to such
location); or (b) amend, restate, supplement, or otherwise modify any Material Contract without Agent’s prior written consent.

9.2.12     
[Reserved] 

9.2.13     
Covenants Regarding Borrower Advances.

(a)               
At any time that the aggregate Net Amount of Eligible Borrower Advances is less than the greater of 300% of the Commitments
and $20,000,000:

(i)       Permit
a default or event of default to exist under the applicable Transaction Documents with respect to Customers accounting for thirty-five
percent (35%) or more of the Net Amount of all Borrower Advances;

(ii)       Permit
more than thirty percent (30%) of Borrower Advances of any Borrower to be on non-accrual at any time; or

(iii)       Permit
more than fifteen percent (15%) of Borrower Advances to be charged off during any period of four (4) Fiscal Quarters ending on
the last day of each Fiscal Quarter;

(b)              
Convey, assign, transfer or sell a participation (as opposed to rights as a co-lender in a syndicated transaction otherwise
permitted hereunder) in Borrower Advance or the Transaction Documents relating thereto.

9.3              
Financial Covenants. As long as any Commitments or Obligations are outstanding, Borrowers shall:

9.3.1         
Fixed Charge Coverage Ratio. Maintain, as of the last day of each Fiscal Quarter, a Fixed Charge Coverage Ratio of
at least 1.25 to 1.0 for the period of four (4) Fiscal Quarters then ending. “Fixed Charge Coverage Ratio” means, for
Borrowers, as of any date, the quotient obtained by dividing (a) the difference between (i) Borrowers’ EBITDA for such the
most recently four (4) Fiscal Quarter period, minus (ii) the sum of (A) all of Borrowers’ unfinanced Capital Expenditures
made in such period, and (B) any Distributions paid by Borrowers in such period, and (C) cash Taxes paid by Borrowers in such period
(without benefit of any refund), divided by (b) the sum of (i) the current portion of scheduled principal amortization on
Debt for Borrowed Money plus(ii) cash interest payments paid by Borrowers in such period.

9.3.2         
Tangible Net Worth. Maintain, as of the end of each Fiscal Quarter, commencing with the Fiscal Quarter ending June
30, 2018, a Tangible Net Worth of not less than $160,000,000. “Tangible Net Worth” means, on a consolidated basis for
Borrowers and their Subsidiaries, as of any date, the total assets of Borrowers, calculated in accordance with GAAP, minus the
total Debt of Borrowers, calculated in accordance with GAAP, minus the amount of all intangible items reflected therein, including
all unamortized debt discount and expense, unamortized research and development expense, unamortized deferred charges, goodwill,
patents, trademarks, service marks, trade names, copyrights, and all similar items that should properly be treated as intangibles
in accordance with GAAP, minus all amounts due from Borrowers’ Affiliates, plus all Subordinated Debt. As used herein, “Subordinated
Debt” means all Debt incurred by a Borrower or Subsidiary that is expressly subordinated and made junior to the Full Payment
of the Obligations and contains terms and conditions (including terms relating to interest, fees, repayment and subordination)
satisfactory to Agent. Nothing in this Section 9.3.2 shall be deemed to permit any Person to incur any Debt that is not
otherwise permitted by the terms of Section 9.2.1.

    	 	-63-	 

     

    

SECTION
10.         
EVENTS OF DEFAULT; REMEDIES ON DEFAULT

10.1           
Events of Default. Each of the following shall be an “Event of Default” hereunder, if the same shall
occur for any reason whatsoever, whether voluntary or involuntary, by operation of law or otherwise:

(a)               
A Borrower or any other Obligor fails to pay any Obligations when due (whether at stated maturity, on demand, upon acceleration
or otherwise);

(b)              
Any representation, warranty or other written statement of an Obligor made in connection with any Loan Documents or transactions
contemplated thereby is incorrect or misleading in any material respect (or, if any such representation, warranty or other written
statement is qualified by “materiality”, “Material Adverse Effect” or similar language, in any respect)
when given or deemed given;

(c)               
A Borrower or any other Obligor breaches or fail to perform any covenant contained in Section 5.5, 7.2, 7.4, 7.6, 8.1,
9.1.1, 9.1.2, 9.1.3, 9.1.4, 9.1.6, 9.1.7, 9.2 or 9.3;

(d)              
An Obligor breaches or fails to perform any other covenant contained in any Loan Documents, and such breach or failure is
not cured within 15 days after a Senior Officer of such Obligor has knowledge thereof or receives notice thereof from Agent, whichever
is sooner; provided, however, that such notice and opportunity to cure shall not apply if the breach or failure to
perform is not capable of being cured at all or within such period or is a willful breach by an Obligor;

(e)              
A Guarantor repudiates, revokes or attempts to revoke its Guaranty; an Obligor or third party denies or contests the validity
or enforceability of any Loan Documents or Obligations, or the perfection or priority of any Lien granted to Agent; or any Loan
Document ceases to be in full force or effect for any reason (other than a waiver or release by Agent and Lenders);

(f)                
Any breach or default of an Obligor or Subsidiary occurs under any Hedging Agreement, or any document, instrument or agreement
to which it is a party or by which it or any of its Properties is bound, relating to any Debt (other than the Obligations) in excess
of $100,000, if the maturity of or any payment with respect to such Debt may be accelerated or demanded due to such breach (including,
without limitation, pursuant to a required mandatory prepayment or “put” of such Debt to any person);

(g)               
Any judgment or order for the payment of money is entered against an Obligor or its assets in an amount that exceeds, individually
or cumulatively with all unsatisfied judgments or orders against all Obligors, $250,000 (net of any insurance coverage therefor
acknowledged in writing by the insurer) and, in any case, (A) enforcement proceedings are commenced by any creditor upon such judgment
or order, or (B) there is a period of 30 consecutive days during which a stay of enforcement of such judgment or order, by reason
of a pending appeal or otherwise, is not in effect;

    	 	-64-	 

     

    

(h)              
(i) a loss, theft, damage or destruction occurs with respect to any Collateral if the amount not covered by insurance exceeds
$250,000 or if a material portion of the Collateral is effected, or (ii) there shall occur any levy upon, or attachment, garnishment,
or other seizure of, any portion of the Collateral or other assets of any Obligor or Subsidiary in excess of $250,000;

(i)                 
An Obligor is enjoined, restrained or in any way prevented by any governmental authority from conducting any material part
of its business; an Obligor suffers the loss, revocation or termination of any material license, permit, lease or agreement necessary
to its business; there is a cessation of any material part of an Obligor’s business for a material period of time; an Obligor shall
take any action, or shall make a determination, whether or not formally approved by an Obligor’s board of directors or similar
governing body, as applicable, to suspend the operation of its business in the ordinary course, liquidate all or a material portion
of its assets or store locations, or employ an agent or other third party to conduct a program of closings, liquidations or “Going-Out-Of-Business”
sales of any material portion of its business; any material Collateral or Property of an Obligor is taken or impaired through condemnation;
there occurs any uninsured loss to any material Collateral or Property of an Obligor; an Obligor agrees to or commences any liquidation,
dissolution or winding up of its affairs; or an Obligor is not Solvent;

(j)                
An Insolvency Proceeding is commenced by an Obligor; an Obligor makes an offer of settlement, extension or composition to
its unsecured creditors generally; a trustee, receiver or similar official is appointed to take possession of any substantial Property
of or to operate any of the business of an Obligor; or an Insolvency Proceeding is commenced against an Obligor and the Obligor
consents to institution of the proceeding, the petition commencing the proceeding is not timely contested by the Obligor, as applicable,
the petition is not dismissed within 60 days after filing, or an order for relief is entered in the proceeding;

(k)               
A reportable event (consisting of any of the events set forth in Section 4043(b) of ERISA) shall occur which Agent, in its
reasonable discretion, shall determine constitutes grounds for the termination by the Pension Benefit Guaranty Corporation of any
Plan or the appointment by the appropriate United States district court of a trustee for any Plan, or if any Plan shall be terminated
or any such trustee shall be requested or appointed, or if a Borrower or any other Obligor is in “default” (as defined
in Section 4219(c)(5) of ERISA) with respect to payments to a Multiemployer Plan resulting from Borrower’s, or such other
Obligor’s complete or partial withdrawal from such Multiemployer Plan, or any similar event as any of the foregoing occurs in respect
of any employee benefit plan or arrangement maintained or contributed to by any Obligor or Subsidiary that is not subject to the
laws of the United States or is mandated by a government other than the United States for employees of any Obligor or Subsidiary.

(l)                 
An Obligor or any of its Senior Officers is criminally indicted or convicted for (i) a felony committed in the conduct of
the Obligor’s business, or (ii) violating any state or federal law (including the Controlled Substances Act, Money Laundering Control
Act of 1986 and Illegal Exportation of War Materials Act) that could lead to forfeiture of any material Property or any Collateral;

(m)            
A Change of Control occurs; or Winston Black ceases to be the Chief Executive Officer of Holdings for any reason (unless
replaced by an individual satisfactory to Agent within ninety (90) days after the date on which he ceases to hold such position);
or any event occurs or condition exists that has a Material Adverse Effect;

(n)              
A Borrower ceases to perform or be able to perform its obligations under the Transaction Documents;

    	 	-65-	 

     

    

(o)              
Any Person other than a Borrower acts at any time as the servicer of Borrower Advances made or acquired by any Borrower
or as the custodian for certain Collateral and Transaction Documents pursuant to which any Borrower makes or has acquired Borrower
Advances unless Agent has approved of the replacement servicer or custodian, as applicable, and Borrowers have delivered to Agent
all documents or agreements with such replacement servicer or custodian as Agent may request, duly executed by all Persons party
thereto; or

(p)              
Unless waived by Agent in writing on a case-by-case basis, any Obligor or any Subsidiary thereof fails to make any payment
when due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of any Material Contract
or fails to observe or perform any other agreement or condition relating to any such Material Contract or contained in any instrument
or agreement evidencing, securing or relating thereto, or any other event occurs, the effect of which default or other event is
to cause the termination of such Material Contract or to permit the counterparty to such Material Contract to terminate such Material
Contract.

10.2           
Remedies upon Default. If an Event of Default described in Section 10.1(j) occurs, then to the extent
permitted by Applicable Law, all Obligations (other than Secured Bank Product Obligations) shall become automatically due and payable
and all Commitments shall terminate, without any action by Agent or notice of any kind. In addition, or if any Event of Default
exists, Agent may in its discretion (and shall upon written direction of Required Lenders) do any one or more of the following
from time to time:

(a)               
declare any Obligations (other than Secured Bank Product Obligations) immediately due and payable, whereupon they shall
be due and payable without diligence, presentment, demand, protest or notice of any kind, all of which are hereby waived by Borrowers
to the fullest extent permitted by law;

(b)              
terminate, reduce or condition any Commitment, or make any adjustment to the Borrowing Base;

(c)               
require Obligors to Cash Collateralize Secured Bank Product Obligations and other Obligations that are contingent or not
yet due and payable, and, if Obligors fail promptly to deposit such Cash Collateral, Agent may (and shall upon the direction of
Required Lenders) advance the required Cash Collateral as Revolver Loans (whether or not an Overadvance exists or is created thereby,
or the conditions in Section 6 are satisfied);

(d)              
replace any Borrower with another Person acceptable to Agent to act as servicer for the Borrower Advances of such Borrower,
which replacement Person, in Agent’s discretion, could be Agent;

(e)              
enforce any right, remedy, power or privilege available to Borrowers under any Transaction Document; and

    	 	-66-	 

     

    

(f)                
exercise any other rights or remedies afforded under any agreement, by law, at equity or otherwise, including the rights
and remedies of a secured party under the UCC. Such rights and remedies include the rights to (i) take possession of any Collateral;
(ii) require Obligors to assemble Collateral or Customer Collateral, at Borrowers’ expense, and make it available to Agent
at a place designated by Agent; (iii) enter any premises where Collateral is located and store Collateral on such premises until
sold (and if the premises are owned or leased by an Obligor, Obligors agree not to charge for such storage); (iv) demand, sue for,
collect or receive any money or property at any time payable or receivable in respect of the Collateral including instructing the
obligor or obligors on any agreement, instrument or other obligation constituting part of the Collateral to make any payment required
by the terms of such agreement, instrument or other obligation directly to Agent, and in connection with any of the foregoing,
compromise, settle, extend the time for payment and make other modifications with respect thereto; provided, however,
that in the event that any such payments are made directly to any Obligor, prior to receipt by any such Obligor of such instruction,
such Obligor shall segregate all amounts received pursuant thereto in trust for the benefit of Agent and shall promptly pay such
amounts to Agent; (v) sell, assign, grant a license to use or otherwise liquidate, or direct any Obligor to sell, assign, grant
a license to use or otherwise liquidate, any and all investments made in whole or in part with the Collateral or any part thereof,
and take possession of the proceeds of any such sale, assignment, license or liquidation; (vi) withdraw all moneys, instruments,
securities and other property in any bank, financial securities, deposit or other account of any Obligor constituting Collateral
for application to the Obligations as provided herein; (vii) exercise any and all rights as beneficial and legal owner of the Collateral,
including perfecting assignment of and exercising any and all voting, consensual and other rights and powers with respect to any
Collateral; (viii) exercise all the rights and remedies of a secured party under the UCC; and (ix) sell or otherwise dispose of
any Collateral in its then condition, or after any further manufacturing or processing thereof, at public or private sale, with
such notice as may be required by Applicable Law, in lots or in bulk, at such locations, all as Agent, in its discretion, deems
advisable. Each Obligor agrees that 10 days’ notice (unless the Collateral is perishable or threatens to decline speedily in value,
or is of a type customarily sold on a recognized market (in which event, such advance notice as may be practicable under the circumstances))
of any proposed sale or other disposition of Collateral by Agent shall be reasonable. Agent shall have the right to conduct such
sales on any Obligor’s premises, without charge, and such sales may be adjourned from time to time in accordance with Applicable
Law. Agent shall have the right to sell, lease or otherwise dispose of any Collateral for cash, credit or any combination thereof,
and Agent may purchase any Collateral at public or, if permitted by law, private sale and, in lieu of actual payment of the purchase
price, may credit bid and set off the amount of such price against the Obligations. Each purchaser, assignee, licensee or recipient
at any such sale shall acquire the property sold, assigned or licensed absolutely free from any claim or right on the part of any
Obligor, and each Obligor hereby waives, to the fullest extent permitted by Applicable Law, all rights of redemption, stay and/or
appraisal which it now has or may at any time in the future have under any rule of law or statute now existing or hereafter enacted.
Agent shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. To the fullest extent
permitted by Applicable Law, each Obligor hereby waives any claims against Agent arising by reason of the fact that the price at
which any Collateral may have been sold, assigned or licensed at such a private sale was less than the price which might have been
obtained at a public sale, even if Agent accepts the first offer received and does not offer such Collateral to more than one offeree.

10.3           
License. Agent is hereby granted an irrevocable, non-exclusive license or other right to use, license or sub-license
(without payment of royalty or other compensation to any Person) any or all Intellectual Property of Obligor, computer hardware
and software, trade secrets, brochures, customer lists, promotional and advertising materials, labels, packaging materials and
other Property, in advertising for sale, marketing, selling, collecting, completing manufacture of, or otherwise exercising any
rights or remedies with respect to, any Collateral. Each Obligor’s rights and interests under Intellectual Property shall inure
to Agent’s benefit.

10.4           
Setoff. At any time during an Event of Default, Agent, Lenders, and any of their Affiliates are authorized, to
the fullest extent permitted by Applicable Law, to set off and apply any and all deposits (general or special, time or demand,
provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by
Agent, such Lender or such Affiliate to or for the credit or the account of an Obligor against any Obligations, regardless of the
adequacy of any other Collateral and regardless of whether or not Agent, such Lender or such Affiliate shall have made any demand
under this Agreement or any other Loan Document and although such Obligations may be contingent or unmatured or are owed to a branch
or office of Agent, such Lender or such Affiliate different from the branch or office holding such deposit or obligated on such
indebtedness. The rights of Agent, each Lender and each such Affiliate under this Section are in addition to other rights and remedies
(including other rights of setoff) that such Person may have.

    	 	-67-	 

     

    

10.5           
Remedies Cumulative; No Waiver.

10.5.1     
Cumulative Rights. All agreements, warranties, guaranties, indemnities and other undertakings of Obligors under the
Loan Documents are cumulative and not in derogation of each other. The rights and remedies of Agent and Lenders are cumulative,
may be exercised at any time and from time to time, concurrently or in any order, and are not exclusive of any other rights or
remedies available by agreement, by law, at equity or otherwise. All such rights and remedies shall continue in full force and
effect until Full Payment of all Obligations.

10.5.2     
Waivers. No waiver or course of dealing shall be established by (a) the failure or delay of Agent or any Lender to
require strict performance by any Obligor with any terms of the Loan Documents, or to exercise any rights or remedies with respect
to Collateral or otherwise; (b) the making of any Loan during a Default, Event of Default or other failure to satisfy any conditions
precedent, or Agent’s or any Lender’s permitting to remain outstanding any Loan during a Default or Event of Default;
or (c) acceptance by Agent or any Lender of any payment or performance by an Obligor under any Loan Documents in a manner other
than that specified therein. It is expressly acknowledged by Obligors that any failure to satisfy a financial covenant on a measurement
date shall not be cured or remedied by satisfaction of such covenant on a subsequent date.

SECTION
11.         
AGENT

This Section
11 and the provisions contained in Exhibit D attached hereto (which are hereby incorporated by reference) are an agreement
solely among Secured Parties and Agent, and shall survive Full Payment of the Obligations. Neither Exhibit D, nor this Section
11, confer any rights or benefits upon Obligors or any other Person. As between Obligors and Agent, any action that Agent may
take under any Loan Documents or with respect to any Obligations shall be conclusively presumed to have been authorized and directed
by Secured Parties.

SECTION
12.         
BENEFIT OF AGREEMENT; ASSIGNMENTS

12.1           
Successors and Assigns. This Agreement and the other Loan Documents shall be binding upon and inure to the benefit
of Borrowers, each other Obligor, Agent, Lenders, Secured Parties, and their respective successors and assigns, except that (a)
no Obligor shall have the right to assign its rights or delegate its obligations under any Loan Documents; and (b) any assignment
by a Lender must be made in compliance with Section 12.3. Agent may treat the Person which made any Loan as the owner thereof
for all purposes until such Person makes an assignment in accordance with Section 12.3. Any authorization or consent of
a Lender shall be conclusive and binding on any subsequent transferee or assignee of such Lender.

12.2           
Participations

12.2.1     
Permitted Participants; Effect. Any Lender may, subject to Section 12.3.3 and with the prior written consent
of Agent, in the ordinary course of its business and in accordance with Applicable Law, at any time sell to a financial institution
(“Participant”) a participating interest in the rights and obligations of such Lender under any Loan Documents.
Despite any sale by a Lender of participating interests to a Participant, such Lender’s obligations under the Loan Documents shall
remain unchanged, such Lender shall remain solely responsible to the other parties hereto for performance of such obligations,
such Lender shall remain the holder of its Loans and Commitments for all purposes, all amounts payable by Borrowers shall be determined
as if such Lender had not sold such participating interests, and Obligors and Agent shall continue to deal solely and directly
with such Lender in connection with the Loan Documents. Each Lender shall be solely responsible for notifying its Participants
of any matters under the Loan Documents, and Agent and the other Lenders shall not have any obligation or liability to any such
Participant. A Participant that would be a Foreign Lender if it were a Lender shall not be entitled to the benefits of Section
5.9 unless Borrowers agree otherwise in writing.

    	 	-68-	 

     

    

12.2.2     
Voting Rights. Each Lender shall retain the sole right to approve, without the consent of any Participant, any amendment,
waiver or other modification of any Loan Documents other than that which forgives principal, interest or fees, reduces the stated
interest rate or fees payable with respect to any Loan or Commitment in which such Participant has an interest, postpones the Commitment
Termination Date or any date fixed for any regularly scheduled payment of principal, interest or fees on such Loan or Commitment,
or releases any Borrower, Guarantor or substantial portion of the Collateral.

12.2.3     
Benefit of Set-Off. Borrowers agree that each Participant, if consented to in writing by Agent, shall have a right
of set-off in respect of its participating interest to the same extent as if such interest were owing directly to a Lender, and
each Lender shall also retain the right of set-off with respect to any participating interests sold by it. By exercising any right
of set-off, a Participant agrees to share with Lenders all amounts received through its set-off, in accordance with Section
V of Exhibit D as if such Participant were a Lender.

12.3           
Assignments.

12.3.1     
Permitted Assignments. A Lender may assign to an Eligible Assignee any of its Loans, rights and obligations under
the Loan Documents, as long as (a) each assignment is of a constant, and not a varying, percentage of the transferor Lender’s rights
and obligations under the Loan Documents and, in the case of a partial assignment, is in a minimum principal amount of $5,000,000
(unless otherwise agreed by Agent in its discretion) and integral multiples of $5,000,000 in excess of that amount; (b) except
in the case of an assignment in whole of a Lender’s rights and obligations, the aggregate amount of the Commitments retained by
the transferor Lender is at least $5,000,000 (unless otherwise agreed by Agent in its discretion); (c) Agent shall have consented
to such assignment (except to the extent such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund with respect
to such Lender) and (d) the parties to each such assignment shall execute and deliver to Agent, for its acceptance and recording,
an Assignment and Acceptance. Nothing herein shall limit the right of a Lender to pledge or assign any rights under the Loan Documents
to secure obligations of such Lender, including a pledge or assignment to a Federal Reserve Bank; provided, however, that no such
pledge or assignment shall release the Lender from its obligations hereunder nor substitute the pledge or assignee for such Lender
as a party hereto.

12.3.2     
Effect; Effective Date. Upon delivery to Agent of an assignment notice in form and substance satisfactory to Agent
and a processing fee of $3,500 (unless otherwise agreed by Agent in its discretion), the assignment shall become effective as specified
in the notice, if it complies with this Section 12.3. From such effective date, the Eligible Assignee shall for all purposes
be a Lender under the Loan Documents, and shall have all rights and obligations of a Lender thereunder. Upon consummation of an
assignment, the transferor Lender, Agent and Borrowers shall make appropriate arrangements for issuance of replacement and/or new
promissory notes, as applicable, in favor of such assignee Lender. The transferee Lender shall comply with Section 5.10
and deliver, upon request, an administrative questionnaire satisfactory to Agent.

    	 	-69-	 

     

    

12.3.3     
Certain Assignees. No assignment or participation may be made to a Borrower, an Affiliate of a Borrower, a Defaulting
Lender or a natural person. In connection with any assignment by a Defaulting Lender, such assignment shall be effective only upon
payment by the Eligible Assignee or Defaulting Lender to Agent of an aggregate amount sufficient, upon distribution (through direct
payment, purchases of participations or other compensating actions as Agent deems appropriate), (a) to satisfy all funding and
payment liabilities then owing by the Defaulting Lender hereunder, and (b) to acquire its Pro Rata share of all Loans. If an assignment
by a Defaulting Lender shall become effective under Applicable Law for any reason without compliance with the foregoing sentence,
then the assignee shall be deemed a Defaulting Lender for all purposes until such compliance occurs.

12.3.4     
Certain Pledges. Any Lender may, at any time and without consent of any Borrower or Agent, pledge or assign a security
interest in all or any portion of its rights under this Agreement (including under any notes issued for its benefit) to secure
obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or any funding source
of such Lender; provided that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute
any such pledgee or assignee for such Lender as a party hereto.

12.4           
Replacement of Certain Lenders. If a Lender (a) fails to give its consent to any amendment, waiver or action
for which consent of all Lenders was required and Required Lenders consented, (b) claims compensation under Section 3.7
or 5.9, or (c) is a Defaulting Lender, then, in addition to any other rights and remedies that any Person may have, Agent
or Borrower Agent may, by notice to such Lender within 120 days after such event, require such Lender to assign all of its rights
and obligations under the Loan Documents to Eligible Assignee(s), pursuant to appropriate Assignment and Acceptance(s), within
20 days after the notice. Agent is irrevocably appointed as attorney-in-fact to execute any such Assignment and Acceptance if the
Lender fails to execute it. Such Lender shall be entitled to receive, in cash from such Eligible Assignee, concurrently with such
assignment, all amounts owed to it under the Loan Documents, including all principal, interest and fees through the date of assignment
(but excluding any prepayment charge).

SECTION
13.         
MISCELLANEOUS

13.1           
Consents, Amendments and Waivers.

13.1.1     
Amendment. No modification of any Loan Document, including any extension or amendment of a Loan Document or any waiver
of a Default or Event of Default, shall be effective without the prior written agreement of Agent (with the consent of Required
Lenders) and, each Obligor party to such Loan Document; provided, however, that (a) without the prior written consent
of Agent, no modification shall be effective with respect to any provision in a Loan Document that relates to any rights, duties
or discretion of Agent; (b) without the prior written consent of each affected Lender, including a Defaulting Lender, no modification
shall be effective that would (i) increase the Commitment of such Lender; (ii) reduce the amount of, or waive or delay payment
of, any principal, interest or fees payable to such Lender (except as provided in Section 4.2); (iii) extend the Revolver
Termination Date applicable to such Lender’s Obligations; or (iv) amend this clause (b); (c) without the prior written consent
of all Lenders (except any Defaulting Lender), no modification shall be effective that would (i) alter Section 5.7, 7.1 (except
to add Collateral) or 13.1.1; (ii) amend the definition of Pro Rata or Required Lenders; (iii) release all or substantially
all of the Collateral, except as currently contemplated by the Loan Documents; or (iv) release any Obligor from liability for any
Obligations, if such Obligor is Solvent at the time of the release; (d) without the prior written consent of Required Supermajority
Lenders, (i) increase any advance rate with respect to the Borrowing Base; or (ii) amend or waive the conditions to eligibility
of Borrower Advances or other components (or subcomponents of such components) of the calculation of the Borrowing Base, in each
case, if as a result thereof the amounts available to be borrowed by Borrowers would be increased; provided that the foregoing
shall not limit the discretion of Agent to change, establish or eliminate any Availability Reserves; and (e) without the prior
written consent of a Secured Bank Product Provider, no modification shall be effective that affects its relative payment priority
under Section 5.7.

    	 	-70-	 

     

    

13.1.2     
Limitations. The agreement of Obligors shall not be necessary to the effectiveness of any modification of a Loan
Document that deals solely with the rights and duties of Lenders and/or Agent as among themselves. Only the consent of the parties
to the Fee Letter or any agreement relating to a Bank Product shall be required for any modification of such agreement, and any
non-Lender that is party to a Bank Product agreement shall have no right to participate in any manner in modification of any other
Loan Document. Any waiver or consent granted by Agent or Lenders hereunder shall be effective only if in writing and only for the
matter specified.

13.1.3     
Payment for Consents. No Borrower will directly or indirectly, pay any remuneration or other thing of value, whether
by way of additional interest, fee or otherwise, to any Lender (in its capacity as a Lender hereunder) as consideration for agreement
by such Lender with any modification of any Loan Documents, unless such remuneration or value is concurrently paid, on the same
terms, on a Pro Rata basis to all Lenders providing their consent.

13.2           
Indemnity. EACH BORROWER AND EACH OTHER OBLIGOR SHALL INDEMNIFY AND HOLD HARMLESS THE INDEMNITEES AGAINST
ANY CLAIMS, LIABILITIES, COSTS, EXPENSES AND OTHER AMOUNTS OF ANY KIND THAT MAY BE INCURRED BY OR ASSERTED AGAINST ANY INDEMNITEE
IN ANY WAY RELATED TO THE LOAN DOCUMENTS, THE COLLATERAL, ANY BREACH OF APPLICABLE LAW, OR OTHERWISE, INCLUDING CLAIMS ASSERTED
BY ANY OBLIGOR OR OTHER PERSON OR ARISING FROM THE NEGLIGENCE OF AN INDEMNITEE. In no event shall any party to a Loan Document
have any obligation thereunder to indemnify or hold harmless an Indemnitee with respect to any claims, liabilities, costs, expenses
and other amounts of any kind in any way related to the Loan Documents or Collateral that are determined in a final, non-appealable
judgment by a court of competent jurisdiction to result from the gross negligence or willful misconduct of such Indemnitee.

13.3           
Notices and Communications.

13.3.1     
Notice Address. Subject to Section 4.1.4, all notices and other communications by or to a party hereto shall
be in writing and shall be given to any Obligor, at Borrower Agent’s address shown on the signature pages hereof, and to any other
Person at its address shown on the signature pages hereof (or, in the case of a Person who becomes a Lender after the Closing Date,
at the address shown on its Assignment and Acceptance), or at such other address as a party may hereafter specify by notice in
accordance with this Section 13.3. Each such notice or other communication shall be effective only (a) if given by mail,
three Business Days after deposit in the U.S. mail, with first-class postage pre-paid, addressed to the applicable address; (b)
if given by personal delivery, when duly delivered to the notice address with receipt acknowledged; or (c) if given by electronic
means, only at the time and to the extent provided in Section 13.3.2. In no event shall a voicemail message be effective
as a notice, communication or confirmation under any of the Loan Documents. Notwithstanding the foregoing, no notice to Agent pursuant
to Section 2.1.4, 2.3, 4.1.1 or 5.3.3 shall be effective until actually received by the individual to whose attention
at Agent such notice is required to be sent. Any written notice or other communication that is not sent in conformity with the
foregoing provisions shall nevertheless be effective on the date actually received by the noticed party. Any notice received by
Borrower Agent shall be deemed received by all Obligors.

    	 	-71-	 

     

    

13.3.2     
Electronic Communications. (i) Borrowers authorize Agent and Lenders to extend Loans, effect selections of interest
rates, and transfer funds to or on behalf of Borrowers based on instructions sent by electronic mail. Borrowers shall confirm each
such request by prompt delivery to Agent of a Notice of Borrowing, but if the foregoing differs in any material respect from the
action taken by Agent, the records of Agent shall govern.

(ii)       Electronic
mail and internet websites may be used for delivery of financial statements, Borrowing Base Certificates and other information
required by Section 9.1.3 (other than notices), administrative matters and distribution of Loan Documents for execution,
pursuant to procedures approved by Agent or as otherwise determined by Agent. Anything herein to the contrary notwithstanding,
except as expressly provided Section 13.2.2(i), notices delivered by electronic mail may not be used as effective notice
under the Loan Documents.

(iii)       Unless
Agent otherwise requires, communications sent to an electronic mail address of Agent shall be deemed received upon the sender’s
receipt of an acknowledgement from the intended recipient (such as by the “return receipt requested” function, as available,
return e-mail, or other written acknowledgement); provided that if such communication is not sent during the normal business hours
of the recipient, such communication shall be deemed to have been sent at the opening of business on the next Business Day for
the recipient.

(iv)       Agent
shall not have any liability for any loss suffered by any Obligor as a result of Agent’s acting upon its understanding of electronic
mail requests or instructions from a Person believed in good faith by Agent to be a Person authorized to give such requests or
instructions on an Obligor’s behalf. Each Obligor shall indemnify, defend and hold harmless each Indemnitee from any claims arising
from any electronic communication purportedly given by or on behalf of an Obligor.

(v)       Agent
may, in its discretion and upon notice to Borrower Agent (A) cease or suspend any actual or implied obligation it may have to act
based on such electronic communications and (B) thereafter, disregard any such electronic communications.

13.3.3     
Non-Conforming Communications. Agent and Lenders may rely upon any notices purportedly given by or on behalf of any
Obligors even if such notices were not made in a manner specified herein, were incomplete or were not confirmed, or if the terms
thereof, as understood by the recipient, varied from a later confirmation. Each Obligor shall indemnify and hold harmless each
Indemnitee from any liabilities, losses, costs and expenses arising from any telephonic communication purportedly given by or on
behalf of an Obligor.

13.4           
Performance of Obligors’ Obligations. Agent may, in its discretion at any time and from time to time, at
Borrowers’ and the other Obligors’ expense, pay any amount or do any act required of an Obligor under any Loan Documents or otherwise
lawfully requested by Agent to (a) enforce any Loan Documents or collect any Obligations; (b) protect, insure, maintain or realize
upon any Collateral; or (c) defend or maintain the validity or priority of Agent’s Liens in any Collateral, including any payment
of a judgment, insurance premium, warehouse charge, finishing or processing charge, or landlord claim, or any discharge of a Lien.
All payments, costs and expenses (including Extraordinary Expenses) of Agent under this Section shall be reimbursed to Agent by
Borrowers and the other Obligors, on demand, with interest from the date incurred to the date of payment thereof at the
Default Rate applicable to Revolver Loans. Any payment made or action taken by Agent under this Section shall be without prejudice
to any right to assert an Event of Default or to exercise any other rights or remedies under the Loan Documents.

    	 	-72-	 

     

    

13.5           
Credit Inquiries. Each Obligor hereby authorizes Agent and Lenders (but they shall have no obligation) to respond
to usual and customary credit inquiries from third parties concerning any Obligor or Subsidiary.

13.6           
Severability. Wherever possible, each provision of the Loan Documents shall be interpreted in such manner as
to be valid under Applicable Law. If any provision is found to be invalid under Applicable Law, it shall be ineffective only to
the extent of such invalidity and the remaining provisions of the Loan Documents shall remain in full force and effect.

13.7           
Cumulative Effect; Conflict of Terms. The provisions of the Loan Documents are cumulative. The parties acknowledge
that the Loan Documents may use several limitations, tests or measurements to regulate similar matters, and they agree that these
are cumulative and that each must be performed as provided. Except as otherwise provided in another Loan Document (by specific
reference to the applicable provision of this Agreement), if any provision contained herein is in direct conflict with any provision
in another Loan Document, the provision herein shall govern and control.

13.8           
Counterparts. Any Loan Document may be executed in counterparts, each of which shall constitute an original,
but all of which when taken together shall constitute a single contract. This Agreement shall become effective when Agent has received
counterparts bearing the signatures of all parties hereto. Delivery of a signature page of any Loan Document by telecopy or other
electronic means shall be effective as delivery of a manually executed counterpart of such agreement.

13.9           
Entire Agreement. Time is of the essence of the Loan Documents. The Loan Documents constitute the entire contract
among the parties relating to the subject matter hereof, and supersede any and all previous agreements and understandings, oral
or written, relating to the subject matter hereof.

13.10       
Relationship with Lenders. The obligations of each Lender hereunder are several, and no Lender shall be responsible
for the obligations or Commitments of any other Lender. Amounts payable hereunder to each Lender shall be a separate and independent
debt. It shall not be necessary for Agent or any other Lender to be joined as an additional party in any proceeding for such purposes.
Nothing in this Agreement and no action of Agent, Lenders or any other Secured Party pursuant to the Loan Documents or otherwise
shall be deemed to constitute Agent and any Secured Party to be a partnership, association, joint venture or any other kind of
entity, nor to constitute control of any Obligor.

13.11       
No Advisory or Fiduciary Responsibility. In connection with all aspects of each transaction contemplated by any
Loan Document, Borrowers and the other Obligors acknowledge and agree that (a)(i) this credit facility and any related arranging
or other services by Agent, any Lender, any of their Affiliates or any arranger are arm’s-length commercial transactions between
Obligors and such Person; (ii) Obligors have consulted their own legal, accounting, regulatory and tax advisors to the extent they
have deemed appropriate; and (iii) Obligors are capable of evaluating, and understand and accept, the terms, risks and conditions
of the transactions contemplated by the Loan Documents; (b) each of Agent, Lenders, their Affiliates and any arranger is and has
been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and
will not be acting as an advisor, agent or fiduciary for Obligors, any of their Affiliates or any other Person, and has no obligation
with respect to the transactions contemplated by the Loan Documents except as expressly set forth therein; and (c) Agent, Lenders,
their Affiliates and any arranger may be engaged in a broad range of transactions that involve interests that differ from those
of Obligors and their Affiliates, and have no obligation to disclose any of such interests to Obligors or their Affiliates. To
the fullest extent permitted by Applicable Law, each Borrower and each other Obligor hereby waives and releases any claims that
it may have against Agent, Lenders, their Affiliates and any arranger with respect to any breach of agency or fiduciary duty in
connection with any transaction contemplated by a Loan Document.

    	 	-73-	 

     

    

13.12       
Confidentiality. Agent and Lenders each shall maintain the confidentiality of all Information (as defined below),
except that Information may be disclosed (a) to its Affiliates and funding or financing sources, and to its and their partners,
directors, officers, employees, agents, advisors and representatives (provided such Persons are informed of the confidential nature
of the Information and instructed to keep it confidential); (b) to the extent requested by any governmental, regulatory or self-regulatory
authority purporting to have jurisdiction over it or its Affiliates; (c) to the extent required by Applicable Law or by any subpoena
or other legal process; (d) to any other party hereto; (e) in connection with any action or proceeding, or other exercise of rights
or remedies, relating to any Loan Documents or Obligations; (f) subject to an agreement containing provisions substantially the
same as this Section, to any Transferee or any actual or prospective party (or its advisors) to any Bank Product; (g) with the
consent of Borrower Agent; or (h) to the extent such Information (i) becomes publicly available other than as a result of a breach
of this Section or (ii) is available to Agent, any Lender or any of their Affiliates on a nonconfidential basis from a source other
than Obligors. Notwithstanding the foregoing, Agent and Lenders may publish or disseminate general information describing this
credit facility, including the names and addresses of Borrowers and a general description of Obligors’ businesses, and may use
Obligors’ logos, trademarks or product photographs in advertising materials, including “tombstones”, league tables and
press releases. As used herein, “Information” means all information received from an Obligor or Subsidiary relating
to it or its business that is identified as confidential when delivered. Any Person required to maintain the confidentiality of
Information pursuant to this Section shall be deemed to have complied if it exercises the same degree of care that it accords its
own confidential information. Agent and Lenders each acknowledge that (i) Information may include material non-public information
concerning an Obligor or Subsidiary; (ii) it has developed compliance procedures regarding the use of material non-public information;
and (iii) it will handle such material non-public information in accordance with Applicable Law, including federal and state securities
laws. Obligors consent to the publication by Agent or any Lender of advertising material relating to the financing transactions
contemplated by this Agreement using any Obligor’s name, product photographs, logo or trademark. Agent reserves the right to provide
to industry trade organizations information necessary and customary for inclusion in league table measurements.

13.13       
GOVERNING LAW. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS, UNLESS OTHERWISE SPECIFIED, SHALL BE GOVERNED
BY THE LAWS OF THE STATE OF GEORGIA, WITHOUT GIVING EFFECT TO ANY CONFLICT OF LAW PRINCIPLES (BUT GIVING EFFECT TO FEDERAL LAWS
RELATING TO NATIONAL BANKS).

13.14       
Consent to Forum. EACH BORROWER AND EACH OTHER OBLIGOR HEREBY CONSENTS TO THE NON-EXCLUSIVE JURISDICTION OF ANY FEDERAL
OR STATE COURT SITTING IN OR WITH JURISDICTION OVER ATLANTA, GEORGIA, IN ANY PROCEEDING OR DISPUTE RELATING IN ANY WAY TO ANY LOAN
DOCUMENTS, AND AGREES THAT ANY SUCH PROCEEDING SHALL BE BROUGHT BY IT SOLELY IN ANY SUCH COURT. EACH BORROWER AND EACH OTHER OBLIGOR
IRREVOCABLY WAIVES ALL CLAIMS, OBJECTIONS AND DEFENSES THAT IT MAY HAVE REGARDING SUCH COURT’S PERSONAL OR SUBJECT MATTER JURISDICTION,
VENUE OR INCONVENIENT FORUM. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN
SECTION 13.3.1. Nothing herein shall limit the right of Agent or any Lender to bring proceedings against any Obligor in any other
court, nor limit the right of any party to serve process in any other manner permitted by Applicable Law. Nothing in this Agreement
shall be deemed to preclude enforcement by Agent of any judgment or order obtained in any forum or jurisdiction.

    	 	-74-	 

     

    

13.15       
Waivers by OBLIGORS. To the fullest extent permitted by Applicable Law, EACH
Borrower AND EACH OTHER OBLIGOR hereby knowingly, intentionally and intelligently waives (with the benefit of advice of legal counsel
of its own choosing), (a) the right to trial by jury (which Agent and each Lender hereby also waives) in any proceeding or dispute
of any kind relating in any way to any Loan Documents, Obligations or Collateral; (b) presentment, demand, protest, notice of presentment,
default, non-payment, maturity, release, compromise, settlement, extension or renewal of any commercial paper, accounts, documents,
instruments, chattel paper and guaranties at any time held by Agent on which AN OBLIGOR may in any way be liable, and hereby ratifies
anything Agent may do in this regard; (c) notice prior to taking possession or control of any Collateral; (d) any bond or security
that might be required by a court prior to allowing Agent to exercise any rights or remedies; (e) the benefit of all valuation,
appraisement and exemption laws; (f) any claim against Agent or any Lender, on any theory of liability, for special, indirect,
consequential, exemplary or punitive damages (as opposed to direct or actual damages) in any way relating to any enforcement action
or exercise of rights or remedies, of any kind, the Obligations, Loan Documents or transactions relating thereto; (g) notice of
acceptance hereof; and (h) the right to assert any confidential relationship that it may have under applicable law with any accounting
firm and/or service bureau in connection with any information requested by Agent pursuant to or in accordance with this Agreement
(and OBLIGORS AGREE that Agent may contact directly and such accounting firm and/or service bureau in order to obtain any such
information). EACH OBLIGOR acknowledges that the foregoing waivers are a material
inducement to Agent and Lenders entering into this Agreement and that they are relying upon the foregoing in their dealings with
OBLIGORS. EACH OBLIGOR has reviewed the foregoing waivers with its legal counsel and has knowingly and voluntarily waived its jury
trial and other rights following consultation with legal counsel. In the event of litigation, this Agreement may be filed as a
written consent to a trial by the court.

13.16       
Power of Attorney. Each Borrower and each other Obligor hereby irrevocably constitutes and appoints Agent (and
all Persons designated by Agent) as such Borrower or other Obligor’s true and lawful attorney (and agent-in-fact) for the
purposes provided in this Section. Agent, or Agent’s designee, may, without notice and in either its or a Borrower’s name,
but at the cost and expense of Borrowers and the other Obligors: (a) endorse an Obligor’s name on any check, draft or other item
of payment or other proceeds of Collateral (including proceeds of insurance) or any Collections that come into Agent’s possession
or control; and (b) following the occurrence and during the continuance of an Event of Default, (i) notify any Collections Paying
Party of the assignment of Borrowers Advances and/or Customer Collateral, demand and enforce payment of the same by legal proceedings
or otherwise, and generally exercise any rights and remedies with respect to Borrower Advances or Customer Collateral; (ii) settle,
adjust, modify, compromise, discharge or release any Borrower Royalty Receivables or other Collateral or any Customer Collateral,
or any legal proceedings brought to collect Borrower Advances, Borrower Royalty Receivables or other Collateral or Customer Collateral;
(iii) sell or assign any Borrower Royalty Receivables and other Collateral or any Customer Collateral upon such terms, for such
amounts and at such times as Agent deems advisable; (iv) collect, liquidate and receive balances in Deposit Accounts or investment
accounts, and take control, in any manner, of proceeds of Collateral (including Borrower Royalty Receivables) or Customer Collateral;
(v) prepare, file and sign an Obligor’s name to a proof of claim or other document in a bankruptcy of a Collections Paying Party,
or to any notice, assignment or satisfaction of Lien or similar document; (vi) receive, open and dispose of mail addressed to an
Obligor, and notify postal authorities to deliver any such mail to an address designated by Agent; (vii) endorse any Chattel Paper,
Document, Instrument, bill of lading, or other document or agreement relating to any Collateral or any Customer Collateral; (viii)
use an Obligor’s stationery and sign its name to verifications of Accounts or Customer Assets consisting of Accounts and notices
to Collections Paying Parties; (ix) use information contained in any data processing, electronic or information systems relating
to Collateral; (x) make and adjust claims under insurance policies; (xi) take any action as may be necessary or appropriate to
obtain payment under any letter of credit, banker’s acceptance or other instrument for which a Borrower is a beneficiary; and (xii)
take all other actions as Agent deems appropriate to fulfill any Obligor’s obligations under the Loan Documents. To the extent
of any direct conflict between the provisions of this Section 13.16 and the provisions of the Borrower Assignment Agreement,
the provisions of the Borrower Assignment Agreement shall govern and control.

    	 	-75-	 

     

    

13.17       
PATRIOT Act Notice. Agent and Lenders hereby notify Borrowers and the other Obligors that pursuant to the requirements
of the PATRIOT Act, Agent and Lenders are required to obtain, verify and record information that identifies each Obligor, including
its legal name, address, tax ID number and other information that will allow Agent and Lenders to identify it in accordance with
the PATRIOT Act. Agent and Lenders will also require information regarding each personal guarantor, if any, and may require information
regarding Obligors’ management and owners, such as legal name, address, social security number and date of birth.

[Remainder of page intentionally left
blank; signatures begin on following page]

    	 	-76-	 

     

    

IN WITNESS WHEREOF,
this Agreement has been executed under seal and delivered as of the date set forth above.

	
        ATTEST:

         

         

         

         

        /s/ David Earhart

        David Earhart, Secretary

         

        [SEAL]
	
        BORROWERS:

         

        SWK HOLDINGS CORPORATION

         

         

        By: /s/ Winston Black

        Name: Winston Black, III

        Title:   Chief Executive Officer

         

	 	 
	
        ATTEST:

         

         

         

        /s/ David Earhart

        David Earhart, Secretary of SWK Holdings Corporation, the
        sole manager of SWK

        Funding LLC

         

        [SEAL]
	
        SWK FUNDING LLC

         

        By:  SWK HOLDINGS CORPORATION,

         its sole manager

         

         

        By: /s/ Winston Black

        Name:  Winston Black, III

        Title:    Chief
        Executive Officer

         

	 	
         

         

	 	
        Address (for each Borrower):

        14755 Preston Road, Ste.
        105

        Dallas, Texas 75254

        Attn: Chief Executive
        Officer

         

 

    	 

     

    

 

	 	
        AGENT AND LENDERS:

         

        STATE BANK AND TRUST COMPANY,

        as Agent and a Lender

         

         

        By: /s/ B. Earl Garris

        Name: B. Earl Garris

        Title:    Vice President

        Address:

        State Bank and Trust Company

        3399 Peachtree Road, N.E.,
        Suite 1900

        Atlanta, GA 30326

        Attn: SWK Loan
        Administration Officer / Susan Hall

         

	 	
        with courtesy copies to (which shall
        not be deemed notice):

        Parker, Hudson, Rainer & Dobbs LLP

        303 Peachtree Street N.E.

        Suite 3600

        Atlanta, Georgia 30308

        Attention: Bobbi Acord NolandExhibit 10.1

 

LICENSE
AGREEMENT

 

THIS
LICENSE AGREEMENT (“Agreement”) is made and entered into as of this 26th day of June, 2018 (the “Effective
Date”), by and between Level Brands, Inc., a North Carolina corporation, its subsidiary Level H & W, LLC a North Carolina
limited liability company, together (“Licensor”), and Boston Therapeutics, Inc., a Delaware corporation (“Licensee”).
Licensor and Licensee sometimes collectively referred to herein as “Parties” or, individually, as “Party.”

 

RECITAL

 

Licensor
has the exclusive rights to sublicense the kathy ireland Health & Wellness TM trademark (“Licensed Marks”) and
Licensor desires to grant the Licensee the right and license to use the Licensed Marks in the marketing, developing, manufacturing,
selling and distributing of therapies, therapeutics, supplements and diagnostics . It is understood that Licensor will be non-exclusive
to Licensee and that Licensor owns all kathy ireland Health & Wellness TM related intellectual property. Licensee owns its
intellectual property. Neither party will interfere or dispute the ownership of each other’s respective intellectual property.
Licensee is an importer, manufacturer, distributor and/or seller of its products and desires to use the Licensed Marks.

 

AGREEMENT

 

In
consideration of the mutual promises herein contained, it is hereby agreed:

 

	1.
     	GRANT
    OF LICENSE

 

License
Grant . Upon the terms and conditions set forth herein, Licensor hereby grants to Licensee the non-transferable right, license,
and privilege, of using the Licensed Marks solely for the sale, marketing and distribution of Sugardown and those products of
Licensee which are approved in writing by Licensor and the Licensee (“Licensed Products”), through the channels of
distribution in the Territory (as defined below) during the Term, and the non-exclusive, non-transferable right, license, and
privilege of using the Licensed Marks solely upon and in connection with the manufacture of Licensed Products in the Territory
.. All proposed channels of distribution and distribution outlets must be submitted in advance to Licensor and shall be subject
to Licensor’s prior written approval. Licensor agrees to assist Licensee in establishing agreed upon distribution and sales
sub-contractors subject to section 1.4. The Licensor agrees that the Licensee may continue to sell the Licensed Products without
the Licensed Marks within the Territory.

 

Term
. The term of this Agreement shall commence on the Effective Date as set forth above and end on the seventh anniversary of
the date hereof, plus any extensions or renewals (the “Term”); provided, that after such seventh anniversary or any
extension or renewal, the Term shall be automatically extended for an additional two year periods unless terminated by either
Party by providing notice to the Licensee not less than ninety (90) days prior to the expiration of any such term, extension or
renewal.  

 

Territory. The territory shall be all domestic and international jurisdictions in which Licensee is in compliance with all applicable
jurisdictional laws (“Territory”).

 

No
Sub-License . Licensee shall not assign or sub-license the use of the Licensed Marks to any third party without prior written
approval by Licensor, and such right is expressly withheld from this Agreement. In the event Licensor approves a sub-license to
a third party, the Parties shall mutually agree upon the terms and conditions of said sub-license, including without limitation
the royalty rate, in a separate writing signed by the Parties, including but not limited to a sublicense with a sales and distribution
contractor.

 

Competing
Brands . Licensee will not be permitted to enter into any other branded relationship without the express prior written approval
of Licensor. Licensor will not be permitted to enter into any other branded relationship without the express prior written approval
of Licensee for products having the following attributes: (a) food supplements for regulation of post-prandial blood sugar, and
(b) non-systemic chewable tablets for prevention or delay of diabetes (the “Licensee Business”).

 

Licensee
Obligations . During the Term, the Licensee agrees to (a) comply with the Code of Conduct attached hereto as Exhibit A
and incorporated herein by reference, and (b) fully adopt, as well as meaningfully contribute to, the following Millennium
Development Goal(s) (all of which are attached hereto as Exhibit C and incorporated herein by reference) (“Licensee
Millennium Development Goal(s)”). Licensee agrees to become a member and utilize Dependable Solutions, a product approval
and royalty reports service, and ireland pay, a credit card process service or any similar web platform as may be utilized by
Licensor from time to time as a means of conducting brand business and coordinating with Licensor and other licensees. Licensee
agrees to become a member of Send Out Cards within 30 days of the execution of this Agreement. Licensee will use Send Out Cards
as a powerful marketing tool to help communicate our partnership and promote sales.  

 

    	 -1-

     

    

 

Boston
Therapeutics

 

	2.
     	LICENSING,
    ROYALTY AND OTHER FEES

 

Marketing
Fee . Licensee shall pay Licensor the following marketing related fees: (a) Eight Hundred and Fifty Thousand Dollars (US$850,000)
for the Video Content and Electronic Press Kit services set forth on Exhibit D (the “Services”) in the form
of (a) a Promissory Note for Four Hundred and Fifty Thousand Dollars (USD $450,000) in the form attached hereto as Exhibit
E , and (b) a number of shares of Licensee common stock (the “Shares”) that would equal Four Hundred Thousand
Dollars (US$400,000), using the closing trading price on the prior day to the Effective Date. Licensee shall grant Licensor unlimited
piggy-back registration rights on all of the Shares issued hereunder for a period of six months from the Effective Date.

 

Royalty
. Commencing on the Effective Date, Licensee shall pay the Licensor royalties in U.S. Dollars, an amount equal to (a) Licensed
Mark Royalty Rate (as defined below) of 100% the Gross Licensed Marks Sales (as defined below), and (b) one percent of Revenues
(as defined below) (amounts under (a) and (b) above, collectively, the “Royalty”); The term “Licensed Mark Royalty
Rate” shall mean five percent (5%) of the first Ten Million Dollars (US$10,000,000) in Gross Licensed Marks Sales, seven
and one half percent (7.5%) of the Gross Licensed Marks Sales between Ten Million Dollars (US$10,000,000) and Fifty Million Dollars
(US$50,000,000) and ten percent (10%) on any Gross Licensed Marks Sales in excess of Fifty Million Dollars (US$50,000,000); the
term “Revenues” shall mean the gross amount billed for worldwide product sales of all products of Licensee at the
time the Agreement is executed (exclusive of any refunds, return allowances, sales, use or value added tax (VAT)), minus any Gross
Licensed Marks Sales; and the term “Gross Licensed Marks Sales” shall mean the gross amount billed for all Licensed
Products sold under the Licensed Marks (exclusive of any refunds, return allowances, sales, use or value added tax (VAT)). No
other costs incurred in the manufacturing, selling, advertising, and/or distribution shall be deducted from Revenues or Gross
Licensed Marks Sales, and both shall be determined in accordance with generally accepted accounting principles established and
maintained by the U.S. Financial Accounting Standards Board.

 

Licensor
Promotional Obligations . For quarterly performance of the Licensor Promotional Obligations services as set forth in Exhibit
D , Licensee will pay Licensor within fifteen (15) days of the end of each calendar quarter during period commencing on July
1, 2018 and ending June 30, 2020, as follows: (a) issue a number of Shares (using the closing trading price of the Shares on the
last day of such calendar quarter) equal to the Sales Target (as defined below), multiplied by 11,250,000 (450,000 x 25) which
in no event will be greater than $100,000 per quarter, and (b) payment in cash of the Sales Target multiplied by $450,000 which
in no event will be greater than 100,000 shares of common stock per quarter. Licensee, in its sole discretion, may pay such fee
set forth under Section 2.3(a) in cash in lieu of Shares. For purposes hereof, “Sales Target” shall mean the Gross
Licensed Marks Sales for such applicable quarter divided by US$2,500,000. For illustration purposes, if the Gross Licensed Marks
Sales for a given quarter is US$1,000,000, and the closing price on the last day of such quarter is $.05 per share, then the number
of Shares to be so issued under (a) above shall be 4,500,000 ($1,000,000 / $2,500,000 x 11,250,000), and the cash payment under
(b) above shall be $180,000 ($1,000,000 / $2,500,000 x $450,000), which shall be limited as set forth above.

 

Royalty
Payments . Within fifteen (15) days after the end of each month, Licensee shall furnish to Licensor a complete sales and royalty
report certified to be accurate by the Chief Financial Officer of Licensee or by some other authorized designee of Licensee showing
the number, description, and Gross Sales Price of the Licensed Products distributed and/or sold by Licensee during the preceding
month, as well as the number of Licensed Products in inventory at the beginning and end of the month along with payment of the
royalties due which shall be sent by wire transfer to the following account:

 

Domestic
Wire / Routing #: 121000248

Account
Name: Level Brands, Inc.

Account
#: 5842344581

Bank
Name: Wells Fargo Bank

 

Royalty
Report; Late Fees . For this purpose, Licensee shall use a sales and royalty report form acceptable to Licensee. Such report
shall be furnished to Licensor whether or not any of the Licensed Products have been sold during the preceding month, and shall
specifically include what contributions have been made during such period to the Licensee Millennium Development Goal(s), the
form of such contribution and, with respect to financial contributions, the basis upon which it was determined. Licensee shall
tender the report of the sales and royalty report in Excel spreadsheet format to Licensor, separated by each Licensed Product
and sent to Level Brands, Inc., 4521 Sharon Rd., Ste. 450, Charlotte, NC 28211, with a copy to: mark@levelbrands.com. Any amounts
not paid to Licensor when due under this Agreement shall bear a late payment charge on the unpaid balance at the rate of 1.5%
per month, compounded, or the maximum amount permitted by law, whichever is less.

  

    	 -2-

     

    

 

Boston
Therapeutics

 

Subcontracting
and Delegation . Licensor may subcontract, delegate or assign any its rights or subcontract or delegate any of its duties
or obligations hereunder to any entity with which it is affiliated, related or shares common ownership (a “Delegated Entity”),
and Licensee agrees to allocate or pay any compensation owed or accrued to Licensor under Section 2 to any Delegated Entity as
directed by Licensor. No such subcontract, delegation or assignment to any Delegated Entity shall relieve Licensor of responsibility
for the due and full performance hereof. Licensor shall be liable to Licensee for all acts and omissions of any Delegated Entity
in performing any duties hereunder.

 

Expense
Reimbursement . During the Term of this Agreement, the Licensor may also be retained to provide, on a non-exclusive basis,
strategic brand marketing advisory services to the Licensee to be mutually agreed to from time to time.   The Licensor shall
be reimbursed for all out of pocket costs and expenses incurred by it in the performance of the strategic brand marketing advisory
services that are mutually agreed upon, subject to Licensees prior written approval which will not be unreasonably withheld, to
the Licensee hereunder up to Two Hundred and Fifty Thousand Dollars (US$250,000), at a cost-plus twenty percent (20%) basis.

 

	3.
     	ACCOUNTING

 

Licensee
agrees to keep accurate books of account and records covering all transactions relating to the license hereby granted, and Licensor
and its duly authorized representatives shall have the right two (2) times per year after giving reasonable notice at all reasonable
hours of the day to an examination of said books of account and records relating to Licensee’s performance under the Agreement,
and shall have free and full access thereto for said purposes and for the purpose of making extracts therefrom. Upon request of
Licensor, which shall not be more than once per year, Licensee shall furnish to Licensor a detailed statement by an independent
certified public accountant showing the number, description, and Gross Sales of the Licensed Products covered by this Agreement
distributed and/or sold by Licensee to the date of Licensor’s demand. Each calendar year in which this Agreement is in effect,
and after expiration or termination of this Agreement, no more than once per year, Licensor shall be entitled to an independent
audit of and be given access to Licensee’s account books, records, invoices and other pertinent data by Licensor or its
designated representative during normal business hours. The cost of the audit shall be borne by Licensor unless the audit reveals
that Licensee understated sales and or royalties of Licensed Products by more than five percent (5%), in which case Licensee shall
be required to pay all Licensor’s costs of the audit.

 

	4.
     	QUALITY
    ASSURANCE

 

Quality
of Licensed Products . The quality of the Licensed Products shall be consistent with or exceed the average of similar products
manufactured, distributed, and/or sold by Licensee, shall serve to enhance Brand recognition of the Licensed Products to the mutual
benefit of the Parties, and shall be suitable for the use for which they are intended. Licensee agrees to provide a reasonable
number of samples of the Licensed Product to Licensor at no cost upon request for quality assurance, and provide Licensed Products
to Licensor at cost for promotional purposes (not for resale).

 

Licensor
Approval . All Licensed Products developed, manufactured and sold hereunder, and all labels, hang tags, packaging, catalogs,
brochures, publications, printed matter, advertising, signs, promotional displays, websites, webpages, video and sound recordings,
online social media pages and other forms of publicity material for the Licensed Products, shall be in English and subject to
Licensor’s written approval in advance of use, distribution, marketing or sale.

 

Licensee
Approval. The Licensor will perform the Services in compliance with all applicable laws. Licensor will not make or provide
any representations, warranties or statements about the Licensee or its products which are not based on the marketing and background
materials provided to the Licensor by the Licensee; provided, that it is understood and agreed that Licensor may discuss the Licensee
and its products in TV interviews and through other immediate social media in a generally positive manner. All written materials
are subject to Licensee’s written approval in advance of use, distribution, marketing or sale.

 

	5.
     	DISPLAY;
    LABELING; PROMOTIONAL MATERIAL

 

IP
Notices. Licensee agrees that it will cause to appear on each Licensed Product manufactured, sold, and/or distributed under
this Agreement and on or within all advertising, marketing, promotional, or display material bearing the Licensed Marks, the appropriate
trademark and copyright notices, markings or designations requested by Licensor. In the event any Licensed Product is distributed
and/or sold in a carton, container, packing or wrapping material bearing the Licensed Marks, such notices shall also appear upon
the said carton, container, packing or wrapping material. Licensee agrees to remove any product for sale, regardless of location,
which so fails to include the proper notices under this Section 5.1 and such failure shall be deemed a material breach hereof.

  

    	 -3-

     

    

 

Boston
Therapeutics

 

Promotions
. No advertising, marketing, promotional, and display materials, or other artwork depicting the Licensed Marks or Licensed
Product shall be used without prior written approval by Licensor. Licensee agrees that it will only run full page advertisements
in trade publications to ensure retail recognition for the Brand. Licensee will use its best efforts to convey to the market that
it is a licensee of the Brand, including but not limited to placing signage depicting the Brand prominently at Licensee's corporate
offices and showrooms, and on Licensee's corporate stationery, point of sale, marketing and other materials. The Parties further
agree that all artwork and designs involving the Licensed Marks shall be produced under appropriate “work for hire”
provisions, or are hereby assigned to and shall remain the property of Licensor, notwithstanding their creation by Licensee or
others, and any such parties creating such materials will execute the necessary valid agreements to convey the ownership and copyrights
to these items to Licensor.

 

	6.
     	PHOTOGRAPHY

 

All
photo shoots, photography, designs and media will be directed by Licensor’s Global Creative Director, Jon Carrasco. The
photographs resulting from any photo session(s) shall be contracted for under “work for hire” provisions and all rights,
including without limitation copyright, to the photos, negatives, and any other tangible materials bearing Ms. Ireland’s
image or relating to said photo session(s), shall be the property of Licensor and are hereby assigned to Licensor. Guild/Union
Requirements (SAG-AFTRA) – Kathy Ireland is a union member and Licensee will make payments accordingly for any audio or
visual recordings. With respect to any expenses associated therewith, to the extent not included in the Services or in Section
2.7, such expenses shall subject to prior written prior approval of Licensee.

 

	7.
     	LICENSOR’S
    RIGHTS AND PROTECTIONS

 

Proprietary
to Licensor . Licensor has the exclusive rights to sublicense the licensed marks. Licensee agrees that during the term of
this Agreement, or thereafter, it will not register or attempt to register any of the Licensed Marks, nor will Licensee form or
incorporate any entity under a name that includes the Licensed Marks. Licensee will not attack the title or any rights of Licensor
in and to the Licensed Marks. Licensee further agrees to cooperate fully and in good faith with Licensor for the purpose of securing
and preserving Licensor’s rights in and to the Licensed Marks. Licensee acknowledges that Licensor has sole and exclusive
ownership of all right, title, and interest in and to the Licensed Marks and any registrations that have been issued or may be
issued thereon. Nothing contained in this Agreement shall give Licensee any right, title or interest in or to the Licensed Marks
except for the rights expressly licensed by this Agreement, and subject to its terms and conditions. Adaptations and modifications
of Licensed Marks prepared under this Agreement shall be included as part of the Licensed Marks, including, without limitation,
Licensor’s ownership thereof.

 

7.2
  Pre-Existing Intellectual Property . Each Party shall continue to own all rights, title and interest (including,
without limitation, all copyrights, trade secrets, patents, trademarks, and any other intellectual property or proprietary rights)
relating to its business that existed prior to the Effective Date (“Pre-Existing IP”). No right, title, or interest
in or to any of Pre-Existing IP of a Party is transferred or assigned to the other Party. Except for the limited license granted
in Section 1, neither Party grants to the other Party any licenses, by implication or otherwise, to any of its Pre-Existing IP.

 

7.3
  Not an Exclusive License . Nothing in this Agreement shall be construed to prevent Licensor from granting any
other license for the use of the Licensed Marks or from utilizing the Licensed Marks in any manner whatsoever ; provided, however,
that Licensor shall not license or independently utilize the Licensed Marks in connection with any business that is similar to
the Licensee Business during the Term of this Agreement. . Licensee agrees that rights not specifically granted to Licensee are
reserved by Licensor and may be freely exploited by Licensor without limitation.

 

7.4
  Registrations . All registrations for intellectual property, Internet domain names and social media user/screen
names in the Licensed Marks are to be applied for and obtained exclusively in Licensor’s name. Licensee shall not file or
register any intellectual property applications or seek any Internet domain name and/or social media user/screen name registration
in the Licensed Marks, Licensed Products or any derivations, improvements, variations or modification thereof, without Licensor’s
prior written approval. Licensee shall notify Licensor, or its designated representative, prior to entering into any agreement
with any individual, company or business, for sales outside the United States of any Licensed Product, to permit the timely filing
of foreign and/or international trademark and copyright applications, or other intellectual property protection, covering the
Licensed Marks, in Licensor’s sole discretion. Licensee agrees to cooperate fully and in good faith with Licensor for the
purpose of securing and preserving Licensor’s rights in and to the Licensed Marks. In the event there has not been a previous
registration of any Licensed Mark and/or any material relating thereto for a particular Licensed Product, Licensor may register
and maintain, at Licensee’s expense if for a Licensed Product, trademarks and/or service marks in the appropriate class(es)
and/or copyrights in the name of Licensor. Licensee is not permitted to register any copyright, trademark, and/or service mark
on behalf of Licensor. It is further agreed that nothing contained in this Agreement, and no act or omission by Licensor and/or
by Licensee shall be construed as an assignment or grant to Licensee of any right, title, or interest in or to the Licensed Marks,
it being understood that all rights relating thereto are reserved by Licensor, except for the license hereunder to Licensee of
the right to use and utilize the Licensed Marks only as specifically and expressly provided in this Agreement.

 

    	 -4-

     

    

 

Boston
Therapeutics

 

	8.
     	INDEMNIFICATION
    AND REPRESENTATIONS

 

Licensor
Indemnification . Licensor shall defend, indemnify, and hold Licensee and its affiliates, and their officers, directors, employees,
managers, owners, agents and representatives harmless against any claims or suits, demands, losses, injuries, liabilities costs,
judgments, arbitration awards, license fees, settlement, damages and expenses (including reasonable attorneys’ fees and
costs, whether or not any legal proceeding is commenced) (“Losses”) for trademark infringement arising solely out
of the validity of the rights to the Licensed Marks and from Licensee’s use of the Licensed Marks as granted herein, provided
that prompt written notice is given to Licensor within ten (10) days of any such claim or suit, and provided, further, that Licensor
shall have the option to undertake and conduct the defense of any suit so brought, and no settlement of any such claim or suit
is made without the prior written consent of Licensor. Licensor’s indemnification under this Section 8.1 shall be apportioned
and limited to only the portion of, and extent that, such Losses are, or are claimed to be, proximately caused by or attributable
specifically to Licensee’s use of Licensed Marks in a manner permitted by this Agreement. It is further agreed that Licensor
reserves the right, in its sole discretion, to select counsel to defend any such claims. For purposes of this Section 8, the term
“Licensor” shall mean Licensor and, without limitation, any of its agents, employees, servants, representatives, parents,
subsidiaries, affiliates, officials, directors, officers, shareholders, owners, attorneys, divisions, branches, units, affiliated
organizations, successors, predecessors, contractors, assigns, and all persons acting on their behalf, past or present.

 

Licensee
Indemnification . Licensee shall defend, indemnify, and hold Licensor and its affiliates, and their officers, directors, employees,
managers, owners, agents and representatives harmless against any and all actions, claims, demands, lawsuits, loss, costs, damages,
judgments, liabilities, license fees, settlement or expenses incurred, claimed, obtained, or sustained, including without limitation
attorneys’ fees and costs, of any nature whatsoever, whether in law or in equity, including without limitation claims relating
to or allegedly relating to the design, manufacture, sale, purchase, use, advertising, marketing, and/or distribution of any Licensed
Product, whether for personal injury, product liability, intellectual property infringement, dilution, misappropriation or otherwise.
Licensor reserves the right to select counsel to defend and/or bring any such claims, and Licensee shall solely be responsible
for any and all attorneys’ fees, costs, and expenses relating to any and all such actions. Licensee shall provide Licensor
with prompt written notice of any lawsuits or threatened lawsuits, or other significant developments, investigations, claims,
or final refusals in which Licensee is or may be named as a party or for which Licensee is obligated or has agreed to indemnify
any party, and Licensee shall thereafter provide Licensor with periodic written updates concerning relevant developments in any
such lawsuits as they arise.

 

Licensed
Products . Licensor makes no representations or warranties with respect to the design, manufacture, sale, purchase, use, marketing,
and/or distribution of any Licensed Product manufactured, sold, and/or distributed by Licensee and disclaims any liability arising
out of the design, manufacture, sale, purchase, use, marketing, and/or distribution of any Licensed Product, and any such express
or implied warranties are hereby disclaimed and Section 8.2 shall apply.

 

Licensee
Representations and Warranties . Licensee represents and warrants to Licensor that: (i) Licensee has the full power and authority
to enter into this Agreement on behalf of Licensee and to perform all Licensee’s material obligations pursuant to this Agreement,
and that the Licensed Products manufactured, sold, and/or distributed by Licensee under this Agreement shall be suitable for the
purpose for which they are intended to be used and shall comply with all applicable Federal, State, and local laws, and industry
standards , (ii) Licensee will not harm or misuse the Licensed Property or bring the Licensed Marks into disrepute, (iii)
except as specifically provided in this Agreement, Licensee will not create any expenses chargeable to Licensor or Ms. Ireland
without the express prior written approval of Licensor, (iv) all Licensed Products (and the content contained or used in the Licensed
Products) designed, developed, marketed, distributed, published, performed or sold by Licensee pursuant to this Agreement do not,
and will not, infringe any intellectual property right or any personal right of any third party, and (v) Licensee will not knowingly
permit, do or commit any act or thing that would degrade, tarnish or deprecate or disparage the Licensed Property or Licensor’s
or Ms. Ireland’s public image in society or standing in the community, or prejudice Licensor or Ms. Ireland and that it
will terminate such activities promptly upon written notice, and failure to do so constitutes a material breach of this Agreement.
Licensee acknowledges and agrees that there are no warranties, guarantees, conditions, covenants, or representations by Licensor
as to marketability, fitness for a particular purpose, or other attributes of the Licensed Products, whether express or implied
(in law or in fact), oral or written.

 

Definition
of “Licensor” . For purposes of this Section 8, the term “Licensor” shall mean Licensor and, without
limitation, any of its agents, employees, servants, representatives, parents, subsidiaries, affiliates, officials, directors,
officers, shareholders, attorneys, divisions, branches, units, affiliated organizations, successors, predecessors, contractors,
assigns, and all persons acting by, through, under, or in concert with them, past or present, specifically including Ms. Ireland,
kathy ireland Worldwide, any Delegated Entity, kathy ireland LLC, Sterling/Winters Company, ACDC, LLC, Jardin du Jour, LLC, Moretz
Marketing, LLC their executives and employees.

  

    	 -5-

     

    

 

Boston
Therapeutics

 

	9.
     	INSURANCE

 

Licensee
represents that it has obtained, and agrees to maintain, at its own expense, in full force and effect at all times during which
the Licensed Products are being manufactured, sold, and distributed, insurance for bodily injury, advertising injury, property
damage, and product liability from a recognized insurance company approved by Licensor, which is qualified to do business in the
State of California, providing protection at least in the amount of $5,000,000 per occurrence and $5,000,000 in the aggregate
for Licensor and for Licensee against any actions, claims, demands, lawsuits, loss, costs, attorneys’ fees, damages, judgments,
and liabilities of any nature whatsoever relating to the Licensed Products. As proof of such insurance, a fully paid certificate
of insurance naming Licensor as Licensee shall submit an insured party to Licensor for Licensor’s prior written approval
before any Licensed Product is manufactured, sold, or distributed. Any proposed change in certificates of insurance shall be submitted
to Licensor for its prior written approval. Licensor shall be entitled to a copy of the prevailing certificate of insurance, which
shall be furnished to Licensor by Licensee. The certificate(s) shall conform to the language requirements set out in Exhibit
B attached hereto.

 

	10.
     	INSOLVENCY

 

If
Licensee files a petition in bankruptcy or is adjudicated a bankrupt or if a petition in bankruptcy is filed against Licensee,
or if it becomes dissolved, or becomes insolvent or unable to pay or discharge its liabilities in the ordinary course of business,
or if Licensee assigns the whole or any substantial part of its assets or undertakings for the benefit of creditors or makes an
assignment for the benefit of its creditors or any similar arrangement pursuant to any federal or state law, compulsory or voluntarily,
or if a receiver or other similar officer is appointed for the whole or any part of the assets or undertakings of Licensee or
its business, or if Licensee stops payment to its creditors generally, or ceases or threatens to cease to carry on its business
or any substantial part thereof, or if Licensee merges or consolidates with or into any other corporation, or directly or indirectly
sells or otherwise transfers, sells, or disposes of all or a substantial portion of its business or assets, or if a third party
who does not own stock acquires a majority of the voting stock of Licensee, Licensor may terminate this Agreement by giving notice
to Licensee of its intention to terminate and such termination shall be effective immediately. In the event this Agreement is
so terminated, Licensee, its receivers, representatives, trustees, agents, administrators, successors, and/or assigns shall have
no right to sell, exploit, or in any way deal with or in any Licensed Products covered by this Agreement or any related advertising,
marketing, promotional, and display materials, including without limitation cartons, containers, packing, and wrapping materials,
except with and under the special consent and instructions of Licensor in writing, which they shall be obligated to follow. In
the event this Agreement is so terminated under this Section 10, Licensee, its receivers, representatives, trustees, agents, administrators,
successors, and/or assigns shall have no right to sell, exploit, or in any way deal with or in any Licensed Products covered by
this Agreement or any related advertising, marketing, promotional, and display materials, including without limitation cartons,
containers, packing, and wrapping materials, except with and under the special consent and instructions of Licensor in writing,
which they shall be obligated to follow.

 

	11.
     	TERMINATION

 

Material
Breach . Except as otherwise provided herein, in the event either party materially breaches this Agreement, the non-breaching
party shall have the right to terminate this Agreement upon thirty (30) days’ notice in writing, and such notice of termination
shall become effective unless the breaching party shall remedy the breach within the thirty (30) day period to the reasonable
satisfaction of the non-breaching party. Failure to pay any amounts owed hereunder shall be deemed a material breach hereof.

 

Effect
of Termination . Termination of this Agreement shall be without prejudice to any rights, which Licensor may otherwise have
against Licensee and all amounts owed hereunder including the prorated earned Marketing Fee’s, as of the termination hereof,
shall become immediately due and payable, and all rights and licenses granted hereunder shall cease and revert to Licensor. Upon
termination, Licensee shall immediately cease and desist from using the Licensed Marks in any way and return any confidential
information to Licensor.

 

Force
Majeure . The Parties shall be released from their obligations hereunder, and this Agreement shall terminate in the event
governmental regulations or state or national emergency or war or causes beyond the control of the Parties render performance
impossible, and one Party so informs the other in writing of such causes and its desire to be so released. In such event, all
royalties on sales and all other monies due, theretofore made shall become immediately due and payable to Licensor.

  

    	 -6-

     

    

 

Boston
Therapeutics

 

Change
of Control . In the event Licensee or any of its subsidiaries incurs or enters into any agreement pursuant to which a Change
of Control (as defined below) would occur, Licensee shall provide Licensor notice of such Change of Control. Following such notice,
at the option of Licensor and upon written notice to Licensee provided within 30 days following Licensee’s provision of
notice of the Change of Control to Licensor (the “Change of Control Termination Notice”), this Agreement, together
with the Royalty paid to Licensor under Section 2 shall immediately terminate and Licensor shall be paid, in lieu thereof, a one-time,
lump sum aggregate payment equal to the cumulative Royalties paid to Licensor over the previous trailing 12-month period. The
lump sum payment shall be paid to Licensor within 30 days of the occurrence of the Change of Control. For purposes hereof, “Change
of Control” means (a) any consolidation or merger of such entity in which the entity is not the continuing or surviving
entity, or pursuant to which the shares are converted to cash, other securities or other property, other than a consolidation
or merger of the entity in which the holders of the entities shares immediately prior to the consolidation or merger hold more
than 50% of the voting securities of the continuing or surviving entity immediately after the consolidation or merger, or (b)
any sale, lease, exchange or other transfer (in one transaction or in a series of transactions and not in the ordinary course
of business) of all or substantially all of the entities assets, (c) a sale of fifty percent (50%) or more of the then outstanding
voting securities of the entity to one party, or (d) any other event, pursuant to which the members of the Board of Directors
(or similar governing body) who were elected prior to the occurrence no longer constitute a majority of the members of such governing
body. Notwithstanding the above, any conveyance, transfer or grant of security title to or a security interest in any goods, accounts,
inventory, general intangibles or other assets of such entity to secure the obligations of the entity or any of its subsidiaries,
or the exercise of any rights or remedies by such entity after a default of indebtedness, shall not constitute a “Change
of Control” as used herein.

 

	12.
     	NOTICES

 

Any
notice, communication, statement, payment, or legal service of process required or permitted under this Agreement shall be in
writing and shall be effective when hand delivered; or on the date when the notice, communication, statement, payment, or legal
service of process is transmitted by confirmed electronic facsimile (with a confirmation copy sent by mail); or the day after
the notice, communication, statement, payment, or legal service of process is sent by reputable overnight air courier service.
All such communications shall be sent to the Parties at the notice addresses listed below or to such other persons and the Parties
to each other may designate notice addresses as in writing.

 

Licensor:
             Level Brands, Inc.

4521
Sharon Road, Suite 450

Charlotte,
NC 28211

Attention:
Mark Elliott - CFO

Email:
mark@levelbrands.com

 

Copy
to:               Paul Porter 

4521
Sharon Road, Ste. 450

Charlotte,
NC 28211

Email:
paul@levelbrands.com

 

    And

 

Erik
Sterling

PO
Box #1410

Rancho
Mirage, CA 92270

Facsimile:
310 557-1722

Attention:
Erik Sterling

Email:
esterling@sterlingwinters.com

 

If
to Licensee:     Boston Therapeutics, Inc. 

354
Merrimack Street, #4

Lawrence,
MA 01843

Attention:
Carl Rausch, CEO

Email:
Carl.Rausch@bostonti.com

 

Copy
to:               Fleming PLLC 

30
Wall Street, 8 th Floor

New
York, New York 10005

Attention:
Stephen Fleming, Esq.

Email:
smf@flemingpllc.com

 

    	 -7-

     

    

 

Boston
Therapeutics

 

	13.
     	MISCELLANEOUS

 

Independent
Contractor . Licensee is an independent contractor with respect to Licensor. Nothing contained herein shall be deemed to create
an agency, joint venture, franchise, or partnership relation between the Parties, and neither Party shall so hold itself out.

 

Assignability
. This Agreement shall not be assignable by either Party without the prior written consent of the other.

 

Amendment
. Except as otherwise provided herein, no agreement or understanding purporting to add to or to modify the terms and conditions
of this Agreement shall be binding unless agreed to by the Parties in writing. Any terms and conditions set forth in any forms
used by the Parties, which are in conflict with the terms and conditions of this Agreement, shall be void and have no effect.

 

Waiver
. It is agreed that no waiver by either Party hereto or any breach or default of any of the provisions set forth herein shall
be deemed a waiver as to any subsequent and/or similar breach or default.

 

Governing
Law . This Agreement shall be construed in accordance with and the laws of the State of California which shall govern all
disputes relating hereto without giving effect to any conflicts of law provisions. The Parties agree that any and all disputes,
controversies or claims arising out of, regarding, or in any way relating to the interpretation, application, or enforcement of
this Agreement, or any matter reasonably related thereto, shall be handled by way or arbitration and administered by and in accordance
with the JAMS streamlined Arbitration Rules and Regulations (the ''JAMS Rules '') of the Judicial Arbitration and Mediation Service
in effect at the time of any such proceedings. Such arbitration shall be the sole, exclusive, and final remedy for resolving any
such claims and disputes. Judgment on the final award rendered by the arbitrator may be entered into in any court of competent
jurisdiction and shall be final and binding upon the Parties. In the event the Parties cannot agree on an arbitrator within ten
(I0) days, the arbitrator shall be appointed by the Parties in the following manner JAMS, and/or another alternative dispute resolution
provider agreed upon by the Parties, shall furnish the Parties with a list of potential qualified arbitrators. For purposes of
this Section, a ''qualified arbitrator, shall mean a retired judge of a superior or appellate court or an experienced attorney
agreed upon by the Parties. If any Party objects to all the names on the list. AAA and/ or another alternative dispute resolution
provider agreed upon by the Parties shall provide the Parties with an alternative list of potential qualified arbitrators; provided,
however, that each Party shall be entitled to so object only once. Once the Parties have agreed upon a particular list, or a list
is furnished pursuant to the preceding sentence the Parties shall alternately eliminate unacceptable arbitrators until only one
name remains. The remaining person shall be appointed arbitrator. The Parties agree to draw lots to decide which Party shall remove
the first name from the list of arbitrators. Should a Party whose turn it is to eliminate any unacceptable arbitrator fail to
do so within twenty-four (24) business hours of the written request of the other Party, then the choice of the other Party of
an arbitrator then remaining on such list shall be binding on the Parties. All costs of the arbitration, including the cost of
any record or transcript of the arbitration proceedings, all administrative fees, the fee of the arbitrator, and all other fees
and costs shall initially be borne equally by the Parties, provided, however, that the arbitrator shall award the prevailing Party
its reasonable attorneys' fees, expenses and costs, including all costs of arbitration. The arbitrator shall not extend, modify,
or suspend any of the terms of this Agreement. The arbitration and all proceedings related thereto shall be deemed private and
confidential and, subject to the provisions of paragraph 29.1, shall not be disclosed to the public by either the arbitrator or
the Parties to the arbitration. If the rules of AAA, JAMS or another agreed upon alternative dispute resolution provider differ
from those of this Section, the provisions of this Section shall control. Notwithstanding the foregoing, the Parties may seek
provisional relief, including a preliminary injunction or temporary restraining order, in any federal or state court of competent
jurisdiction located in Los Angeles, California, without prejudice to the above described arbitration procedures, if in that Parties
sole judgment such provisional relief is necessary to avoid a irreparable injury or to preserve the status quo. Never the less,
the arbitration procedure set forth in this section is intended to be the sole and exclusive method of resolving any claims arising
out of, relating to, or regarding this agreement.

  

    	 -8-

     

    

 

Boston
Therapeutics

 

Confidentiality
. The Parties agree that the terms, conditions, and subject matter of this Agreement constitute confidential and proprietary
information belonging to Licensor. Licensee agrees not to divulge any confidential and proprietary information pertaining to Licensor
or this Agreement to any third party without prior written consent of Licensor, except as required by law. Licensee agrees to
keep all such information as confidential. Licensee may disclose such confidential and proprietary information to its officers,
directors, employees, agents, and authorized representatives to the extent necessary to enable Licensee to perform its obligations
under this Agreement; provided said officers, directors, employees, agents, and/or authorized representatives execute an appropriate
confidentiality agreement. Licensee shall be liable for any unauthorized use and disclosure of such confidential information by
its officers, directors, employees, agents, and authorized representatives, including without limitation its attorneys and accountants.
The Parties further agree that any breach or threatened breach of this Section 13.6 would cause irreparable harm to Licensor,
that a remedy at law or in damages would be inadequate, and that the provisions of this Section 13.6 may be enforced by way of
injunctive relief in addition to any other rights available to Licensor in law or in equity. For purposes of this Agreement, “confidential”
or “proprietary” information includes, but is not limited to, the terms, conditions, and subject matter of this Agreement,
and Licensor’s business, including any financial, cost, pricing, and royalty information; product development, business,
marketing, promotion, distribution, sales, sales plans, and strategies; information concerning Licensor’s product development
and intellectual property; information concerning manufacturing processes relating to the Licensed Products, or trade secrets.
The foregoing confidentiality obligations shall not apply to information that: (a) was previously known to the recipient
free of any obligation to keep it confidential; (b) was independently developed by recipient; or (c) is or becomes publicly
available by means other than the unauthorized disclosure by recipient. In the event any judicial or regulatory authority requests
or requires disclosure of any Confidential Information of the other party, the receiving party shall promptly notify the disclosing
party of the requested or required disclosure and shall cooperate with the disclosing party in any effort to avoid or limit such
disclosure.

 

Entire
Agreement; Counterparts . This Agreement constitutes the complete understanding between the Parties and supersedes any and
makes void all prior agreements, promises, representations, or inducements, no matter their form, concerning the subject matter
of this Agreement. The Parties desire that this Agreement represent a single and completely integrated contract expressing the
entire agreement of the Parties with respect to the subject matter of this Agreement. This Agreement may be executed in two or
more duplicate bond or facsimile counterparts, each of which shall be considered an original, but all of which together shall
constitute one and the same instrument, and in pleading or proving any provision of the Agreement, it shall not be necessary to
produce more than one such counterpart.

 

Severability
. Whenever possible, each provision of this Agreement shall be interpreted in such a manner to be effective and valid under
applicable law. Should any of the provisions or terms of this Agreement be determined illegal, invalid, or unenforceable by any
court of competent jurisdiction, validity of the remaining parts, terms, or provisions shall not be affected thereby, and said
illegal, invalid, or unenforceable part, term, or provision shall be deemed not to be a part of this Agreement.

 

Headings
. All recitals are incorporated by reference into this Agreement. Caption and Section headings are used for convenience and
reference only, are no part of this Agreement, and shall not be used in interpreting, construing, defining, limiting, extending,
or describing the scope of this Agreement, or any provision hereof, in any way.

 

[signature
page follows]

 

    	 -9-

     

    

 

Boston
Therapeutics

 

IN
WITNESS WHEREOF, the Parties hereto have caused this instrument to be duly executed as of the day and year first above written.

 

	Licensor:	 	 
	 	 	 
	 	Level Brands, Inc.	 
	 	 	 
	 	Martin A. Sumichrast, CEO	 
	 	 	 
	Licensor:	 	 
	 	 	 
	 	Level H & W, LLC.	 
	 	 	 
	 	Mark Elliott, CFO / COO	 
	 	 	 
	Licensee:	 	 
	 	 	 
	 	Boston Therapeutics, Inc.	 
	 	 	 
	 	Carl Rausch, CEO	 

 

    	 -10-

     

    

 

Boston Therapeutics

 

EXHIBIT A

CODE
OF CONDUCT 行为守则

 

	1.	PURPOSE: Licensee is committed to using only manufacturers to strive to conduct business in a highly professional and ethical manner. This document outlines those commitments each facility makes in respect to its compliance with applicable law and tis personal practices and policies.

 

目的:[被许可人]承诺只使用了力争在一个高度专业和道德的方式开展业务的厂家。本文概述了这些各设施使得在尊重其遵守适用的法律和个人的做法和政策的承诺。

	2.	CHILD LABOR: The facility agrees not to use child labor in the manufacturing, or distribution of the Goods. The term “child” refers to a person younger than the local legal minimum age for employment or the age for completing compulsory education; provided, however, in no event shall the Facility use any person below the age of (15) fifteen. The Facility also agrees to comply with all other Laws applicable to employees, regardless of the age of an employee.

 

童工:该中心同意不使用童工在制造,或货物配送。
“童工”是指一个人年龄低于当地法定最低就业年龄或年龄在完成义务教育;
提供的,但是,在任何情况下,基金使用任何人(15)15岁以下。该基金还同意遵守适用于所有员工的其他法律,不论雇员的年龄。

	3.	FORCED LABOR: The Facility agrees to employ only persons whose presence is voluntary. The Facility agrees not to use any forced or involuntary labor, whether prison, bonded, indentured or otherwise.

 

强迫劳动:该基金同意只雇用人员,其存在是自愿的。该基金同意不使用任何强迫或非自愿劳动,无论是监狱,保税,契约或其他方面。

	4.	ABUSE OF LABOR: The Facility agrees to treat each employee with dignity and respect and not to use corporal punishment, threats of violence, or other forms of physical, sexual, psychological or verbal harassment or abuse.

 

滥用劳动:该基金同意把每个员工的尊严和尊重,不使用体罚,暴力威胁或其他形式的身体,性,心理或言语上的骚扰或虐待。

	5.	NON-DISCRIMINATION: The Facility agrees not to discriminate in hiring and employment practices, including salary, benefits, advancement, discipline, termination, or retirement on the basis of race, religion, age, nationality, social or ethnic origin, sexual orientation, gender, political opinion or disability.

 

不歧视:该基金同意不会在雇佣和招聘活动,包括工资,福利,晋升,纪律,终止或退休种族,宗教,年龄,国籍,社会或民族,性取向,性别的基础上歧视,政治观点或残疾。

	6.	ASSOCIATION: The Facility agrees to follow employees to organize and bargain collectively without penalty or interference in accordance with local Laws.

 

关联关系:该基金同意遵守雇员组织和集体谈判不受处罚或干预按照当地的法律。

	7.	WAGES, BENEFITS AND WORKING HOURS: The facility recognizes that wages are essential to meeting employee’s basic needs. The Facility agrees to comply, at a minimum, with all applicable wages and hour Laws, including minimum wage, overtime hours, maximum hours, piece rates and other elements of compensation and shall provide legally mandated benefits.

 

工资,福利和工作时间:该厂认识到,工资是必要的,以满足员工的基本需求。该基金同意遵守,至少,所有适用的工资和工时的法律,包括最低工资,加班,最长工时,计件工资和补偿等内容,并应提供法定福利。

	8.	HEALTH AND SAFETY: The Facility agrees to provide employees with a safe and healthy workplace environment in accordance with all applicable Laws, ensuring at a minimum, reasonable access to potable water and sanitary facilities, fine safety and adequate lighting and ventilation. The Facility also agrees to ensure that the same standards of health and safety are applied to any housing it provides for employees.

 

健康和安全:该基金同意为员工提供一个安全和健康的工作环境符合所有适用法律,确保在最低限度,合理获得饮用水和卫生设施,精美的安全性和足够的照明和通风。该基金也同意,以确保健康和安全的相同标准适用于它提供了雇员的住房

	9.	COMPLIANCE: The Facility agrees to take appropriate steps to ensure that the provisions of the COC are communicated to its employees, including by prominent posting a copy of this COC in the local language on one or more bulletin boards in places readily accessible to employees at all times.

 

合规性:本基金同意采取适当措施,以确保奥委会的规定传达给员工,其中包括由著名张贴在当地语言的一个或多个电子公告板的名额该行为准则的副本容易获得员工的所有次。

 

    -11-

     

    

 

Boston Therapeutics

 

	10.	ENVIRONMENT: Business partners should share our concern for the environment and adhere to their local and national laws regarding the protection and preservation of the environment.

 

环境:业务合作伙伴应该分享我们对环境的关注,并坚持对环境的保护和维护当地和国家法律。

	11.	LEGAL REQUIREMENTS: Business partners should be in compliance with all legal requirements involved in conducting the business.

 

法律要求:业务合作伙伴应符合参与开展业务的所有法律要求。

	12.	Our Business Partners are required to provide full access to their facilities and those of their manufacturers, vendors and subcontractors, and to release records relating to employment practices. We may conduct on-site inspections of facilities to monitor the standards and assure the quality of our products.

 

我们的业务合作伙伴必须提供完全访问他们的设备和那些他们的制造商,供应商和分包商,并发布有关用工行为记录。我们可以进行现场视察设施,以监控标准,确保了产品的质量。

Please report Violations Anonymously
by emailing to: mark@levelbrands.com

 

    -12-

     

    

 

Boston Therapeutics

 

EXHIBIT B

 

REQUIRED INSURANCE CERTIFICATE

 

Under Description of Operations state
the following : 

 

“Certificate Holder Level Brands,
Inc., Level H&W, LLC, IM1 Holdings, LLC, Encore Endeavor 1, LLC, Tommy Meharey , Kathy Ireland, kathy ireland Worldwide, Inc.,
kathy ireland LLC, The Sterling/Winters Company, and their partners, owners, subsidiaries, affiliates, directors, officers,
managers and employees are named additional insured with regards to liability arising out of operations of the named insured.”

 

The Certificate Holder should be listed
as:

 

Level Brands, Inc.

4521 Sharon Road, Ste. 450

Charlotte, NC 28211

 

Send copies of Certificate to:

 

Mitchka Lyonnais

mlyonnais@mmibi.com

Momentous Insurance Brokerage, Inc.

 

Mark Elliott

mark@levelbrands.com

Level Brands, Inc.

 

    -13-

     

    

 

Boston Therapeutics

 

EXHIBIT C

 

MILLENNIUM DEVELOPMENET GOALS

 

1. We must eradicate extreme poverty and hunger! 

 

2. Achieve universal primary education.

 

3. Promote gender equality and empower women.

 

4. Reduce child mortality.

 

5. Improve maternal health.

 

6. Combat HIV/AIDS, Malaria, and other diseases.

 

7. Ensure environmental sustainability.

 

8. Build global partnerships for development.

 

9. Bring opportunities of financial stability and healthcare
to American Veterans and their families.

 

10. Stop Human Trafficking.

 

    -14-

     

    

 

Boston Therapeutics

 

EXHIBIT D

 

LICENSOR OBLIGATIONS

 

	●	Video Content . Licensor will produce and deliver four (4) branded videos that promote the Licensed Products and/or Boston Therapeutics, Inc., generally (the “Video Content”). All Video Content will be produced by EE1 and will be delivered by June 30, 2018.

 

	●	Electronic Press Kit . Licensor will produce an Electronic Press Kit (EPK) to answer media questions about the relationship, and for online posting. Licensor will prepare Frequently Asked Questions (FAQ) for use by Licensee on its website. The EPK will be prepared by EE1 and delivered by June 30, 2018.

 

	●	Production Services . Licensor shall make the Level Brands Media and Marketing teams available to Licensee for use in creating the Video Content, which will be separately compensated by Licensee at commercially reasonable rates (the “Production Services”). All Production Services will be produced by EE1.

 

Licensor Promotional Obligations:

 

	●	Media Releases . Media Release announcing the relationship between the Licensee and Licensor (kathy ireland Health & Wellness, Chef Andre Carthen Sunday Dinner, and I’M1 Tommy Meharey) and other media releases as mutually agreed to with Licensee. All media releases will be prepared by EE1.

 

	●	Social Media Pushes . Ms. Ireland, Chef Andre Carthen, I’M1 Co-Founder, Tommy Meharey, and Licensor Teams shall curate social media posts in social media channels. Such posts may be prepared well in advance, and released at the appropriate time for Licensee. All Social Media Content will be prepared by EE1.

 

All of the above deliverables will be prepared
at agreed upon timelines, and will be appropriate for release at the times of Licensee’s quarterly requests.

 

    -15-

     

    

 

Boston Therapeutics

 

EXHIBIT E

 

PROMISSORY NOTE

 

	$450,000	Charlotte, North Carolina
	 	June __, 2018

 

FOR VALUE RECEIVED
, the undersigned, Boston Therapeutics, Inc., a Delaware Corporation (the “ Maker ”), hereby promise(s) to pay
to the order of Level Brands, Inc., a North Carolina corporation (together with its successors and assigns, the “ Holder
”), the principal sum of Four Hundred and Fifty Thousand Dollars ($450,000), together with interest on all principal amounts
available for advancement hereunder at eight percent (8%) per annum, on the earliest to occur of: (a) December 31, 2019, or (b)
a Qualified Capital Raise (as defined below) (“ Maturity ”). Interest shall be paid in arrears at Maturity and
computed on the basis of a 365-day year.

 

For purposes hereof,
“ Qualified Capital Raise ” shall mean the issuance or sale by Maker of its equity securities in a public or
private offering or one or more financings through loans or issuance of debt securities, in any event, which results in gross proceeds
to the Maker of at least Seven Hundred Fifty Thousand Dollars (US$750,000).

 

The Maker reserves
the right to prepay all or any portion of this Promissory Note at any time and from time to time without premium or penalty of
any kind. All payments made hereunder shall be made in lawful currency of the Unites States of America to the Holder at its business
address, or at such other place as the Holder may designate in writing. All payments made hereunder, whether a scheduled payment,
prepayment, or payments as a result of acceleration, shall be allocated first to accrued but unpaid interest, and then to payments
of principal remaining outstanding hereunder.

 

Each person liable
hereon agrees to pay all reasonable costs of collection, including attorneys’ fees, paid or incurred by the Holder in enforcing
this Promissory Note on default or the rights and remedies herein provided.

 

The Maker, for itself
and for any guarantors, sureties, endorsers and/or any other person or persons now or hereafter liable hereon, if any, hereby waives
demand of payment, presentment for payment, protest, notice of nonpayment or dishonor and any and all other notices and demands
whatsoever, and any and all delays or lack of diligence in the collection hereof, and expressly consents and agrees to any and
all extensions or postponements of the time of payment hereof from time to time at or after maturity and any other indulgence and
waives all notice thereof.

 

No delay or failure
by the Holder in exercising any right, power, privilege or remedy hereunder shall affect such right, power, privilege or remedy
or be deemed to be a waiver of the same or any part thereof; nor shall any single or partial exercise thereof or any failure to
exercise the same in any instance preclude any further or future exercise thereof, or exercise of any other right, power, privilege
or remedy, and the rights and privileges provided for hereunder are cumulative and not exclusive. The delay or failure to exercise
any right hereunder shall not waive such right.

 

    -16-

     

    

 

Boston Therapeutics

 

The Holder may sell,
assign, pledge or otherwise transfer all or any portion of its interest in this Promissory Note at any time or from time to time
without prior notice to or consent of and without releasing any party liable or to become liable hereon.

 

This Promissory Note
shall be governed by and construed and enforced in accordance with the laws of the State of North Carolina.

 

IN WITNESS WHEREOF
, the undersigned has duly caused this Promissory Note to be executed and delivered as of the date first written above.

 

	By:	 	 
	 	 	 
	By:	 	 
	Carl Rausch, CEO	 
	 	 	 

 

    -17-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}]]